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NGS next generation sequencing  
NHEJ non-homologous end joining 
NHS N-hydroxysuccinimide 
NHS-LC N-hydroxysuccinimide-long chain 
nm nanometer  
N-phosphorylation phosphorylation at nitrogen of HLR 
N-terminal amino-terminal 
Nα amino-terminal primary amine group 
o.n. over night  
OD405 optical density at 405 nm 
O-GlcNAc N-acetyl-glucosamine at hydroxyl group of STY 
O-phosphorylation phosphorylation at hydroxyl group of STY 
PAM protospacer adjacent motif  
PBS phosphate-buffered saline 
PCR  polymerase chain reaction 
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pCREB cAMP responsive element binding protein 1 phosphorylated at S133 
PD  Proteome Discoverer 
Pen/Strep penicillin/streptomycin 
PEP posterior error probability  
pep. peptide 
PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 
phospho phosphorylation  
PI isoelectric point 
PI(3,5)P2 phosphatidylinositol 3,5-bisphosphate 
PIKFYVE phosphatidylinositol 3-phosphate 5-kinase 
PKA protein kinase A 
PKB protein kinase B 
PNK T4-polynucleotide kinase 
ppm parts per million  
PSM peptide spectrum matches 
PTM posttranslational modification 
Pumilio2 Pumilio homolog 2 
R  arginine  
RE  recycling endosomes  
red. reductive 
rel. relative 
Rep replicate 
RT room temperature  
s seconds 
S133 serine at amino acid position 133 
S133A substitution of serine at amino acid position 133 with alanine 
S133E substitution of serine at amino acid position 133 with glutamate 
S6 40S ribosomal protein S6  
S6K p70S6 kinase 
sAC soluble adenylyl cyclases  
Sc  succinylation 
SCX strong cation exchange 
SDC sodium deoxycholate  
SDM site directed mutagenesis  
SDS sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis  
sec. AB. Ctrl Secondary antibody control 
SIK salt-inducible kinase  
SILAC stable isotope labeling by amino acids in cell culture 
SNAP-23 synaptosomal-associated protein 23 
SNAP-25 synaptosomal-associated protein 25 
SNAPIN SNARE-associated protein 
SNARE soluble N-ethylmaleimide-sensitive-factor attachment receptor 
S-phosphorylation phosphorylation at thiol group of C 
Strep streptavidin  
SV synaptic vesicles  
t time 
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TBS Tris-buffered saline  
TEAB triethylammonium bicarbonate  
TEMED N,N,N’,N’-Tetramethyl ethylenediamine 
term terminal 
TFA trifluoroacetic acid 
TFEB transcription factor EB 
TGN trans-Golgi network  
TiO2 titanium dioxide 
Tip47  Perilipin-3 
TLS T-loading solution 
TOF  time of flight 
TORC transducers of regulated CREB  
tr technical replicate 
tracrRNA trans-activating crRNA 
Tricine N-(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)glycine 
Tris tris(hydroxymethyl)aminomethane 
U unit 
UK United Kingdom  
USA United States of America  
UV ultraviolet 
v/v volume per volume  
VAMP7 Vesicle-associated membrane protein 7 
Vsample sample volume 
v-SNARE vesicular soluble N-ethylmaleimide-sensitive-factor attachment 
receptor 
Vtotal total volume of mixture 
w/o without 
w/v weight per volume 
WB Western Blot 
wt wildtype 
X derivatization position 
β-Hex β-hexosaminidase 
ε405 molar extinction coefficient 
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1. Summary 
 
Cyclic adenosine monophosphate (cAMP) is an important second messenger which can be 
generated in response to signals binding to stimulatory G-protein coupled receptors. Inside the 
cell, protein kinase A is a well-known cAMP sensor. Within the present study, cAMP-dependent 
changes in the phosphorylation (phospho) pattern of lysosomal membrane and lysosome-
associated proteins were investigated. The serine phospho-site at position 133 (S133) of the 
lysosome-associated SNARE-associated protein (SNAPIN) was found to be significantly 
downregulated in the phosphoproteomic data set of the lysosomal membrane fraction after 
elevating the intracellular cAMP level by a Forskolin/dibutyryl-cAMP (FSK/db-cAMP) treatment. 
In addition to that, a tendency of SNAPIN to dissociate from the lysosomes upon elevated cAMP 
levels was observed. Therefore, the cAMP-dependent downregulation of the S133 phospho-site 
detected in the MS-based approach could have also been caused by a translocation of SNAPIN 
after FSK/db-cAMP treatment. Nevertheless, a dephosphorylation of SNAPIN was observed in 
2D-gelelectrophoresis of whole cell protein lysate after elevating the intracellular cAMP level. 
This observation confirmed the findings of the phosphoproteomic study although the 
dephosphorylation site could not be mapped to a specific amino acid position by 2D-
gelelectrophoresis. Pull-down assays with a phosphomimetic proteoform of the S133 phospho-
site (S133E) indicate an interaction of the biogenesis of lysosome-related organelles complex-1 
subunit 6 (BLOC1S6) with the S133E but not the S133A SNAPIN isoform (serine to alanine 
substitution mimics unphosphorylated SNAPIN at position 133). Furthermore, SNAPIN knock-
out (KO) was associated with decreased endocytosis and increased exocytosis of lysosomal 
hydrolases compared to wildtype cells. Elevation of intracellular cAMP levels neither influenced 
these processes in wildtype nor in SNAPIN KO cells. This indicates that the dephosphorylation of 
SNAPIN detected after FSK/db-cAMP treatment might not be involved in regulating these 
secretion or uptake events. 
Posttranslational modifications (PTMs) of lysine and arginine residues are important regulators 
in different cellular processes. In bottom-up mass spectrometry-based approaches, these PTMs 
are most commonly enriched with pan-specific antibodies. Here, the investigations are limited 
to one specific PTM and depend on the quality and availability of proper antibodies in order to 
obtain an efficient enrichment of modified peptides. In addition to that, huge amounts of 
samples are usually required in these immunoprecipitation approaches which might be 
problematic when dealing with limited amounts of starting material. The present study aimed 
at developing and testing of two novel antibody-free techniques for improving the detection of 
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specific PTMs from small quantities of starting sample. For example, such techniques would 
facilitate PTM analysis of enriched lysosomes or other purified subcellular compartments. The 
first technique, called the serial digestion workflow, was assumed to enhance the identification 
of lysine modifications. Compared to that, the second method, called the Nα-selective 
derivatization workflow (derivatization of primary amine group at amino-terminus), was 
hypothesized to improve the detection of PTMs occurring on both, lysine and arginine residues. 
Applying the two workflows to proteins from human embryonic kidney (HEK 293) cell lysate was 
not associated with an increased identification of lysine modifications. In contrast, sample 
treatment according to the Nα-selective derivatization method yielded an increase in the 
detection rate of arginine methylation. However, a similar rise was observed in both workflows 
after strong cation exchange chromatography which was originally performed as a sample clean-
up procedure. Here, depending on the sample type, either the identification of arginine or of 
lysine and arginine methylation was increased. Comparison of the methylated peptides detected 
in the different samples showed only a partial overlap. This indicates the necessity of analyzing 
different samples coming from both workflows in order to get the most comprehensive protein 
methylation data set. Based on these findings, a new hybrid workflow is suggested. 
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2. Introduction 
 
2.1. Proteins  
Proteins are macromolecules consisting of sequentially arranged amino acids covalently linked 
by an amide bond. Within the cell, amino acid sequence information is stored in protein coding 
regions of the deoxyribonucleic acid (DNA). After DNA transcription, the messenger ribonucleic 
acid (mRNA) is processed and translated into an amino acid sequence. The interaction among 
amino acid residues within the newly formed polypeptide chain determines the formation of 
secondary structures such as α-helices and β-sheets, thus being crucial for protein folding 
(tertiary structure) and function. 
In 2004, the complete human euchromatic DNA sequence was published by the International 
Human Genome Sequencing Consortium. Within this article, the authors predicted the human 
genome to comprise a total number of 20,000 to 25,000 protein coding genes (International 
Human Genome Sequencing Consortium 2004). Today, the latest assembly of the human 
genome by the Genome Reference Consortium suggests a total number of 23,376 (primary 
assembly + alternative sequences) open reading frame containing genes (ensembl.org, retrieved 
11.02.2019, GRCh38.p12). Although the quantity of protein coding genes has been refined 
within the last couple of years, processes such as alternative mRNA splicing and 
posttranslational chemical modification (PTM) of amino acids increase proteome complexity, 
thus hampering estimations on the total number of proteins and proteoforms present within 
the human body based on the genomic data.  
 
2.1.1. Mass spectrometry-based proteomic studies 
The proteome is the highly dynamic set of proteins present inside a cell under specific 
conditions. Its composition varies depending on the cell type, differentiation, drug treatment as 
well as on other internal and external stimuli (Ribet et al. 2010; Walther et al. 2015; Doll et al. 
2017; Ebhardt et al. 2018; Hurrell et al. 2019). Mass spectrometry (MS) is a frequently used 
method for protein identification in proteomic studies. In this technique, peptides or proteins 
are ionized followed by the analysis of their mass to charge ratio (reviewed by Aebersold and 
Mann 2003).  
In bottom-up MS approaches, protein identifications are based on the detection and sequencing 
of unique peptides during mass spectrometric analysis. Therefore, this method requires the 
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enzymatic digestion of the proteins prior to the MS run. The protease trypsin is commonly used 
for cleaving the protein backbone in proteomic studies. Based on its specificity towards lysine 
and arginine, tryptic digestion offers the advantage of generating peptides with lengths 
compatible with common detector capabilities (reviewed by Vandermarliere et al. 2013). In 
order to be detectable by mass spectrometry, peptides must be ionized. Two of the most 
commonly used ionization techniques are the electrospray ionization (ESI) and the matrix-
assisted laser desorption/ionization (MALDI) (Tanaka et al. 1988; Fenn et al. 1989). Once the 
peptide has been ionized and entered the spectrometer, its mass to charge ratio is determined 
by a mass analyzer (MS1 scan). In low complex peptide samples, the mass to charge ratios 
obtained in the MS1 scan might be enough to uniquely assign the measured ions to certain 
peptides and proteins (Henzel et al. 1993; Pappin et al. 1993). When investigating complex 
samples, several peptide ions with different sequences might feature the same mass to charge 
ratio on MS1 level. Therefore, the peptide identification usually involves an additional step. In 
data dependent MS analysis, usually the most abundant ions (precursor ions) detected in the 
MS1 scan are selected and isolated before their fragmentation (Stahl et al. 1996). In the latter 
step, the peptide backbone is fragmented by collision with an inert gas followed by the mass to 
charge ratio measurement of the fragment ions in the mass analyzer (MS2 scan) (Hunt et al. 
1986; Stahl et al. 1996). As a result of the dissociation, the MS2 spectra contain information 
about the amino acid sequence of the fragmented peptide ion (Hunt et al. 1986). During data 
processing, the precursor MS1 mass to charge ratio and the ions detected in the MS2 scan are 
compared to sequence information provided in a database in order to assign the spectra to a 
certain peptide (Eng et al. 1994).  
In proteomic approaches, the mass spectrometers are often coupled to liquid chromatography 
(LC) systems (LC-MS), thus allowing peptide separation prior to the MS analysis (Huang and 
Henion 1990). During peptide elution, changes in the intensities of each precursor ion can be 
traced over time. As the chromatographic peak area is proportional to the peptide abundance, 
this information can be used for relative precursor ion-based quantification (reviewed by Ong 
and Mann 2005). However, comparison of the abundances determined with these MS 
approaches are only possible among peptides with the same sequence. This is caused by the fact 
that differences in the amino acid composition might influence the ionization behavior and 
therefore the chromatographic peak area of the precursor ion (reviewed by Ong and Mann 
2005; reviewed by Gillet et al. 2016). 
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2.2. Posttranslational modifications 
Posttranslational modifications of proteins have been known for many decades. Their functional 
impacts range from modulation of enzyme function, signal transduction and polypeptide 
degradation to changes in protein localization, interaction and the regulation of other cellular 
processes (Ciechanover et al. 1980; Sette and Conti 1996; Holz et al. 2005; Martina et al. 2012; 
Napolitano et al. 2018; Borodinova et al. 2019).  
Besides the addition of small functional groups (e.g. methyl- and phosphoryl-groups) and more 
complex chemical compounds such as carbohydrates, peptides or lipids to amino acid side 
chains or termini of proteins, the group of PTMs also comprises the proteolytic cleavage of 
precursor proteins. (Burnett and Kennedy 1954; Kim and Paik 1965; Carlson 1966; Ciechanover 
et al. 1980; Erickson et al. 1981; Magee and Courtneidge 1985). The processing of zymogens is 
an example for such a modification of the primary protein structure (Sanny et al. 1975). 
However, whereas these proteolytic modulations are static and irreversible, other PTMs are 
highly dynamic and reversible (reviewed by Neurath and Walsh 1976; reviewed by Deribe et al. 
2010). Especially these dynamic PTMs enable a quick cellular response to certain stimuli thus 
facilitating adaptations to changing conditions inside and outside of the cell (reviewed by Deribe 
et al. 2010). 
Crosstalk describes the functional interplay between two or more modifications, caused by the 
competition of PTM for the same amino acid residue or their occurrence at adjacent sites within 
the protein (Kamemura et al. 2002; Yang et al. 2006). This phenomenon has been well studied 
among modifications reactive towards the same functional group such as O-GlcNAcylation and 
O-phosphorylation (reviewed by Hart et al. 2007). Nevertheless, PTM occurring at different side 
chains might also be able to influence each other. A prominent example for such an interplay is 
the crosstalk between phosphorylation and lysine acetylation. In 2015, Bryson and White 
described a site-specific acetylation and deacetylation of lysine residues upon stimulation of 
receptor tyrosine kinases. Vice versa, inhibition of the class I/II histone deacetylase was 
associated with significant alterations in the phosphorylation of four different tyrosine residues, 
thus further supporting the interplay between these two PTM (Bryson and White 2015). 
 
2.2.1. Mass spectrometry-based identification of posttranslational modifications 
Within the past decades, bottom-up mass spectrometry (MS) has evolved as the method of 
choice for PTM analysis. Based on the mass shift caused by the PTM, modified peptides can be 
identified, and modifications can be assigned to specific amino acids within the sequence after 
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tandem MS measurement. However, one major challenge during these analyses is the low 
abundance of the PTM containing peptides within the sample. Hence, reduction of sample 
complexity is required prior to MS measurements as most peptides present within proteolytic 
peptide mixture are unmodified and might be preferably selected for fragmentation (reviewed 
by Zhang et al. 2015).  
 
2.2.2. Phosphorylation 
Protein phosphorylation is a well-studied PTM and a key regulator in processes such as enzyme 
activation, protein localization and gene expression (Acosta-Jaquez et al. 2009; Settembre et al. 
2012). Recently, data mining of high- and low-throughput phosphoproteomic studies estimated 
a total number of 13,000 phosphoproteins and 230,000 phosphorylation sites in humans 
(Vlastaridis et al. 2017). Although the percentage of false predictions is unknown, the high 
number of potential phospho-sites emphasizes the importance of investigating this PTM under 
different cellular conditions.  
According to the functional group to which the phosphoryl-group is attached, phosphorylation 
events can be classified as O-phosphorylation (serine, threonine, tyrosine), S-phosphorylation 
(cysteine), N-phosphorylation (lysine, arginine, histidine) and acyl-phosphorylation (glutamate 
and aspartate) (Olsen et al. 2006; Hardman et al. 2019). Among those, O-phosphorylation is the 
most frequently investigated PTM as these modifications are stable during acidic conditions 
used in the process of sample preparation and for peptide separation during LC (reviewed by 
Zhang et al. 2015). 
In bottom-up MS based phosphorylation studies, phosphopeptides are first enriched and 
subsequently investigated by liquid chromatography coupled tandem MS (LC-MS2) analysis. 
Most prominently, positively charged metal ions with high affinity towards the negatively 
charged phosphate groups are used for the enrichment (Neville et al. 1997; Nühse et al. 2003). 
Another popular method is based on the binding of phosphopeptides to TiO2 columns (Pinkse et 
al. 2004; Larsen et al. 2005). However, these methods enrich all phosphopeptides present within 
a sample and do not distinguish between the different amino acids which are phosphorylated. 
Therefore, antibodies have been developed to selectively enrich for phosphopeptides 
comprising the phosphorylation at a specific amino acid residue (reviewed by Mann et al. 2002; 
Sathe et al. 2018).  
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2.2.3. Lysine modification 
Within the past decades, many different types of lysine modifications have been reported. 
Among those, acetylation, methylation and ubiquitination are the most prominent ones. 
Whereas ubiquitination is known to play an important role in proteasome based protein 
degradation, the functional impact of lysine acetylation and methylation ranges from regulating 
gene expression and protein interactions to the stimulation of signaling pathways and other 
cellular processes (Ciechanover et al. 1980; Hershko et al. 1980; Hebbes et al. 1988; Gu and 
Roeder 1997; Strahl et al. 1999; Chen et al. 2001; Huang et al. 2006; Wang et al. 2008; Elkouris 
et al. 2016; Kaimori et al. 2016; Fischer et al. 2017).  
Lysine modification containing peptides are often enriched by using PTM-specific antibody-
based pull-down assays followed by their analysis via LC-MS2 (Kim et al. 2006; Xu et al. 2010; 
Guo et al. 2014). However, the specificity of the antibody towards one single modification makes 
investigations of the plethora of different lysine modifications expensive and laborious. 
Additionally, antibodies against rare modifications might not be easily accessible, thus 
highlighting the importance of developing non-antibody-based techniques for the enrichment 
of lysine-modified peptides.  
 
2.2.4. Arginine modification 
Different types of arginine modifications have been identified within the past years with 
methylation probably being the best characterized PTM occurring at this amino acid. Primarily 
considered as a histone modification involved in the regulation of gene expression, arginine 
methylation has also been observed at non-histone proteins playing key roles in other cellular 
processes such as signal transduction, pre-mRNA splicing and protein-protein interactions 
(Bedford et al. 2000; Mowen et al. 2001; Boisvert et al. 2002; Zhao et al. 2009; Geoghegan et al. 
2015) . 
Arginine methylated peptides are often enriched by pan-specific antibodies (Guo et al. 2014). 
After the enrichment, peptides are analyzed by LC-MS2 in order to map the modification site to 
a specific amino acid position. 
 
2.3. Lysosomes 
Lysosomes are eukaryotic, membrane coated organelles predominantly responsible for 
macromolecule breakdown by the action of acidic hydrolases (de Duve et al. 1955; Coffey and 
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de Duve 1968). Up to now, more than 50 different lysosomal hydrolases are known (reviewed 
by Perera and Zoncu 2016). Their common characteristic is the requirement of an acidic pH in 
order to fulfill their molecular function (Coffey and de Duve 1968; Aronson and de Duve 1968; 
Fowler and de Duve 1969). Therefore, protons are pumped into the lysosomal lumen by 
membranous, adenosine triphosphate (ATP)-dependent v-ATPases (vacuolar-ATPase), thus 
generating and maintaining an acidic inner lysosomal pH which is optimal for the activity of these 
hydrolases (Ohkuma et al. 1982).  
The molecules degraded by the lysosomes originate from different pathways such as 
endocytosis and autophagy, an intracellular catabolic process (reviewed by Perera and Zoncu 
2016). Here, cargo delivery depends on the tethering of endosomes or autophagosomes to the 
lysosomes, followed by the assembly of soluble N-ethylmaleimide-sensitive factor-attachment 
protein receptor (SNARE) complexes and the fusion of the membrane bound compartments 
(Ward et al. 2000; Itakura et al. 2012; Pols et al. 2013; Jiang et al. 2014). Recently, a study by 
Bright et al. (2016) suggest that the hydrolytic activity primarily occurs in these intermediate 
endolysosomes whereas hydrolases are inactive in terminal lysosomes.  
 
2.3.1. Biogenesis of soluble, lysosomal enzymes 
During their translation, soluble lysosomal proteins are translocated into the endoplasmic 
reticulum (ER) mediated by an amino-terminal (N-terminal) signaling sequence (Erickson and 
Blobel 1979; Erickson et al. 1981). In the ER lumen, proteins are modified by processes such as 
N-glycosylation. Here, complex glycans are added to selected asparagine residues of the 
polypeptides before the glycosylated proteins are further transported to the Golgi apparatus 
(Erickson and Blobel 1979; Erickson et al. 1981; reviewed by Braulke and Bonifacino 2009). Once 
reaching the Golgi, glycan chains are further modified. In a two-step process, mannose residues 
are phosphorylated thus leading to the formation of mannose-6-phosphate (M6P) and allowing 
the binding of the protein to transmembrane M6P receptors (MPR) (Kaplan et al. 1977; Hasilik 
et al. 1980; Tabas and Kornfeld 1980; Varki and Kornfeld 1980; Waheed et al. 1981). Inside the 
cell, one can distinguish between 46 kDa cation-dependent (MPR46) and the 300 kDa cation-
independent MPR (MPR300) (Sahagian et al. 1981; Hoflack and Kornfeld 1985). Subsequent to 
the MPR binding, M6P containing enzymes exit the trans-Golgi network (TGN) by formation of 
vesicles and are transported to endosomes (reviewed by van Meel and Klumperman 2008). After 
dissociation of the M6P containing ligand from the MPR in the acidic lumen of the endosomes, 
the receptor cycles back to the Golgi where it can be reused for the transport of newly 
synthesized lysosomal enzymes (Duncan and Kornfeld 1988).  
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In addition to the pathway described above, acidic hydrolases can also be transported to the 
lysosomes by M6P independent pathways (Dittmer et al. 1999). For example, such a mechanism 
has been identified for the LIMP-2 mediated lysosomal transport of β-glucocerebrosidase 
(Reczek et al. 2007). 
Besides the TGN and endosomal vesicles, the MPR are also localized at the plasma membrane 
(Kaplan et al. 1977). Here, the MPR300 has been described in mediating endocytosis of M6P 
containing enzymes as well as in binding non-glycosylated proteins such as the insulin-like 
growth factor II (Kaplan et al. 1977; MacDonald et al. 1988).  
 
2.3.2. Biogenesis of lysosomal membrane proteins 
Lysosomal membrane proteins are targeted to the lysosomes through cytosolic peptide signal 
sequences and require the interaction with vesicle coat components such as the adaptor 
protein-1 complex (Williams and Fukuda 1990; Höning and Hunziker 1995; Höning et al. 1996). 
In contrast to the luminal lysosomal enzymes, this sorting is independent of M6P modifications 
of the membrane proteins (Barriocanal et al. 1986; Waheed et al. 1988).  
Two different pathways have been described in order to transport lysosomal membrane 
proteins from the TGN to the lysosomes (reviewed by Braulke and Bonifacino 2009). In the 
indirect pathway, the lysosomal membrane proteins are first translocated to the plasma 
membrane before they are re-internalized and delivered to the endosomal system (Braun et al. 
1989). In contrast, the direct pathway is based on the immediate transport of lysosomal 
membrane proteins from the TGN to the endosomes or lysosomes (Harter and Mellman 1992).  
 
2.3.3. Lysosomal secretion 
Originally found in Tetrahymena pyriformis, the Ca2+ dependent secretion of lysosomal 
hydrolases has been described for different mammalian cell types (Müller 1972; Rodríguez et al. 
1997). The involvement of SNARE complexes in such exocytotic processes has been suggested 
by studies focusing on the secretion of lysosome related secretory granules in mast cells 
(Paumet et al. 2000). In 2004, Rao et al. identified synaptotagmin VII as well as a SNARE complex 
consisting of the synaptosomal-associated protein 23 (SNAP-23), Syntaxin-4 and the v-SNARE 
(vesicular SNARE) vesicle-associated membrane protein 7 (VAMP7) as components being 
involved in Ca2+ dependent lysosome secretion. It has been proposed that the exocytosis of 
lysosomes plays important roles in processes such as plasma membrane repair upon cell 
disruption (Reddy et al. 2001). Besides conventional lysosomes, some cell types comprise 
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lysosome related organelles (LRO) specialized for secretion (reviewed by Luzio et al. 2014). 
Among others, such LRO can be found as lytic granules in cytotoxic T-lymphocytes involved in 
the targeted apoptosis of infected or tumorigenic cells (Yannelli et al. 1986; Stinchcombe et al. 
2001). 
 
2.3.4. Lysosomes as an important intracellular signaling hub 
Besides their importance in macromolecule degradation, lysosomes are an important hub in 
processes such as cellular signaling and nutrition sensing (Sancak et al. 2008; Kim et al. 2008). 
For example, an increasing body of evidence indicates the sensitivity of the lysosome-associated 
mechanistic target of rapamycin complex 1 (mTORC1) towards the availability of amino acids 
(Sancak et al. 2008; Kim et al. 2008). If amino acids are present, Ras-related GTPases (Rag) 
promote the translocation of mTORC1 to the lysosomes where its kinase function is activated 
by the Rheb protein (Long et al. 2005; Sancak et al. 2008; Kim et al. 2008; Sancak et al. 2010). As 
a result of its activation, mTORC1 phosphorylates different target proteins such as the 
transcription factor EB (TFEB) thus inhibiting catabolic pathways. After its phosphorylation, TFEB 
binds to 14-3-3 proteins leading to its cytosolic localization (Martina et al. 2012; Settembre et 
al. 2012). However, upon starvation, mTORC1 is inactive and dissociates from the lysosomes. 
Therefore, the phosphorylation status of TFEB changes which facilitates its dissociation from the 
14-3-3 proteins and enables its translocation into the nucleus (Martina et al. 2012; Settembre 
et al. 2012). Here, TFEB induces the transcription of lysosome- and autophagy-related genes 
thus promoting cellular catabolic processes (Martina et al. 2012; Settembre et al. 2012).  
 
2.4. cAMP-based signal transduction  
Since its discovery in 1957/58, cyclic adenosine monophosphate (cAMP) has been described as 
an important cellular second messenger (Berthet et al. 1957; Rall and Sutherland 1958; 
Sutherland and Rall 1958). Inside the cell, cAMP is produced in response to various signals 
sensed by stimulatory G-protein coupled receptors (GSPCRs). For example, glucagon, a hormone 
secreted by pancreatic cells in response to hypoglycemia, is a well-known activator of the cAMP 
pathway after complexing with GSPCRs (Jelinek et al. 1993; reviewed by Habegger et al. 2010). 
Upon ligand binding, guanosine diphosphate (GDP) bound to the stimulatory G-protein is 
exchanged by guanosine triphosphate (GTP) (reviewed by Freissmuth et al. 1989). This activates 
intracellular adenylyl cyclases (AC) thus leading to an increase of the cytoplasmic cAMP level 
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(Rodbell et al. 1971; Northup et al. 1980; reviewed by Freissmuth et al. 1989). The exchange 
proteins directly activated by cAMP (EPAC) and the protein kinase A (PKA) are two main 
intracellular cAMP sensors (Walsh et al. 1968; Tao et al. 1970; Kawasaki et al. 1998; Rooij et al. 
1998). Degradation of cAMP is achieved by the conversion of cAMP to AMP catalyzed by cyclic 
3’,5’-cyclic nucleotide phosphodiesterase (Butcher and Sutherland 1962). 
 
2.4.1. Protein kinase A (PKA) 
PKA is a cAMP dependent, tetrameric serine/threonine kinase consisting of two regulatory and 
two monomeric catalytic subunits (R2C2-complex) (Walsh et al. 1968; Tao et al. 1970; Ramseyer 
et al. 1974). According to the isoform of the regulatory subunit, the holoenzymes are either 
classified as PKA-I or PKA-II (Corbin et al. 1975; Zoller et al. 1979). The spatial localization of the 
tetramer is regulated by the interaction of the regulatory subunits with A-kinase anchoring 
proteins (AKAPs) (Theurkauf and Vallee 1982; Lohmann et al. 1984; reviewed by Welch et al. 
2010). PKA phosphorylates its substrates at the R-R/K-X-S/T consensus sequence (reviewed by 
Kennelly and Krebs 1991).  
PKA is activated upon binding of cAMP to the regulatory subunit of the holoenzyme (Walsh et 
al. 1968; Tao et al. 1970). It has been shown that cAMP binding to the regulatory subunit can 
result in dissociation of the R2C2-complex (Tao et al. 1970; Ramseyer et al. 1974). Here, the 
release of the catalytic subunit is believed to be crucial for fulfilling its kinase activity. However, 
there is strong evidence that cAMP induced activation of PKA-II is also possible while the 
holoenzyme stays intact (Yang et al. 1995; Smith et al. 2017). In this case, PKA-IIs sphere of 
action is limited to the proximity to its anchorage site, thus maybe affecting the functional role 
of the holoenzyme compared to its dissociated form (Smith et al. 2017).  
The regulatory role of PKA in retrograde and anterograde vesicle transport has been described 
intensively within the past years (Muñiz et al. 1996; Muñiz et al. 1997; Birkeli et al. 2003). 
However, PKA also influences organelle-specific processes. In 2008, Vergarajauregui et al. 
identified the serine residues at the positions 557 and 559 of the lysosomal cation channel 
Mucolipin 1 as PKA targets. Additionally, the authors demonstrated that PKA inhibition increases 
the activity of Mucolipin 1. When mutating S557 and S559 to alanine, no difference in the 
channel activity between the control and the PKA inhibited samples was observed 
(Vergarajauregui et al. 2008). 
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2.4.2. Exchange protein directly activated by cAMP (EPAC) 
In contrast to PKA, the two EPAC family members are monomeric proteins consisting of an N-
terminal regulatory domain and a catalytic region located at the C-terminus of the polypeptide 
chain (Kawasaki et al. 1998). cAMP binding to the regulatory domain activates EPAC’s carboxy-
terminal (C-terminal) guanine exchange factor function (Kawasaki et al. 1998; Rooij et al. 1998). 
Once active, the EPACs are able to mediate the activation of the small GTPases such as Rap1A 
which belongs to the Ras superfamily (Kawasaki et al. 1998; Rooij et al. 1998).  
EPACs have been demonstrated to play important roles in different cellular processes such as in 
cell adhesion and exocytosis (Ozaki et al. 2000; Rangarajan et al. 2003). Although EPAC can act 
independent from PKA activation, both cAMP sensors might affect downstream effects in a 
synergistic fashion (Shibasaki et al. 2007). For example, such a converging action has been 
described for secretion of neurotensin in endocrine cells (Li et al. 2007). Besides that, PKA and 
EPAC were also described in having opposing effects. Here, the phosphorylation/activation of 
protein kinase B (PKB) is an example for such an antithetic function of these cAMP sensors (Mei 
et al. 2002). The synergistic and antagonistic functions of PKA and EPAC indicate the complexity 
of the cAMP-based signaling machinery.  
 
2.5. SNAPIN  
In the course of this thesis, a phospho-site of the SNARE-associated protein (SNAPIN) was 
identified to be downregulated in the lysosomal membrane fraction upon FSK/db-cAMP 
treatment (see section 5.1.2.2). Based on this finding, this protein has been further investigated 
in different biochemical approaches.  
SNAPIN was first described in neurons as being potentially involved in docking and the release 
of synaptic vesicles to the plasma membrane via its interaction with the SNARE complex protein 
SNAP-25 (synaptosomal-associated protein 25) (Ilardi et al. 1999). Starting from this initial 
observation, the function of SNAPIN in tethering vesicles to the outer membrane has also been 
suggested for non-neuronal cells (Somanath et al. 2016). In 2016, Somanath et al. demonstrated 
that SNAPIN is involved in insulin secretion of pancreatic beta-cells by docking the secretory 
granules to the membrane after binding to SNAP-25. Besides its vesicle tethering function, 
SNAPIN has been shown to be crucial for dynein-driven retrograde vesicle transport, such as 
cargo delivery from the presynaptic terminals to the endolysosomal system and the transfer of 
the beta-site amyloid precursor protein cleaving enzyme 1 to the lysosomes for its degradation 
(Cai et al. 2010; Ye and Cai 2014; Di Giovanni and Sheng 2015).  
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SNAPIN is phosphorylated by PKA at its serine 50 position (S50) (Chheda et al. 2001). Studies 
with PKA stimulated cells and expression systems comprising the phosphomimetic SNAPIN S50D 
proteoform revealed an increased SNAPIN/SNAP-25 interaction in cells derived from rat 
hippocampal slices and pancreatic beta-cells thus suggesting the importance of this PTM in 
exocytosis (Chheda et al. 2001; Song et al. 2011). This altered interaction behavior might be 
attributed to changes in SNAPINs secondary structure, as the phosphomimetic S50D isoform 
comprises less alpha helical structures compared to is non-phosphorylatable S50A counterpart 
(Navarro et al. 2012).  
Homozygous SNAPIN knock-out has been shown to be perinatal lethal, likely caused by 
developmental defects of the brain which might be associated with the previously mentioned 
role of SNAPIN in vesicle tethering but also with alterations in the autophagy-lysosomal pathway 
(Tian et al. 2005; Zhou et al. 2011). The effect of SNAPIN on lysosomal function has been 
investigated in detail within the past years. Within these studies, the importance of SNAPIN in 
lysosome maturation and retrograde cargo delivery by late endocytic trafficking as well as its 
interaction with the late endosomal SNARE complex has been demonstrated (Lu et al. 2009; Cai 
et al. 2010).  
SNAPIN has been identified as a subunit of two complexes, the biogenesis of lysosome related 
organelles complex-1 (BLOC-1) and the BLOC-1 related complex (BORC) (Starcevic and 
Dell'Angelica 2004; Pu et al. 2015). Besides SNAPIN, both complexes share two additional 
subunits, namely BLOC subunit-1 (BLOS1) and BLOC subunit-2 (BLOS2) (Pu et al. 2015). 
BLOC-1 consists of eight subunits and plays an important role in the biogenesis of lysosome 
related organelles (Falcón-Pérez et al. 2002; Ciciotte et al. 2003; Li et al. 2003; Starcevic and 
Dell'Angelica 2004; reviewed by Bowman et al. 2019). Several mutations in genes encoding for 
BLOC-1 subunits have been reported to cause the hereditary Hermansky-Pudlak syndrome (HPS) 
(Li et al. 2003; Morgan et al. 2006; Cullinane et al. 2012). Hypopigmentation and extended 
bleeding caused by an impaired function of melanosomes and platelet dense granules are 
common characteristics in HPS (reviewed by Di Pietro and Dell'Angelica 2005). In melanocytes, 
BLOC-1 has been demonstrated to play a key role in cargo delivery from sorting endosomes to 
melanosomes probability by coordinating the formation of tubular recycling endosomes (Setty 
et al. 2007; Delevoye et al. 2016). Downregulation of BLOC-1 subunits reduces the cellular 
melanin content thus indicating the importance of this complex in the biogenesis of 
melanosomes (Delevoye et al. 2016). Although the mechanism is poorly understood, a similar 
role of BLOC-1 has also been proposed during biogenesis of platelet dense granules (reviewed 
by Ambrosio and Di Pietro 2016; reviewed by Chen et al. 2018).  
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BORC is a protein complex consisting of eight subunits with crucial roles in lysosome positioning 
and lysosome-autophagosome fusion (Pu et al. 2015; Guardia et al. 2016; Jia et al. 2017; Filipek 
et al. 2017). Recently, Yordanov et al. (2019) demonstrated a decrease in late 
endosomal/lysosomal size and elevated phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) upon 
knock out of the two BORC subunits Diaskedin and Myrlysin. The authors suggested that the 
increase in PI(3,5)P2 was caused by a dysregulation of phosphatidylinositol 3-phosphate 5-kinase 
(PIKFYVE) activity in the KO cells thus indicating that BORC subunits might also participate in 
enzyme regulation (Yordanov et al. 2019). 
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2.6. Aim of this study 
Glucagon, a peptide hormone secreted by pancreatic cells upon hypoglycemia, is a known 
activator of the cAMP-dependent protein kinase A pathway (Jelinek et al. 1993; reviewed by 
Habegger et al. 2010). After its activation, PKA mediates the break-down of glycogen thus 
directly counteracting the glucose starvation signal (reviewed by Unger 1985). Another process 
known to be upregulated upon nutrient deprivation is the expression of genes encoding for 
lysosomal proteins which correlates with an increase lysosome-dependent macromolecule 
catabolism (Sardiello et al. 2009; Settembre et al. 2011). As PKA and lysosomes play an 
important role in the degradation of complex molecules upon starvation, one could hypothesize 
an involvement of PKA in rapid regulation of lysosomal processes. In order to investigate this 
hypothesis, the first goal of the thesis is the identification of regulated phosphorylation sites at 
lysosomal membrane or lysosome-associated proteins upon elevation of the intracellular cAMP 
levels.  
The low abundance of posttranslationally modified peptides in complex protein digests hinders 
their detection in classical bottom-up MS approaches. Therefore, PTM containing peptides are 
usually enriched prior to the LC-MS analysis. Immuno-affinity purification is the most common 
enrichment procedure used when investigating lysine and arginine PTMs (Guo et al. 2014). 
However, the standard protocol of this antibody-based method requires huge amount of 
starting material. Especially when dealing with limited sample amounts such as enriched 
organelles, this technique cannot be easily applied thus making such investigations laborious. In 
addition to that, the specificity of the antibody restricts the analysis to one specific 
lysine/arginine PTM. Hence, investigations of multiple different modifications in a sample 
require the utilization of several antibodies which not only increase the workload but also the 
experimental costs. As a result of these limitations, the second part of the thesis aims at 
developing an antibody-free technique which allows the MS-based detection of lysine and/or 
arginine PTM from small quantities of starting material. For this purpose, two different 
strategies are tested. These techniques are assumed to be not restricted to a specific 
lysine/arginine PTM, thus potentially allowing the detection of several modifications in a single 
MS experiment. Additionally, these methods are expected to be applicable to enriched lysosome 
factions as they are hypothesized to be compatible with low amounts of starting samples.  
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3. Material 
 
3.1 Chemicals  
As far as not otherwise stated, chemicals were purchased from Sigma-Aldrich (St. Louis, USA), 
Carl Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany), Alfa Aesar (Haverhill, USA) or 
Thermo Fisher Scientific (Waltham, USA). Substances were either of analytical grade or had a 
purity ≥95 %. Organic solvents (HPLC/LC-MS grade) used for MS experiments were bought from 
VWR (Radnor, USA), Merck, Honeywell (Charlotte, USA), AppliChem (Darmstadt, Germany) or 
Biosolve (Valkenswaard, Netherlands).  
 
3.2 Consumables  
Consumables were bought from Sarstedt (Nümbrecht, Germany), Corning (Falcon®) (Corning, 
USA), Greiner Bio-One (Kremsmünster, Austria) or Beckman Coulter (Brea, USA) as far as not 
otherwise mentioned. For mass spectrometry experiments, plastic materials were purchased 
from Corning (Axygen®), Sarstedt or STARLAB (Hamburg, Germany).  
 
3.3 Enzymes 
Enzyme Manufacturer 
Arylsulfatase A Rentschler Biopharma (Laupheim, Germany) 
BamHI (Fast Digest) Thermo Fisher Scientific (Waltham, USA) 
Calf Intestine Alkaline Phosphatase Invitrogen (Carlsbad, USA) 
DpnI Thermo Fisher Scientific (Waltham, USA) 
LysArginase Structural Biology Unit CSIC (Barcelona, Spain) 
LysN Thermo Fisher Scientific (Waltham, USA) 
Pfu DNA Polymerase Thermo Fisher Scientific (Waltham, USA) 
Phusion DNA Polymerase Thermo Fisher Scientific (Waltham, USA) 
Proteinase K Carl Roth (Karlsruhe, Germany) 
RnaseA Thermo Fisher Scientific (Waltham, USA) 
T4-Polynucleotide Kinase Thermo Fisher Scientific (Waltham, USA) 
Trypsin (MS-Experiments) Promega (Fitchburg, USA) 
Trypsin-EDTA solution (cell culture) life technologiesTM (Carlsbad, USA) 
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3.4 Antibodies  
3.4.1 Primary antibodies 
Antigen Host Dilution Application Manufacturer 
Cathepsin D rabbit 1:1000 WB Abcam (Cambridge, UK); Order 
Number: ab97499 
CREB rabbit 1:1,000 WB Cell Signaling Technology (Danvers, 
USA); Order Number: 9197S 
human ASA (Antiserum) rabbit 1:2000 ELISA self-made by AG Matzner 
human MPR300 Dom9 
N1+N2 del* 
rabbit 1:1000 WB self-made by Tilman Schuster 
LAMP-2 mouse 1:50 ICC Hybridoma Bank (Iowa City, USA); 
Order Number: H4B4 
p-CREB rabbit 1:1,000 WB Cell Signaling Technology (Danvers, 
USA) ; Order Number: 9198S 
SNAPIN rabbit 1:500 WB Proteintrech (Manchester, UK); Order 
Number: 10055-1-AP 
α-Tubulin mouse 1:10,000-
1:20,000 
WB Sigma-Aldrich (St. Louis, USA); Order 
Number: T5168 
* Dom9 N1+N2 Del: domain 9 with deletion of two glycosylation sites 
 
3.4.2 Secondary antibodies 
Antigen Tag Host Dilution Application Manufacturer 
mouse IgG (H+L) HRP goat 1:5,000 WB Jackson ImmunoResearch 
(Pennsylvania, USA);  
Order Number: 115-035-044 
rabbit IgG (H+L) HRP goat 1:5,000 WB Jackson ImmunoResearch 
(Pennsylvania, USA);  
Order Number: 111-035-003 
rabbit IgG (H+L) HRP goat 1:2,000 ELISA Jackson ImmunoResearch 
(Pennsylvania, USA); 
Order Number: 111-035-003 
mouse IgG (H+L) Cy3 goat 1:250 ICC Jackson ImmunoResearch 
(Pennsylvania, USA); 
Order Number: 115-165-003 
 
3.5 Cells 
Bacterial Strain Genotype 
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F ́ proAB lacIqZ∆M15 Tn10 
(Tetr)] 
 
Mammalian Cell Lines Supplier 
HEK 293 DSMZ-German Collection of Microorganisms and Cell Culture (Braunschweig, 
Germany) 
HeLa DSMZ-German Collection of Microorganisms and Cell Culture (Braunschweig, 
Germany) 
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3.6 Peptides 
Sequence Supplier 
FSEEKHLEDLER Dr. D. Winter (IBMB) 
MHTGHANAKHIAGLSR JPT, Berlin, Germany 
 
3.7 Primers 
All primers were synthesized by Biomers (Ulm, Germany). 
Name Sequence Application 
SNAPIN 
S133A fwd 
GGAATTTACCCCCCTGGCGCTCCAGGCAAAAGCGGACCG SDM SNAPIN 
S133A 
SNAPIN 
S133A rev 
CGGTCCGCTTTTGCCTGGAGCGCCAGGGGGGTAAATTCC SDM SNAPIN 
S133A 
SNAPIN 
S133E fwd 
GGAATTTACCCCCCTGGCGAGCCAGGCAAAAGCGGACCG SDM SNAPIN 
S133E 
SNAPIN 
S133E rev 
CGGTCCGCTTTTGCCTGGCTCGCCAGGGGGGTAAATTCC SDM SNAPIN 
S133E 
pCMV fwd CCGTTGACGCAAATGGG  Sequencing 
pCMV-
vector 
SNAPIN fwd 
CRISPR-Cas9  
1st PCR  
ACACTCTTTCCCTACACGACGCTCTTCCGATCTGTTGGCAAAAACCTAAGGTCCTG 1st PCR gene 
KO valid. 
SNAPIN rev 
CRISPR-Cas9  
1st PCR 
TGACTGGAGTTCAGACGTGTGCTCTTCCGATCTAAACTGATTCGAGGCGGGGAGGA 1st PCR gene 
KO valid. 
D501_long 
Primer A 
AATGATACGGCGACCACCGAGATCTACACTATAGCCTACACTCTTTCCCTACACGACGCT 2nd PCR gene 
KO valid. 
D502_long 
Primer A 
AATGATACGGCGACCACCGAGATCTACACATAGAGGCACACTCTTTCCCTACACGACGCT 2nd PCR gene 
KO valid. 
D503_long 
Primer A 
AATGATACGGCGACCACCGAGATCTACACCCTATCCTACACTCTTTCCCTACACGACGCT 2nd PCR gene 
KO valid. 
D701_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATCGAGTAATGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D702_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATTCTCCGGAGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D703_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATAATGAGCGGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D704_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATGGAATCTCGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D705_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATTTCTGAATGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D706_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATACGAATTCGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D707_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATAGCTTCAGGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D708_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATGCGCATTAGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D709_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATCATAGCCGGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D710_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATTTCGCGGAGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D711_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATGCGCGAGAGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
D712_long 
Primer B 
CAAGCAGAAGACGGCATACGAGATCTATCGCTGTGACTGGAGTTCAGACGTGTGCT 2nd PCR gene 
KO valid. 
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3.8 Vectors 
Name Construct Supplier 
pCMV6_SNAPIN SNAPIN Myc-DDK Origene (Rockville, USA) 
pCMV6_SNAPIN_S133A SNAPIN S133A Myc-DDK self-made SDM (Template: pCMV6_SNAPIN) 
pCMV6_SNAPIN_S133E SNAPIN S133E Myc-DDK self-made SDM (Template: pCMV6_SNAPIN) 
Edit-R Cas9 nuclease 
expression plasmid (PuroR) 
Cas9 Dharmacon/Horizon (Cambridge, UK),  
 
3.9 Instruments 
Instrument Model Manufacturer 
Centrifuge (max. 2 ml) Z 216 MK Hermle(Wehingen, Germany) 
Centrifuge benchtop Allegra X-15R Beckman Coulter (Brea, USA) 
Centrifuge cell culture Labofuge 400e Heraeus (Hanau, Germany) 
Counting Camber Fuchs-Rosenthal Brand (Wertheim, Germany) 
Cryopreservation system  MVE TS; Tank 800 series-
190 
CHART (Luxembourg, Luxembourg) 
Detection system agarose gels BioDoc Analyze Biometra/Analytik Jena (Jena, Germany) 
Detection system HRP-based 
immune detection 
Fusion Solo Vilbert Lourmat (Collégien, France) 
Dounce homogenizer 7 ml, small clearance pestle Kimble Chase (Rockwood, USA) 
Electrotransfer system  Trans-Blot® Cell Bio-Rad (Hercules, USA) 
Electrotransfer system PerfectBlueTM Semi-Dry 
Electro Blotter 
peqlab (Erlangen, Germany) 
Electrotransfer system Trans-Blot® Turbo Bio-Rad (Hercules, USA) 
Equipment agarose gel 
electrophoresis 
PerfectBlueTM Gel System peqlab (Erlangen, Germany) 
Equipment isoelectic focusing PROTEAN® IEF cell Bio-Rad (Hercules, USA) 
Equipment SDS-PAGE 
electrophoresis (self-made 
gels) 
Mini-PROTEON® Tetra Cell Bio-Rad (Hercules, USA) 
Equipment SDS-PAGE 
electrophoresis (precast gels) 
Mini Gel Tank life technologiesTM (Carlsbad, USA) 
Fluorescence microscope LSM 980 Airyscan 2 
detector, inverse 
AxioObserver 7 
Zeiss (Oberkochen, Germany) 
Freeze dryer Lyovac GT2 Finn-Aqua (Hürth, Germany) 
Heating block MHR23, BM15 Ditabis (Pforzheim, Germany) 
Ice machine   Ziegra (Isernhagen, Germany) 
Incubator bacteria Function Line B12 Heraeus (Hanau, Germany) 
Incubator bacteria (shaking) InnovaTM 43 New Brunswick Scientific (Edison, USA) 
Incubator cell culture HERAcell® 240 Heraeus (Hanau, Germany) 
Laboratory rocker Rotamax 120 Heidolph (Schwabach, Germany) 
Laminar flow cabinet  Clean-Air Bio-Flow (Meckenheim, Germany) 
Liquid chromatography system Ultimate 3000 RSLC nano 
HPLC system 
Dionex (Idstein, Germany) 
Magnetic stand lysosome 
enrichment 
Quadro MACS Separator Miltenyi Biotec (Bergisch Gladbach, Germany) 
Magnetic stirrer WiseStir® MSH-20D Witeg (Wertheim, Germany) 
Mass spectrometer LTQ Orbitrap Velos Thermo Fisher Scientific (Bremen, Germany) 
Mass spectrometer Orbitrap Fusion Lumos Thermo Fisher Scientific (Bremen, Germany) 
Mass spectrometer MALDI-TOF/TOF Autoflex III  Bruker Daltonik (Bremen, Germany) 
Micro scale CP1245-DCE Sartorius (Göttingen, Germany) 
Micropipettes  Gilson (Middleton, USA) 
Microplate reader GENios Tecan (Männedorf, Switzerland) 
Microplate reader Infinite Pro 2000 Tecan (Männedorf, Switzerland) 
Microplate washer HydroFlexTM Tecan (Männedorf, Switzerland)  
Microscope cell culture Axio Vert.A1 Zeiss (Oberkochen, Germany) 
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Instrument Model Manufacturer 
Multi-channel micropipette Transferpette S-12 Brand (Wertheim, Germany) 
Orbital shaker PTR-35 Grant-bio (Cambridge, UK) 
pH electrode WTW SenTix 50 Xylem (Weilheim, Germany) 
pH meter pH-Meter 761 calimatic Knick (Berlin, Germany) 
Power supply PowerPac 300 Bio-Rad (Hercules, USA) 
Spectrophotometer NanoDrop 2000 Thermo Fisher Scientific (Waltham, USA) 
Thermal cycler T3 Thermalcycler Biometra/Analytik Jena (Jena, Germany) 
Tip sonicator Sonifier 250 Branson (Danbury, USA) 
Tip sonicator UP50H Hielscher (Teltow, Germany) 
Tube Rotator  LD79 Labinco (Breda, Netherlands) 
Ultracentrifuge Optima TLX Beckman Coulter (Brea, USA) 
Ultrasonic bath 2510 Branson (Danbury, USA) 
Vacuum centrifuge ScanSpeed 40; Rotor GRV-
m2.0-200 
ScanVac/Labogene (Lynge, Denmark) 
Vortex ZX3 UniEquip (Planegg, Germany) 
Water bath cell culture 1083 GFL (Burgwedel, Germany) 
Water purification system arium® Pro Sartorius, Göttingen, Germany 
 
3.10 Software 
Software Application Supplier 
Capt Advance Solo 4 Software Fusion Solo HRP-
based immune detection 
system; Signal 
quantification 
Vilbert Lourmat (Collégien, France) 
Chromeleon Controlling Dionex LC-
system 
Thermo Fisher Scientific(Waltham, USA) 
CorelDRAW Home & Student 2019 Corel Corporation (Ottawa, Canada) 
Excel 2016 Data analysis and 
visualization 
Microsoft (Redmond, USA) 
flexAnalysis  MALDI TOF data analysis Bruker Daltonik (Bremen, Germany) 
flexControl MALDI TOF data acquisition Bruker Daltonik (Bremen, Germany) 
Genome Compiler Primer design and Sanger 
sequencing analysis 
Genome Compiler Corporation (Los Altos, USA); 
www.genomecompiler.com 
i-controlTM Software Infinite Pro 200 
Microplate Reader 
Tecan (Männedorf, Switzerland) 
ImageJ Maximum intensity 
projection LSM Z-stacks 
Schneider et al. 2012 
MaxQuant Orbitrap data analysis Cox and Mann 2008; Cox et al. 2011 
NetPhos Kinase consensus sequence 
analysis 
Blom et al. 1999; Blom et al. 2004; 
www.cbs.dtu.dk/services/NetPhos 
OutKnocker NGS data analysis  Schmid-Burgk et al. 2014; www.outknocker.org 
PEAKs Orbitrap data analysis Bioinformatics Solutions Inc. (Waterloo, Canada) 
Proteome Discoverer Orbitrap data analysis Thermo Fisher Scientific (Waltham, USA) 
R-studio Data analysis and 
visualization; statistics 
R Core Team 2019 
UCSC Genome Browser Determination of SNAPIN 
reference sequence (NGS 
data analysis) 
Kent et al. 2002; www.genome.ucsc.edu 
Word 2016 Text processing program Microsoft (Redmond, USA) 
Xcalibur Orbitrap data I Thermo Fisher Scientific (Waltham, USA) 
Xfluor4 Software GENios 
Microplate Reader 
Tecan (Männedorf, Switzerland) 
Zen Image Acquisition LSM 980 
Airyscan 2 
Zeiss (Oberkochen, Germany) 
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4. Methods 
 
4.1 Protein-biochemistry techniques 
4.1.1 Determination of protein level in solution 
Colorimetric determination of protein concentrations was either performed with the detergent 
compatible (DC) protein assay (Bio-Rad, Hercules, USA) or the PierceTM bicinchoninic acid (BCA) 
assay (Thermo Fisher Scientific, Waltham, USA). 
For the DC protein assay, solution A´ was prepared by adding 20 µl of solution S to 1 mL of 
solution A. Afterwards, 5 µl of sample was pipetted into one well of a 96-well plate and mixed 
with 25 µL of solution A´. After adding 200 µl of solution B, the mixture was incubated for 15 min 
at room temperature (RT) before measuring the absorption at a wavelength of 750 nm (GENios, 
Tecan). Bovine serum albumin (BSA) solutions served as standards and were used for calculating 
the protein amount of the samples (linear regression).  
In case of the BCA assay, the working solution was prepared by mixing one part of solution B 
with 50 parts of solution A. 25 µl sample or BSA standard solution were added to one well of a 
96-well plate and mixed with 200 µl working solution. The assay was incubated for 30 min at 
37°C. Absorbance was measured at a wavelength of 595 nm (GENios, Tecan). Based on the BSA 
standard curve (polynomial regression), the protein amounts of the samples were calculated.  
 
4.1.2 Cell lysis 
As far as not otherwise stated, cells were lysed according to the following procedure.  
After removing the cultivation medium, cells were washed twice with ice cold PBS. Subsequent 
to this, cells were scraped in 500 µl ice cold lysis buffer (supplemented with 1x HaltTM 
Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific, Waltham, USA) if needed). The cell 
lysate was transferred to a fresh reaction tube and either stored at -20°C or directly treated with 
a tip sonicator (Hielscher, UP50H) in order to shear high molecular DNA. In the next step, the 
lysate was centrifuged for 5 min at 10,000 x g at 4°C. The supernatant was transferred to a fresh 
reaction tube. Protein concentrations were measured by the BCA or DC assay.  
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Solution Concentration Component  
NP-40 Lysis Buffer 
1 % (w/v) NP-40 
25 mM Tris-HCl (pH 7.4) 
1 mM EDTA 
150 mM NaCl 
1x HaltTM Protease Inhibitor Cocktail* 
SDC Lysis Buffer 
5 % (w/v) SDC 
20 mM  TEAB 
1x HaltTM Protease Inhibitor Cocktail* 
Calf Intestine Alkaline 
Phosphatase (CIAP) Lysis Buffer 
0.02 % (w/v) Triton X-100 
50 mM  Tris-HCl (pH 7.9) 
100 mM NaCl 
10 mM MgCl2 
1 mM DTT 
1x HaltTM Protease Inhibitor Cocktail* 
1x PBS 
10 mM Na2HPO4 x 2H2O 
1.77 mM KH2PO4 
137 mM NaCl 
2.7 mM KCl 
* Thermo Fisher Scientific, Waltham, USA 
 
4.1.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) enables separation of 
proteins according to their molecular mass (Laemmli 1970).  
The solutions and recipes used for preparation of a discontinuous SDS polyacrylamide gel are 
listed below. 
Component 
 
Stacking gel  
(5 %) 
Separating gel 
(10 %) 
Separating gel 
(12.5 %) 
Separating gel 
(15 %) 
Acrylamide (40 %) 5 % (v/v) 10 % (v/v) 12.5 % (v/v) 15 % (v/v) 
Tris-HCl, pH 6.8 0.125 M - - - 
Tris- HCl, pH 8.8 - 0.375 M 0.375 M 0.375 M 
SDS 0.1 % (w/v) 0.1 % (w/v) 0.1 % (w/v) 0.1 % (w/v) 
APS 0.04 % (w/v) 0.06 % (w/v) 0.06 % (w/v) 0.06 % (w/v) 
TEMED 0.075 % (v/v) 0.075 % (v/v) 0.075 % (v/v) 0.075 % (v/v) 
 
Prior to the SDS-PAGE, samples were mixed with 4x Laemmli-buffer and incubated for 5 min at 
95°C. In addition to the samples, 3-5 µl PageRulerTM Prestained Protein Ladder (Thermo Fisher 
Scientific, Waltham, USA) were loaded onto the gels. Gel electrophoresis was performed at 80-
140 V by using the vertical Mini-PROTEAN tetra cell system (Bio-Rad). 
In order to investigate the MPR300 level in wt and SNAPIN KO cells, protein samples were mixed 
with 4 x NuPAGETM LDS sample buffer (life technologiesTM, Carlsbad, USA) and incubated for 5 
min at 95°C. Afterwards, the samples and 10 µl Multicolor High Range Protein Ladder (Thermo 
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Fisher Scientific, Waltham, USA) were loaded onto a precast NuPAGETM 3-8 % Tris-Acetate gel 
(life technologiesTM, Carlsbad, USA). For gel electrophoresis, the Mini Gel Tank system (life 
technologiesTM) was used (60-90 V). 
Solution Concentration Component  
SDS-running buffer (for self-
made gels) 
25 mM Tris 
192 mM Glycine 
3.5 mM SDS 
NuPAGE running buffer (for 
precast NuPAGETM Tris-Acetate 
gels) 
50 mM Tricine 
50 mM Tris 
3.5 mM SDS 
4x Laemmli-buffer 
0.25 mM Tris-HCl (pH 6.8) 
8 % (w/v) SDS 
40 % (v/v) Glycerol 
0.004 % (w/v) Bromphenol blue 
100 mM DTT 
 
4.1.4 Coomassie staining of SDS polyacrylamide gels 
After SDS-PAGE, gels were washed three times for 5 min with H2O before incubating with 
PageBlueTM protein staining solution (Thermo Fisher Scientific, Waltham, USA) (1 h – overnight 
(o.n.)). Subsequent to this, gels were washed several times with water in order to reduce 
background staining. 
 
4.1.5 2D gelelectrophoresis 
2-dimensional (2D) gelelectrophoresis is a combination of isoelectric focusing (IEF) and SDS-
PAGE which enhances protein and protein-isoform separation in cell lysates and other complex 
mixtures (O'Farrell 1975; Klose 1975).   
Prior to the IEF, proteins were precipitated according to the method described by Wessel and 
Flügge (1984). In brief, 300 µg protein sample (in 100 µl aqueous solution) were mixed with 
400 µl methanol and centrifuged for 10 s at 9,000 x g. Afterwards, 100 µl chloroform were added 
before the mixture was vortexed and centrifuged again (10 s, 9,000 x g). This step was followed 
by the addition of 300 µl H2O, vigorous mixing and centrifugation for 1 min at 9,000 x g. The 
upper phase was discarded before 300 µl methanol were added to the reaction tube. After an 
additional centrifugation step (2 min, 9,000 x g), the supernatant was discarded and the protein 
pellet was air dried. 
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Dephosphorylation of proteins prior to IEF was performed by incubating 300 µg protein lysate 
with 300 units (U) calf intestine alkaline phosphatase (CIAP) in a total volume of 100 µl lysis 
puffer (see section 4.1.2). The reaction was incubated for 1 h at 37°C before the proteins were 
precipitated by the Wessel-Flügge method.  
For IEF, protein pellets were dissolved in 125 µl rehydration solution. Prior to isoelectric 
focusing, active rehydration of the IEF strip (7 cm, pH range 6-11 (linear), GE Healthcare, Chicago, 
USA) with the protein solution was performed for 12 h at 50 V. The different steps of IEF are 
listed below. The IEF was performed with the PROTEAN IEF cell (Bio-Rad).  
Step Voltage Duration 
Conditioning step 250 V 15 min 
Voltage ramping 4000 V (linear ramp) 2 h 
Final focusing 4000 V (rapid ramp) 20,000 Vh 
Hold step 500 V ∞ 
 
After IEF, the gel stripes were stored at -80°C until gel electrophoresis was performed. For SDS-
PAGE, 15 % separating gels (1.5 mm thickness) without stacking gels were prepared. The IEF 
strip and a small piece of Whatman paper soaked with PageRulerTM prestaind protein ladder 
(Thermo Fisher Scientific, Waltham, USA) were placed on top of the polyacrylamide gel. 
Subsequently, 0.5 % Agarose (w/v), dissolved in SDS-PAGE-running buffer, was added. Gel 
electrophoresis was performed at 110 V in the Mini-PROTEAN gel system (Bio-Rad).  
Solution Concentration Component  
Rehydration solution 
8 M Urea 
2 % (w/v) CHAPS 
0.005 % (w/v) Bromphenol blue 
20 mM DTT 
0.2 % IEF buffer for pH range 6-11* 
* GE Healthcare, Chicago, USA 
 
4.1.6 Western Blot and immune detection of proteins 
The western blot method aims at transferring proteins from polyacrylamide gels onto 
membranes. Subsequently, the immobilized protein of interest can be detected via antibodies. 
For signal visualization, these antibodies are often linked to a fluorophore or a horseradish 
peroxidase (HRP). Whereas fluorophores are emitting electromagnetic radiation after excitation 
with a certain wavelength, the HRP catalyzes a chemical reaction which is associated with the 
emission of light (chemoluminescence) (Towbin et al. 1979).  
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Prior to western blotting, the nitrocellulose membrane was activated in water. Afterwards, the 
gel and the nitrocellulose membrane were dipped in blotting buffer before placing them 
between two stacks of presoaked Whatman paper. Electrotransfer was either performed by 
semi-dry (for self-made gels) or wet blot (for NuPAGETM Tris-Acetate gels) condition. The 
currents used for protein transfer are listed below. 
Method Current [mA ∙ (cm² membrane)-1 ∙ min-1] 
Semi-dry protein transfer 0.02 or 0.1 
Wet protein transfer 0.08 
 
After electrotransfer, proteins bound to the nitrocellulose membrane were stained for 10 min 
with Ponceau staining solution at RT. Subsequent to this, the membrane was blocked with 5 % 
BSA (w/v) or 5 % powdered milk (w/v) in TBST (1x TBS, 0.1 % Tween-20 (v/v)) for 1 h followed 
by the incubation with the primary antibody overnight at 4°C. Afterwards, the membrane was 
washed three times for 5 min with TBST and then incubated with the horseradish peroxidase 
conjugated secondary antibody for 1 h at RT. Three additional washing steps (three times for 
5 min with TBST) were performed before detecting the target proteins by enhanced 
chemoluminescence (ECL).  
Solution Concentration Component  
Blotting buffer (for self-made 
gels) 
25 mM Tris  
0.2 M Glycine 
20 % (v/v) Methanol  
Blotting buffer (for precast 
NuPAGETM Tris-Acetate gels*) 
25 mM Bis-Tris 
25 mM Bicine 
1 mM  EDTA 
20 % (v/v) Methanol 
10x TBS (pH 7.6) 
0.2 M Tris 
1.5 M NaCl 
Ponceau staining solution  
0.2 % (w/v) Ponceau-S 
5 % (v/v) Acetic acid 
* life technologiesTM, Carlsbad, USA 
 
4.1.7 Quantification of Western Blot signals 
ECL signals below saturation were quantified using the FusionCapt Advanced camera software 
version 16.15 (Vilber Lourmat). For normalization, signal intensities derived from the protein of 
interest were divided lane-wise by a corresponding intensity value measured for a 
“housekeeping” protein, such as α-Tubulin.  
If Western Blot signals were statistically analyzed, R-studio was used to test the homogeneity of 
variances by a Levene’s test. Within the present study, all significance value of the Levene’s test 
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were higher than 0.05. Therefore, homoscedasticity was assumed and a normal two sample t-
test was performed by using R-studio (Null-hypothesis = difference in means is 0, two-sided, 
unpaired, confidence interval 0.95) (version 1.2.5019) (R Core Team 2019).  
For calculating the standard deviation, the denominator n-1 was used.  
 
4.2 Molecular biology techniques 
4.2.1 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used to separate DNA fragments according to their 
length. By adding intercalating substances such as ethidium bromide to the agarose gel, DNA 
fragments can be visualized via ultraviolet (UV)-light.  
For gel preparation, agarose was dissolved in hot 1x TAE-buffer. Ethidium bromide (final 
concentration 0.5 µg/ml) was added to the agarose solution before polymerization. Once the 
gel was polymerized, DNA samples were mixed with 6x DNA gel loading dye (Thermo Fisher 
Scientific, Waltham, USA) and loaded onto the gel. The GeneRuler 1 kb DNA Ladder (Thermo 
Fisher Scientific, Waltham, USA) was loaded for size determination of DNA fragments. 
Electrophoresis was performed at 120 V and DNA fragments were visualized by UV-light.  
Solution Concentration Component  
1x TAE 
40 mM Tris  
5.7 % (v/v) Acetic acid 
2 mM EDTA 
 
4.2.2 Transformation 
In molecular biology, transformation is a process which aims at introducing foreign DNA 
constructs into bacteria. Inside the cells, the DNA vector is replicated and the genes encoded on 
the plasmid are expressed (Cohen et al. 1972). 
For transformation, competent Escherichia coli (E. coli) XL1-Blue were thawed on ice before 
10 ng of plasmid DNA were added. The mixture was incubated on ice for 20 min. Heat shock was 
performed for 45 s at 42°C. Subsequently, the cells were placed on ice for 2 min. After adding 
1 ml prewarmed LB-medium, the cell suspension was transferred to a 15 ml reaction tube and 
incubated for 1 h at 37°C and 200 rpm. 50 µl and 100 µl of the bacteria suspension were plated 
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on two antibiotic containing LB agar plates, respectively. The agar plates were incubated at 37°C 
overnight. 
LB-medium (pH 7.2) 
10 g/l tryptone/peptone 
5 g/l BactoTM yeast extract* 
10 g/l NaCl 
* Thermo Fisher Scientific, Waltham, USA 
 
4.2.3 Plasmid extraction and purification  
After transformation, single bacteria colonies were picked and cultivated for 8-10 h at 37°C in 
5 ml LB-medium containing 25 µg/ml kanamycin. Subsequently, the entire pre-culture was 
added to 100 ml LB-medium (25 µg/ml kanamycin). This main culture was incubated at 37°C 
overnight. On the next day, bacteria were harvested and used for plasmid DNA purification. For 
this purpose, either the QIAprep® Spin Miniprep Kit (Qiagen, Hilden, Germany) or the Pure Link® 
HiPure plasmid filter midiprep kit (Invitrogen, Carlsbad, USA) was used according to the 
instruction given in the manual.  
 
4.2.4 Site directed mutagenesis  
Site directed mutagenesis (SDM) is a technique aiming at generating point mutations at a 
specific position within the plasmid DNA sequence, thus leading to an amino acid exchange in 
the gene product. In this method, the mutation is introduced by polymerase chain reaction 
(PCR)-based amplification of the template vector with specific primers carrying the modified 
DNA pattern within their sequence (Agilent Technologies SDM Manual). The technique is often 
used in phosphomimetic studies in order to investigate the functional impact of a certain 
phosphorylation site. Here, the substitution of an amino acid residue at a potential phospho-site 
with an acidic amino acid mimics a permanent phosphorylation. In contrast, the replacement by 
non-charged amino acid such as alanine imitates a non-phosphorylatable isoform.  
Prior to PCR, SDM-primers were phosphorylated by using a T4-polynucleotide kinase (PNK) 
according to the recipe given below. The reaction was incubated for 1 h at 37 °C.  
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Component  
Primer  500 pmol 
10 x T4-PNK buffer 5 µl 
100 mM ATP 1 µl 
T4-PNK 0.5 units 
H2O ad 50 µl 
The pCMV6_SNAPIN plasmid used as a template (purchased from Origene) in SDM was amplified 
in E. coli XL1-Blue stain and purified by the Pure LinkTM HiPure plasmid filter midiprep kit 
(Invitrogen, Carlsbad, USA). SDM was performed via PCR. The master mix components and 
program used for PCR are listed below. For SDM, the master mix was preheated to 95°C before 
1 µl of Pfu DNA polymerase was added. 
Master mix component  
Template 20 ng 
10x Pfu buffer 5 µl 
2 mm dNTP mix 5 µl 
Phospho. forward primer 10 pmol 
Phospho. reverse primer 10 pmol 
DMSO 5 µl 
25 mm MgCl2 3 µl 
H2O ad 49 µl 
 
 
In order to digest the methylated template vector, the PCR mixture was incubated with 1 µl DpnI 
at 37°C overnight. On the next day, the oligonucleotides were purified by using a silica column 
and the buffers of the QIAprep® Spin Miniprep Kit (Qiagen, Hilden, Germany). For this purpose, 
the oligonucleotide mixture after PCR and DpnI digestion was mixed with 150 µl QIAprep® PB-
buffer and added to a QIAprep® silica column. The column was centrifuged for 30 s at 12,000 x g 
and the flow through was loaded again. After another centrifugation step at 12,000 x g for 30 
sec, the column was washed twice with 750 µl QIAprep® PE-buffer (30 sec, 12,000 x g). In order 
to remove residual washing buffer, the column was centrifuged for 1 min at 12,000 x g. 
Oligonucleotides were eluted by adding 30 µl H2O to the column. After incubation for 1 min at 
RT, the column was centrifuged at 12,000 x g for 1 min and the whole flow through was used for 
transformation into E. coli XL1-Blue. The plasmids were purified by the QIAprep® Spin Miniprep 
Step Temperature Time  
Initial denaturation 95°C 30 sec  
Denaturation 95°C 30 sec  
Annealing 55°C 60 sec x 16 cycles 
Elongation 68°C 300 sec  
Final elongation 72°C 5 min  
Storage 4 C ∞  
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Kit followed by a control digestion with BamHI (see section 4.2.5). Digestions with the expected 
fragment pattern were sent for Sanger Sequencing.  
 
4.2.5 Restriction digestion 
Restriction endonucleases are frequently used tools in molecular biology for DNA cleavage at 
specific sequence pattern (Meselson and Yuan 1968; Smith and Wilcox 1970).  
For control digestion after SDM, plasmid DNA was digested with fast-digest (FD) restriction 
BamHI according to the recipe below. The mixture was incubated for 45 min at 37°C. Afterwards, 
DNA fragments were separated according to their length by agarose gel electrophoresis. 
Component  
Plasmid DNA 600-900 ng 
10 x FD green buffer 1.5 µl 
FD BamHI 1 µl 
H2O ad 15 µl 
 
4.2.6 Sanger sequencing 
After cloning, vector assembly was validated by Sanger sequencing (Sanger et al. 1977). 
Sequencing samples were prepared by mixing 500 ng plasmid with 25 pmol sequencing primer 
and adjusting the volume to 10 µl with H2O. For LightRun Sanger sequencing, the samples were 
sent to Eurofins Genomics (Ebersberg, Germany). 
 
4.3 Cell culture 
4.3.1 Cell cultivation 
Human embryonic kidney (HEK 293) and Henrietta Lacks (HeLa) cells were cultivated in DMEM 
GlutaMAXTM medium supplemented with 9 % (v/v) fetal calf serum (FCS) and 0.9 % (v/v) 
penicillin/streptomycin (Pen/Strep). The single medium components were purchased from life 
technologiesTM (Carlsbad, USA).  
For subcultivation, cells were washed twice with Dulbecco’s phosphate-buffered saline (DPBS) 
(life technologiesTM, Carlsbad, USA) and detached from the surface by adding 0.5 ml 0.05 % 
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trypsin-EDTA (life technologiesTM, Carlsbad, USA) solution per 10 cm petri dish. Once the cells 
were in suspension, a minimum of 2.5 ml cultivation medium were added in order to inactivate 
the trypsin. According to the split ratio, cells were transferred to a centrifugation tube and 
centrifuged for 3 min at 328-1,000 x g. Afterwards, the cell pellet was resuspended in fresh 
medium and the cells were cultivated at 37 °C and 5 % (HEK cells) or 5-10 % (HeLa cells) CO2 
respectively.  
 
4.3.2 Cell counting 
Cells were counted with a Fuchs-Rosenthal counting camber. For this purpose, the cell pellet 
after trypsinization and centrifugation was resuspended in cultivation medium and, if necessary, 
further diluted before 10 µl of the suspension were mixed with 10 µl 0.4 % trypan blue stain 
solution (life technologiesTM, Carlsbad, USA). Afterwards, the mixture was pipetted into a Fuchs-
Rosenthal counting camber with 16 one square millimeter areas (16 b-fields) and a depth of 
0.2 mm. The number of cells present within four b-fields was counted and the cell concentration 
of the suspension was calculated with the following formula: 
 cell concentration [cells/ml] = number of cells in 4 b-fields x dilution factor ∙ 1250 
 
4.3.3 Cryopreservation and thawing of cells 
For cryopreservation, cells were trypsinized according to the procedure mentioned for cell 
subcultivation. After centrifugation, cells were resuspended in cultivation medium containing 
10 % DMSO (v/v). The cell suspension was transferred to cryovials and frozen at -80 °C for at 
least 24 h in a polystyrene rack. For long term storage, cryovials were transferred to a liquid 
nitrogen cryopreservation container.  
Frozen cells were thawed by incubating the cryovial at 37 °C in a water bath until approx. 90 % 
of the suspension was defrosted. Afterwards, cells were transferred to 9 ml of prewarmed 
medium and centrifuged for 3 min at 328-1000 x g. Subsequent to this, the cells were 
resuspended in fresh medium and cultivated at 37 °C and 5 % (HEK cells) or 5-10 % (HeLa cells) 
CO2 respectively.  
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4.3.4 Stable isotope labeling with amino acids in cell culture (SILAC) 
In order to label proteins on cell culture level, the cultivation media can be supplemented with 
three different isotopically labeled arginine and lysine variants. These amino acids are 
incorporated into the protein sequence during translation thus leading to light, medium and 
heavy labeled cell populations which originated from the same cell-starting material. After their 
generation, these cells in which the proteins were isotopically labeled according to the SILAC 
procedure can be used for investigating stimulus-induced quantitative changes in the proteome. 
For example, a specific cell treatment can be applied to cells grown in cultivation medium 
containing heavy arginines and lysines (mass shifts compared to light variants R +10 Da and K 
+8 Da). In contrast, cells used as a stimulation control could be cultivated in medium 
supplemented with light variants of these two amino acids. After cell lysis, the lysates of the 
treated and non-treated samples are combined. Tryptic peptides generated during mass 
spectrometry sample preparation contain at least one isotopically labeled arginine or lysine 
(except peptide derived from protein C-terminus). Therefore, a mass shift can be observed for 
peptides with the same sequence derived from the different sample groups. Based on this, 
differences in the peptide abundances can be relatively quantified by MS analysis (Ong et al. 
2002; Ong et al. 2003; Ong and Mann 2006).  
The media used for SILAC and cultivation of isotopically labeled cells are listed below.  
SILAC light cultivation  
medium 
SILAC medium cultivation 
medium 
SILAC heavy cultivation 
medium 
DMEM for SILAC DMEM for SILAC* DMEM for SILAC* 
+ 9 % FCS (v/v)* + 9 % FCS (v/v)* + 9 % FCS (v/v)* 
+ 0.9 % Pen/Strep (v/v)* + 0.9 % Pen/Strep (v/v)* + 0.9 % Pen/Strep (v/v)* 
+ 0.8 mM Lysine light** + 0.8 mM Lysine medium (+4)$ + 0.8 mM Lysine heavy (+8)$ 
+ 0.4 mM Arginine light** + 0.4 mM Arginine medium (+6)$ + 0.4 mM Arginine heavy (+10)$ 
* Thermo Fisher Scientific, Waltham, USA 
** Sigma Aldrich, St. Louis, USA 
$ Cambridge Isotopes Laboratories, Tewksbury, USA 
 
In order to start isotopic labeling of proteins, cells were detached from the cultivation dish like 
mentioned before. The cell suspension after inactivation of trypsin was split into three 
centrifugation tubes. After centrifugation for 3 min at 328-1000 x g, the cell pellets were either 
resuspended in SILAC light, medium or heavy medium. Cells were cultivated at 37 °C and 5 % 
(HEK cells) or 5-10 % (HeLa cells) CO2 respectively. Protein labeling was performed by 
subcultivating the cells in the particular medium for at least seven cell cycles.  
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4.3.5 Cell treatment 
For cell stimulation, the cultivation media was aspirated and replaced by the corresponding 
stimulation medium (cultivation medium plus additives). Adding FSK and Torin1 (both dissolved 
in DMSO) to the media resulted in a final DMSO concentration of 0.1 % (v/v). Therefore, DMSO 
was added to the control media in order to yield the same final DMSO concentration. The 
different stimulation media used in this study are listed below.  
Condition db-cAMP* 
concentration 
Forskolin$ 
concentration 
Torin1**$ 
concentration 
DMSO 
concentration 
Duration 
PKA/EPAC 
stimulation 
medium 
100 µM 10 µM - 0.1 % (v/v) 30 min 
PKA/EPAC 
Stimulation 
control 
- - - 0.1 % (v/v) 30 min 
mTOR 
inhibition 
medium 
- - 125 nM 0.1 % (v/v) 50 min 
mTOR 
inhibition 
control 
- - - 0.1 % (v/v) 30 min 
* dibutyryl-cyclic adenosine monophosphate 
** Tocris Bioscience (Bristol, UK) 
$ dissolved in DMSO 
 
4.3.6 Transfection  
TurboFectTM (Thermo Fisher Scientific, Waltham, USA) is a cationic polymer designed to complex 
DNA and facilitate the introduction of nucleic acids into eukaryotic cells by a process called 
transfection. 
Cells were transfected by using the TurboFectTM reagent according to the manufacturer’s 
instructions. In brief, cells were grown in a 6-well plate to a confluency of 50-90 %. For 
preparation of the transfection mixture, 1 µg of plasmid DNA was mixed with 300 µl DMEM 
GlutaMAXTM (life technologiesTM, Carlsbad, USA) and 6 µl TurboFectTM. The mixture was 
incubated for 15-20 min at room temperature before it was added drop-wise to the cells. After 
incubation at 37 °C in a CO2 incubator for 5 h, the transfection medium was aspirated and 
replaced by fresh cultivation medium.  
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4.3.7 Stable transfection  
For generating cell lines stably expressing the transgene of interest, cells were transfected with 
TurboFectTM (Thermo Fisher Scientific, Waltham, USA) according to the procedure mentioned in 
section 4.3.6. 24 h after transfection, 1 mg/ml G418 (life technologiesTM, Carlsbad, USA) was 
added to the culture in order to select for cells expressing the neomycin resistance gene located 
on the plasmid encoding for the transgene. Every two to three days, the medium was changed 
until stable colonies were formed. Single colonies were picked, transferred to a new cultivation 
plate and further incubated at 37°C and 5 % CO2. After reaching a confluency of min. 50%, the 
cells were prepared for cryopreservation as mentioned before. For Co-immunoprecipitation (Co-
IP) experiments, cells were labeled according to the SILAC procedure. 
 
4.3.8 Gene knock-out via CRISPR-Cas9 
Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 
(Cas9) is a technique which allows genome editing of living organisms. Cells are co-transfected 
with a CRISPR (cr)- and a transactivating cr (tracr)-RNA as well as a plasmid encoding for the Cas9 
endonuclease. After partial binding of the crRNA to the DNA target sequence, the tracrRNA 
hybridized with the free end of the crRNA thus building the recognition site for Cas9 and 
promoting DNA cleavage at this position (Jinek et al. 2012; Le Cong et al. 2013; Mali et al. 2013). 
DNA double strand breaks can be repaired by the host cell DNA repair machinery via processes 
such as non-homologous end joining (NHEJ). However, as NHEJ is an error prone procedure, 
nucleotide insertion or deletion might occur at these positions thus resulting in truncated or 
non-sense gene products and generating a functional gene knock-out (reviewed by Chiruvella et 
al. 2013).  
In order to knock-out the SNAPIN gene with the CRISPR-Cas9 technique, HEK 293 (150,000 cells 
per well) and HeLa cells (80,000 cells per well) were seeded in a 24-well plate and cultivated for 
24 h at 37 °C and 5 % or 10 % CO2, respectively. Prior to co-transfection, the dried nucleotide 
constructs (all obtained from Dharmacon/Horizon (Cambridge, UK)) were dissolved in 10 mM 
Tris-HCl pH 7.5. The CRISPR-Cas9 nucleotide solution was prepared by mixing 35 µl DMEM 
GlutaMAXTM (life technologiesTM, Carlsbad, USA) with 2.5 µl 10 µM Edit-R tracrRNA, 2.5 µl 10 µM 
SNAPIN Edit-R crRNA (target sequence: TTTGTTCCCGGAGCTCTACC; protospacer adjacent motif 
(PAM): TGG; Exon 2) and 10 µl 100 ng/µl Edit-R Cas9-Plasmid solution. For preparation of the 
transfection solutions, DharmaFECT (Dharmacon/Horizon (Cambridge, UK)) (1 mg/ml) was 
diluted in DMEM GlutaMAXTM (life technologiesTM, Carlsbad, USA) in order to generate solutions 
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containing either 20-30 µg/ml (HeLa cells) or 60 µg/ml (HEK 293 cells) of the transfection 
reagent. The dilutions were incubated for 5 min at RT. Subsequently, 50 µl of the transfection 
solutions were mixed with the equal volume of the CRISPR-Cas9 nucleotide solution. After 
incubating for 20 min at RT, the transfection medium was prepared by adding the DharmaFECT-
nucleotide-mixture to 400 µl DMEM GlutaMAXTM supplemented with 9 % FCS (life 
technologiesTM, Carlsbad, USA). For cell transfection, the cultivation medium was replaced by 
500 µl transfection medium and cells were cultivated for 48 h at 37°C and 5 % or 10 % CO2, 
respectively. 
As the Cas9 Plasmid contains a puromycin resistance cassette, this antibiotic can serve as a 
selection marker for validating the transfection of cells with the Cas9 plasmid.  
48 h after transfection, cells were washed three times with PBS and detached from the 
cultivation surface by adding 200 µl 0.05 % Trypsin-EDTA (life technologiesTM, Carlsbad, USA) to 
the wells. After the addition of 1 ml cultivation medium, cells were centrifuged for 5 min at 
300 x g. The cell pellet was resuspended in 500 µl medium before 100 µl of the cell suspension 
were added to one well of a 24-well plate. Subsequent to this, 400 µl puromycin (life 
technologiesTM, Carlsbad, USA) containing media were added in order to obtain a final volume 
of 500 µl and a puromycin concentration of 2.5 µg/ml. Cells were cultivated at 37 °C and 
selection medium was replaced every two days. For HeLa cells, the transfection as well as the 
initial cultivation after transfecting the nucleotides were performed by Pawel Mozolewski 
(laboratory trainee). 
After reaching a confluency of 80 %, cells were detached from the cultivation surface like 
mentioned before and counted with a Fuchs-Rosenthal counting camber. In order to prepare a 
monoclonal cell population, the suspension was diluted to achieve a theoretical cell 
concentration of 0.7 cells per 200 µl. Afterwards, the wells of two 96 well plates were inoculated 
with 200 µl of this suspension before the cells were cultivated at 37°C and 5 % or 10 % CO2, 
respectively. Cell growth was monitored by light microscopy. When observing three-
dimensional cell growth, each monoclonal colony was splitted to one well of three microtiter 
plates. Cells were cultivated at 37°C and 5% or 10 % CO2 until a minimum confluency of 60 % 
was reached.  
For cryopreservation, the cells grown in two 96-well plates were washed twice with 100 µl DPBS 
(life technologiesTM, Carlsbad, USA) before 25 µl 0.05 % Trypsin-EDTA were added. Once they 
were detached, cells were mixed with 50 µl DMEM GlutaMAXTM containing 20 % FCS, 
1 % Pen/Strep (life technologiesTM, Carlsbad, USA) and 10 % DMSO. The cell suspension was 
transferred to a fresh microtiter plate and stored at -80 °C.  
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Monoclonal colonies were further investigated for successful generation of a SNAPIN gene 
knock-out by next generation sequencing (NGS). For this purpose, cells grown on the third 
multitier plate were washed twice with 100 µl DPBS and lysed with 30 µl cold lysis buffer. The 
lysates were transferred to a MicroAmpTM optical 96 well reaction plate (Thermo Fisher 
Scientific, Waltham, USA), sealed with a foil and heated for 10 min at 65 °C and 15 min at 95 °C. 
After a short centrifugation, the cell lysates were stored at -20°C. 
Solution Concentration Component  
Lysis buffer 
1 % (w/v) Triton X-100 
10 mM Tris-HCl (pH 7.5) 
1 mM CaCl2 
3 mM  MgCl2 
1 mM EDTA 
0.2 mg/ml Proteinase K 
 
Functional gene knock out via CRISPR-Cas9 was validated by NGS. For this purpose, the DNA 
region comprising the Cas9 target site was amplified via two PCRs. Besides amplification, the 
first PCR aims in fusing nucleotide adapters to the target site containing DNA sequence. These 
adapter sequences are important for the binding of the barcode primers used in the second PCR. 
The second PCR is performed with a unique set of barcode primers for each monoclone grown 
in a multitier plate after gene knock out via CRISPR-Cas9 (e.g. clone A1: D501_long Primer A + 
D701_long Primer B; see section 3.7 for primer sequences). Together with the gene sequence, 
the barcode primer combinations are used for deducing successful gene knock out among the 
monoclones within the NGS data set. 
The cell lysates of the monoclones were used as a template for the first PCR. Below, the 
components and the program used for PCR are listed.  
Components 1st PCR  
Template 1 µl 
5x Phusion HF buffer 4 µl 
2 mM dNTP mix 2 µl 
Forward primer 10 pmol 
Reverse primer 10 pmol 
Phusion DNA polymerase 0.4 units 
H2O ad 20 µl 
 
Step Temperature Time  
Initial denaturation 98 °C 2 min  
Denaturation 98 °C 10 sec  
Annealing 60 °C 20 sec x 19 cycles 
Elongation 72 °C 30 sec  
Final elongation 72 °C 5 min  
Storage 4 °C ∞  
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For the second PCR, 2 µl of the different forward and reverse barcode primer mixes were added 
to the wells of a MicroAmpTM optical 96 well reaction plate. After adding 3 µl PCR products of 
the first PCR, 15 µl master mix were added. The composition of the master mix is listed below. 
For PCR, the same program was used as in the first PCR.  
Components Master Mix 2nd PCR  
5x Phusion HF buffer 4 µl 
2 mM dNTP mix 2 µl 
Phusion DNA polymerase 0.4 units 
H2O ad 15 µl 
 
For NGS, 3-5 µl of all PCR products of the second amplification reaction were combined in a 
1.5 ml reaction tube and send to the NGS Core Facility of the Medical Faculty of the University 
of Bonn for MiSeq sequencing (Illumina, San Diego, USA). 
Data analysis was performed by using the “OutKnocker” web tool (version 1.31; Indel Threshold 
2%, Phred Score Threshold 27 %) as well as the SNAPIN reference gene sequence obtained from 
the UCSC Genome Browser (retrieved 26.07.2017) by uploading the human genome build (38 
release 2) and the primer sequences used for the first CRISPR-Cas PCR (Kent et al. 2002; Schmid-
Burgk et al. 2014). 
 
4.4 Lysosome enrichment 
Superparamagnetic particles can be used for lysosome isolation in vitro. This technique is based 
on the endocytosis of these dextran coated iron oxide beads and their accumulation in the 
lysosomal compartment after a 24 h chase (Walker and Lloyd-Evans 2015; Thelen et al. 2017).  
Prior to HEK 293 cell seeding for lysosome isolation, the 10 cm cultivation dishes were coated 
with 0.1 mg/ml poly-L-lysine (in DPBS) for 10 min at room temperature. Afterwards, the dishes 
were washed three times with DPBS (life technologiesTM, Carlsbad, USA) before 5 x 106 HEK 293 
cells were seeded in cultivation medium supplemented with 1 mg/ml EndoMAG 
superparamagnetic iron oxide particles (Liquids Research, Bangor, UK). The cells were incubated 
with the magnetite medium for 24 h at 37°C and 5 % CO2. Subsequent to this, the pulse medium 
was removed, and cells were washed three times with DPBS. For the 24 h chase, cells were 
cultivated in normal cultivation medium at 37°C and 5 % CO2.  
Before starting with the lysosome enrichment, cells were stimulated according to the procedure 
described in section 4.3.5. For each condition, two 10 cm dishes were used. Afterwards, cells 
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were washed three times with pre-chilled PBS (recipe see section 4.1.2) and cells were scraped 
in 0.5-1 ml ice-cold isolation buffer per 10 cm dish. Isotopically labeled cells (SILAC) treated with 
the different stimulation media were merged at this point and transferred to a tight-fitting 
Dounce homogenizer. Unlabeled cells were kept separately for homogenization. Cell lysis was 
performed with 25 strokes on ice. Subsequently, the cell lysate was centrifuged at 1,000 x g for 
10 min at 4°C. The supernatant was poured to a fresh 15 ml tube and the pellet was resuspended 
in 4 ml isolation buffer. After transferring the suspension to the homogenizer, the 
homogenization and centrifugation procedure was repeated, and the supernatants of both lysis 
steps were combined.  
For lysosome isolation, a ferromagnetic matrix containing LS column (Miltenyi Biotec, Bergisch 
Gladbach, Germany) was inserted into a magnetic stand (Quadro MACS Separator) and 
equilibrated with 1 ml 0.5 % BSA in PBS. The combined supernatant was mixed with 4 ml 
isolation buffer and afterwards applied to the column. Subsequent to this, 1 ml of 1 µg/ml RNAse 
solution (in isolation buffer) was added and incubated for 10 min at RT. After washing with 5 ml 
isolation buffer, the column was removed from the magnetic stand. Lysosomes were eluted by 
pressing two times 500 µl isolation buffer through the column. The eluate was centrifuged for 
20 min at 20,000 x g and 4°C. Pelletized lysosomes were resuspended in 500 µl isolation buffer. 
From each fraction of the isolation process, a sample was removed and investigated by a β-
hexosaminidase activity assay (see section 4.5.3). 
Lysosomes used for phosphopeptide enrichment were separated into a soluble and membrane 
fraction. For this purpose, lysosomal membranes were disrupted by treating the eluate of the 
magnetic column with a tip sonicator (Branson Sonifier 250; 5 mm Tip; 8 x 45 pulses Duty Cycle 
50 %, Output 3; 1 x 30 s Duty Cycle constant, Output 3). The disruption of the lysosomal 
membrane was validated by performing a β-hexosaminidase activity assay. Here, differences in 
the activity of the same sample incubated with or without detergent could be used as a direct 
measure of lysosome integrity. Lysosomal membranes were pelletized by centrifuging the 
sample for 1 h at 4°C and 100,000 x g. The supernatant was removed (soluble fraction) and the 
membrane pellet was dissolved in 100 µl DB02 containing 1x HaltTM Phosphatase Inhibitor 
Cocktail (membrane fraction). After performing a BCA protein assay, 120 µg protein of the 
soluble and membrane fractions were used for tryptic digestion prior to phosphopeptide 
enrichment. 15 µg of each fraction were prepared for in-gel digestion.   
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Solution Concentration Component  
Isolation buffer 
10 mM HEPES (pH 7.4) 
250 mM Sucrose  
1 mM CaCl2 
1 mM  MgCl2 
1.5 mM Mg(CH3COO)2 
15 mM  KCl 
1 mM DTT 
5 mM  EDTA$ 
1x HaltTM Protease Inhibitor Cocktail* 
1x HaltTM Phosphatase Inhibitor Cocktail* 
DB02 
0.5 % (w/v) SDC 
20 mM TEAB 
* HaltTM Protease Inhibitor Cocktail (Thermo Fisher Scientific, Waltham, USA) 
$ Lysosome enrichment from non-isotopically labeled cells was performed without EDTA in the isolation buffer 
 
4.5 Biochemical assay 
4.5.1 Arylsulfatase A (ASA) biotinylation, endocytosis and quantification via ELISA 
The Enzyme Linked Immunosorbent Assays (ELISA) is an antibody-based technique to detect and 
quantify proteins of interest in a liquid sample. This method is based on the immobilization of a 
specific protein to a microtiter plate surface and its detection via specific antibodies. In presence 
of an appropriate substrate solution, a colorimetric reaction is catalyzed by an enzyme linked to 
the antibody used for detection. Here, the strength of the colorimetric reaction correlates with 
the concentration of the bait protein. Thus, absorbance measurements at a particular 
wavelength can be used for determination of the abundance of the protein of interest within 
the sample (Engvall and Perlmann 1972; Wolters et al. 1976).  
In order to distinguish endogenous and fed arylsulfatase A (ASA), the supplemented ASA was 
biotinylated prior to the endocytosis experiments. For this purpose, a 10 kDa cut off spin filter 
(low protein biding centrifugal filter, VWR, Radnor, USA) was equilibrated with 300 µl 150 mM 
mannitol in PBS (for recipe see section 4.1.2) by centrifugation for 2 min at 10,000 x g. After 
adding human ASA solution to the filter, the volume was adjusted to 300 µl and the mixture was 
centrifuged again (5 min, 10,000 x g). 300 µl 150 mM mannitol in PBS were loaded to the filter 
device before another centrifugation step (5 min at 10,000 x g) was performed. This step was 
repeated twice. EZ-LinkTM sulfo-NHS-biotin (Thermo Fisher Scientific, Waltham, USA) was 
dissolved in 150 mM mannitol (in PBS). Compared to ASA, a 100-fold molar excess of sulfo-NHS 
biotin was added to the protein solution. The mixture was incubated for 30 min at RT. Remaining 
active NHS sites were blocked by adding a 100-fold molar excess of glycine (compared to sulfo-
NHS biotin) to the reaction. After incubating for 15 min at RT, the filter was centrifuged for 5 min 
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at 10,000 x g. Two times 300 µl ASA buffer (150 mM D-mannitol, 27 mM glycine in PBS) were 
sequentially added to the filter device with centrifugation steps of 5 min at 10,000 x g in 
between. Afterwards, the filter supernatant was transferred to a new reaction vial. The 
concentration of biotinylated ASA within the supernatant was determined by DC protein assay.  
For the ASA endocytosis assay, HEK 293 and HEK SNAPIN knock-out (KO) cells were seeded in a 
24-well plate (60,000 cells per well) and cultivated for 72 h at 37°C and 5 % CO2. Prior to the 
assay, stimulation media were prepared in fresh DMEM GlutaMAXTM + 9 % FCS + 0.9 % Pen/Strep 
(all obtained from life technologiesTM, Carlsbad, USA) according to the concentrations listed 
below. Adding FSK (dissolved in DMSO) to the stimulation media resulted in a final DMSO 
concentration of 0.1 % (v/v). Therefore, DMSO was added to the stimulation control media in 
order to yield the same final DMSO concentration. Before applying to the cells, media were pre-
chilled on ice for at least 45 min. Cells were incubated with the respective stimulation medium 
for 35 min at 37°C and 5 % CO2. Compared to the FSK/db-cAMP stimulation condition mentioned 
in section 4.3.5, the duration of the treatment was prolonged for 5 min as the pre-chilled media 
need to warm up to 37°C first. After stimulation, cells were washed twice with cold PBS. ASA 
bound to the extracellular side of the plasma membrane was removed by incubating the cells 
for 2 min with 1 ml of pre-chilled ASA washing buffer (150 mM NaCl, 50 mM glycine pH 3.0). 
Subsequent to this, cells were washed three times with cold PBS before scraping the cells in 250 
µl pre-chilled lysis buffer (0.5 % Triton X-100 in TBS, pH 7.5). The cell lysates were transferred to 
a reaction tube and stored at -20°C. 
Condition db-cAMP 
concentration 
Forskolin$ 
concentration 
DMSO 
concentration 
Biotinylated ASA 
concentration 
Stimulation 
+ ASA 
100 µM 10 µM 0.1 % (v/v) 7.5 µg/ml 
Stimulation 
- ASA 
100 µM 10 µM 0.1 % (v/v) - 
Stimulation control 
+ ASA 
- - 0.1 % (v/v) 7.5 µg/ml 
Stimulation control 
- ASA 
- - 0.1 % (v/v) - 
$ dissolved in DMSO 
 
Cell lysates were first treated with a tip sonicator (Hielscher, UP50H; 12 pulses, Amplitude 90, 
Cycle 0.9) and then centrifuged for 5 min at 10,000 x g and 4°C. The supernatant was transferred 
to a fresh reaction tube and used for BCA assay and ELISA. 
For the ELISA, Nunc Immobilizer streptavidin coated 96-well plate (Thermo Fisher Scientific, 
Waltham, USA) was washed three times with 300 µl PBST (0.05% Tween-20 (v/v) in PBS). 
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Afterwards, 100 µl 5 % BSA (w/v) in PBST were added to the wells and mixed with 100 µl sample. 
Solutions with known concentrations of biotinylated ASA served as standards. After incubation 
for 1 h at RT, the wells were washed three times with 300 µl PBST. Subsequently, 50 µl anti-
human-ASA rabbit antiserum (1:2000 diluted with 5% BSA in PBST) were added to the wells and 
incubated for 1 h at 37°C. The wells were washed three times with 300 µl PBST before 50 µl of 
HRP-conjugated goat anti-rabbit antibody (1:2000 diluted with 5% BSA in PBST) were added. The 
secondary antibody was incubated for 1 h at 37°C followed by three washing steps with 300 µl 
PBST. ABTS substrate was dissolved in ABTS substrate buffer (both obtained from Roche, Basel, 
Switzerland) at a final concentration of 1 mg/ml. 50 µl ABTS solution were added to each well 
and incubated at RT until a slight color change was observed. Absorbance was measured at a 
wavelength of 405 nm (reference wavelength 505 nm) at several times (every 60-90 s; six time 
points in total). Based on a polynomial regression curve, the concentrations of biotinylated ASA 
within the particular samples were calculated. Subsequently, these concentrations were 
normalized to the protein concentrations of the corresponding lysates.  
Prior to the analysis of variance (ANOVA), the homogeneity of the group variances was tested in 
R-studio by using the Brown-Forsythe test (R-package: “car” (version 3.0-6)) (Fox and Weisberg 
2019). After demonstrating the homoscedasticity (p-value = 0.5633), R-studio was used to 
perform the one-way ANOVA and the Tukey honest significant difference (HCD) post hoc test 
(ordered = false, confidence interval 0.95).  
The standard deviation was calculated by using n-1 as the denominator.  
 
4.5.2 Exocytosis Assay 
The secretion of the lysosomal hydrolase β-hexosaminidase (β-Hex) was induced according to 
the procedure described by Rodríguez et al. (1997). For this purpose, HeLa wildtype (wt) and 
SNAPIN KO cells were grown as monolayers in a 6-well plate. Once reaching a confluency of 
100%, cells were incubated for 20 min at 37°C and 5 % CO2 with DMEM cultivation medium 
containing either FSK/db-cAMP or DMSO (see section 4.3.5). Subsequently, secretion was 
induced by replacing the stimulation- with exocytosis-medium comprising 1 mM CaCl2, 10 µM 
ionomycin. Media either without one or both additives served as controls. According to the 
stimulation condition, the exocytosis/control media were also supplemented with FSK/db-cAMP 
or DMSO. After incubation for 10 min at 37°C and 5 % CO2, the cell supernatant was removed, 
centrifuged for 5 min at 11,000 x g at 4°C and mixed with BSA solution (end concentration BSA 
0.1 mg/ml). The amount of β-Hex secreted during the 10 min exocytosis stimulus was 
investigated by determining the activity of this enzyme in the supernatant. Additionally, the cells 
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were washed two times with ice-cold PBS (for recipe see section 4.1.2) and scraped in 250 µl 
lysis buffer (1 % NP-40 in PBS). The lysates were treated with a tip sonicator (Hielscher, UP50H; 
20 pulses, amplitude 90, cycle 0.9) and centrifuged for 5 min at 10,000 x g at 4°C. Afterwards, 
the β-Hex activity in the lysates was investigated and the protein concentrations were estimated 
by a BCA assay. For data comparison, the β-Hex activities were normalized to the protein 
concentration in the cell lysates.  
Prior to the statistical comparison of two sample groups, the homogeneity of variances was 
tested by a Levene’s test (with R-studio). As all significance values of the Levene’s test performed 
in this experiment were higher than 0.05, homoscedasticity was assumed and a normal two 
sample t-test was performed by using R-studio (t-test between two conditions, null-
hypothesis = difference in means is 0, two-sided, unpaired, confidence interval 0.95).  
For calculating the standard deviation, the denominator n-1 was used.  
 
4.5.3 β-hexosaminidase activity assay 
The β-hexosaminidase activity assay is based on the enzymatic conversion of the substrate 4-
nitrophenyl-N-acetyl-β-D-glucosaminide to 4-nitrophenol. The quantity of the hydrolysis 
product directly correlates with the amount of free enzyme and can be determined by 
measuring the absorbance at 405 nm (Chatterjee et al. 1975; Marciniak et al. 2006).  
In the lysosome isolation process, the β-Hex activity can be used for lysosome quantification 
within the different fractions. By investigating the β-Hex activity of the input, flow through, wash 
and elution samples in the presence and in the absence of detergents, the proportion of intact 
and disrupted lysosomes can be quantified. In addition to that, the β-Hex activity assay can be 
used for monitoring lysosomal secretion upon elevated intracellular Ca2+ concentrations.  
For the β-hexosaminidase activity assay with samples of the lysosome enrichment procedure, 
25 µl of each sample were loaded to four different wells of a microtiter plate. The samples 
present in two of those wells were mixed with 8 µl 10 % (w/v) Triton-X100 solution. Afterwards, 
50 µl β-hexosaminidase substrate solution were added and the assay was incubated for 20 min 
at 37 °C. The reaction was stopped by adding 200 µl β-hexosaminidase stop solution to the wells 
before measuring the absorbance at 405 nm. 
Similar to the procedure mentioned above, the β-Hex activity in the cell lysates of the exocytosis 
experiment was investigated by loading 25 µl of each sample to a microtiter plate (double 
determination). After adding 50 µl β-hexosaminidase substrate solution, the reaction was 
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incubated for 30 min at 37°C. The assay was stopped by pipetting 200 µl β-hexosaminidase stop 
solution to each well. The absorbance was measured at 405 nm. 
In order to determine the β-Hex activity in the cell supernatant after the exocytosis experiment, 
200 µl of each sample was mixed with 200 µl β-hexosaminidase substrate solution in a 1.5 ml 
reaction tube (double determination). The mixture was incubated in a water bath at 37°C for 5 h 
before the assay was stopped by the addition of 200 µl β-hexosaminidase stop solution. 
Afterwards, 200 µl of each sample was loaded onto a microtiter plate. Subsequently, the 
absorbance was measured at 405 nm. 
Formula for calculating β-Hex activity: 
mU
ml
=  
Vtotal ∙ 10
6  ∙ OD405
ε405  ∙  Vsample  ∙ t ∙ d
 
ε405 = 18,500 M-1 ∙ cm-1; d = 0.75 cm (layer thickness 96-well plate) 
Solution Concentration Component  
β-hexosaminidase substrate 
solution (pH 4.6) 
0.1 M Citric acid monohydrate 
0.2 % (w/v) BSA 
10 mM  4-Nitrophenyl-N-Acetyl-β-D-glucosaminide 
β-hexosaminidase stop solution  0.4 M Glycine (pH 10.4) 
 
4.6 Interaction studies 
Co-immunoprecipitation (Co-IP) is a technique used to identify protein-protein interactions in 
vitro. The method is based on an antibody mediated pull down of the protein of interest together 
with its interaction partners.  
Co-Immunoprecipitation was performed by using isotopically labeled HEK SNAPIN KO cells 
(SILAC) stably transfected with a plasmid containing the SNAPIN S133A or the SNAPIN S133E 
proteoforms. Non-transfected SNAPIN KO cells served as a control.  
Cells grown on a 10 cm petri dish were harvested by scraping them from the surface (in 500 µl 
PBS (for recipe see section 4.1.2)). The cell suspension was centrifuged for 3 min at 1,000 x g. 
Afterwards the supernatant was removed and the cell pellet was snap frozen in liquid nitrogen. 
Cell lysis was performed by suspending the pellet in 500 µl ice-cold lysis buffer followed by a 
treatment with a tip sonicator (Hielscher, UP50H; 20 pulses, Amp 100%, Cycle 0.9). Subsequent 
to a centrifugation step at 10,000 x g for 5 min at 4 °C, the supernatant of the lysate was 
transferred to a fresh 1.5 ml tube. The protein concentration was determined by a BCA assay. 
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For each Co-IP sample, 45 µl Myc-Trap® beads (ChromoTek, Planegg-Martinsried, Germany) 
were transferred to a fresh 1.5 ml reaction tube and mixed with 500 µl Co-IP lysis buffer. 
Afterwards, the bead suspension was centrifuged for 2 min at 4 °C and 2,500 x g. The 
supernatant was removed and the washing procedure was repeated twice before the beads 
were incubated with 500 µg protein lysate for 2 h at 4°C on an orbital shaker (total volume 
500 µl). Subsequent to this, the beads were centrifuged (2 min, 4°C, 2,500 x g) and the 
supernatant was removed. The beads were washed three times with 500 µl lysis buffer. During 
the second washing step, the beads were transferred to a fresh tube. Proteins were eluted by 
incubating the beads for 5 min at 95 °C in 30 µl 2x SDS sample buffer. Prior to SDS-PAGE and in-
gel digestion, 10 µl of the isotopically labeled protein samples, belonging to the same replicate, 
were combined. SDS-PAGE was performed by using a 5 % stacking and a 10 % separation gel. 
For in-gel digestion, each lane was cut horizontally into six pieces. 
Solution Concentration Component  
Lysis buffer 
1 % (w/v) Triton X-100 
40 mM  HEPES (pH 7.4) 
150 mM  NaCl 
2.5 mM MgCl2 
1x HaltTM Protease Inhibitor Cocktail* 
* Thermo Fisher Scientific, Waltham, USA 
 
4.7 Immunocytochemistry and image acquisition 
High precision cover slips (12 mm) were placed in a 24-well plate and coated with 10 µg/ml 
fibronectin solution (AppliChem, Darmstadt, Germany) (in DPBS) for 60 min at 37 °C. Subsequent 
to this, the cover slips were washed once with DPBS (life technologiesTM, Carlsbad, USA). For 
immunocytochemistry, 60,000 HeLa wt and SNAPIN KO cells were seeded per cover slip/well. 
Cells were incubated at 37°C and 5 % CO2. After 24 h, the cells were treated with FSK/db-cAMP 
or DMSO as mentioned before (see section 4.3.5). Following this treatment, the cells were 
washed once with PBS (for recipe see section 4.1.2) before 300 µl 4 % PFA (w/v) (in PBS) were 
added to each well. Fixation was performed for 10 min at 37°C and 5 % CO2. The cells were 
washed three times with PBS and stored at 4°C covered with this solution until further usage.  
Prior to immune staining, cells were permeabilized with 0.2 % Triton X-100 in PBS (v/v) for 5 min 
at RT. Blocking was performed by incubating the cells for 1h (RT) with 5 % BSA in PBS (w/v). 
Afterwards, the cover slips were transferred to a wet chamber and incubated with the primary 
antibody over night at 4°C. On the next day, cells were washed three times with PBS (5 min, RT) 
on a shaking device before they were incubated with the secondary antibody for 1 h (RT) in a 
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wet chamber. After two washing steps with PBS, cells were shortly dipped in H2O. ProLong 
DiamondTM (with DAPI) (Thermo Fisher Scientific, Waltham, USA) was used in order to mount 
the cover slips to the specimen slides.  
Images were obtained together with Angnes von Keller from Zeiss Microscopy by using a 
LSM 980 equipped with an Airyscan 2 detector (inverse AxioObserver 7 microscope) (Zeiss, 
Oberkochen, Germany). A Zeiss Apochromat 63x/1.4 objective was used to acquire the images 
as Z-stacks. The Cy3 fluorophore was excited by a 561 nm laser (laser power 1 %). For excitation 
of DAPI, a 405 nm laser (laser power 0.99 %) was used. The detection wavelengths were set to 
422-477 and 573-627 nm. Images were processed by the Zeiss software with the 
“FastAiryScanSheppardSum” Airyscan mode. The single Z-stack images were combined by 
maximum intensity projection using the ImageJ software (version 1.51j8; Java 1.8.0_112) 
(Schneider et al. 2012). 
 
4.8 Mass spectrometry sample preparation 
4.8.1 Sample preparation for bottom up mass spectrometry analysis 
Bottom up mass spectrometry is a valuable tool in proteomic studies. The method is based on 
the proteolytic cleavage of proteins and the detection and identification of the resulting 
peptides by a mass spectrometer.  
4.8.1.1 Filter aided sample preparation (FASP) 
In filter aided sample preparation (FASP), proteins are retained above a molecular mass cut off 
spin filter thus allowing precise adjustments in the buffer compositions for protein reduction 
and alkylation prior to the proteolytic cleavage. However, after protein digestion, the peptides 
pass through the filter and can be collected in small reaction tubes for further purification, 
fractionation and mass spectrometric analysis (Manza et al. 2005; Wiśniewski et al. 2009).  
Protein samples from living cells were obtained by cell lysis in a buffer containing 5 % SDC (w/v), 
20 mM TEAB and 1x HaltTM Protease Inhibitor Cocktail (Thermo Fisher Scientific, Waltham, USA). 
Afterwards, the lysate was treated with a tip sonicator (Hielscher, UP50H; 1-3 x 20-30 pluses, 
Amp 90-100, Cycle 0.9) and centrifuged for 5 min and 4°C at 10,000 x g. Subsequent to this, the 
protein concentration in the supernatant was determined by a BCA assay.  
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LysN and LysArginase digestion of biotinylated protein mixtures (DB03 buffer) was performed 
according to the FASP protocol. As far as not otherwise stated, the same technique was used for 
protein digestion with trypsin (DB02 buffer). 
A 10 kilodalton (kDa) cut off filter (VWR, Radnor, USA) was equilibrated with 300 µl DB02 or 
DB03 and centrifuged for 2 min at 10,000 x g. Afterwards, the protein solution was applied to 
the filter device. In case the buffer of the protein solution had to be exchanged, two times 300 µl 
DB02 were sequentially added to the filter (centrifugation at 10,000 x g for 5 min in between). 
Proteins were reduced by adding dithiothreitol (DTT) to a final concentration of 20 mM to the 
filter supernatant followed by an incubation for 30-45 min at 30-55°C. Subsequently, the DTT 
solution was removed by centrifuging two to three times 300 µl DB02 or DB03 through the filter 
(5 min, 10,000 x g). For protein alkylation, the sample was incubated for 30 min at RT in DB02 or 
DB03 containing 40 mM acrylamide. Afterwards, 300 µl digestion buffer was added and the filter 
device was centrifuged for 5 min at 10,000 x g. This step was repeated twice before the volume 
of the filter supernatant was adjusted to 100 µl and proteases were added to a mass ratio of 
1:25 or 1:100 (e.g. 1 µg protease for 100 µg proteins) to the sample. Protein digestion was 
performed at 37°C overnight. On the next day, peptides were collected by centrifuging the filter 
device for 5 min at 10,000 x g. Subsequent to this, the filter was washed with 200-300 µl DB02 
or DB03 and centrifuged again (5-10 min, 10,000 x g). Whereas urea containing peptide solutions 
were acidified with 25 % formic acid (FA) (v/v) and directly desalted via reversed phase 
chromatography, tryptic peptides in DB02 were transferred to a fresh 1.5 ml reaction tube and 
mixed with trifluoroacetic acid (TFA) in order to adjust the TFA concentration to approx. 2.5 % 
(v/v). Acidification of the tryptic peptide solution led to precipitation of SDC which was then 
pelletized by centrifugation at 14,000 x g for 10 min. The supernatant was transferred to a fresh 
reaction tube and the pellet was suspended in 250 µl 0.1 % TFA (v/v). After an additional 
centrifugation step (10 min, 14,000 x g), the supernatants were combined and residual SDC was 
removed by mixing the peptide solution three times with 500 µl ethyl acetate (2 min, 10,000 x g 
centrifugation steps in between). In the end, the peptide solution in the aqueous phase was 
dried in a vacuum centrifuge (1,000 rpm, 40-60 °C).  
Solution Concentration Component  
DB02/trypsin digestion buffer 
0.5 % (w/v) SDC 
20 mM TEAB 
DB03 
8 M Urea 
20 mM TEAB 
LysN digestion buffer 
6 M Urea 
20 mM TEAB 
0.1 mM  MgCl2 
LysArginase digestion buffer 
0.8 M Urea 
20 mM TEAB 
10 mM  CaCl2 
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4.8.1.2 Single vial standard digestion  
Protein mixtures in an aqueous environment can be digested by a single vial standard digestion. 
Compared to FASP, buffers cannot be exchanged during the sample preparation procedure 
because all reactions are taking place in a single vial without any kind of protein collection step 
(e.g. without cut off filter) prior to the digestion.  
In solution digestions of biotinylated and non-biotinylated peptides were performed by adding 
LysN or LysArginase to a mass ratio of 1:25 to 1:100 to the peptides (in TEAB). In case of the 
digestion optimization experiment, the reaction buffer was supplemented with ZnCl2, MnCl2 or 
MgCl2 to achieve final concentrations of 0.1 mM or 1 mM, respectively. Digestion was performed 
at 37°C overnight before the samples were acidified and desalted by reversed phase 
chromatography.  
The cells used for phosphopeptide enrichment from whole cell lysate were lysed in a buffer 
containing 9 M urea, 20 mM HEPES, 1x HaltTM Protease Inhibitor Cocktail (Thermo Fisher 
Scientific, Waltham, USA) and 1x HaltTM Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific, 
Waltham, USA). Afterwards, the lysates were treated with a tip sonicator (Hielscher, UP50H) to 
shear high molecular DNA and centrifuged for 15 min at RT and 18,514 x g. Protein concentration 
of the lysates were measured by a DC protein assay. 2 mg protein were used for in solution 
digestion. First, disulfide bonds were reduced by adding DTT to a final concentration of 10 mM 
to the sample. The mixture was incubated in a water bath at 55°C for 30 min. Afterwards, 
samples were alkylated with 20 mM acrylamide for 30 min at RT. The samples were diluted with 
20 mM HEPES (pH 8.0) to adjust the urea concentration to 2 M before the proteins were digested 
over night with trypsin at 37°C (protein-trypsin-mass ratio of 200:1). On the next day, the 
samples were acidified by adding TFA to a final concentration of 1 % (v/v) to the mixture. The 
samples were incubated on ice for 15 min and subsequently centrifuged at 1,780 x g for 15 min 
at RT. The peptide mixtures were desalted by reversed phase chromatography. 
4.8.1.3 In gel digestion 
In gel digestion is a technique aiming at proteolytic cleavage of proteins separated via SDS-PAGE. 
This method is often used to reduce sample complexity or to remove polyethylene glycol-based 
detergents prior to MS measurements (Shevchenko et al. 1996).  
After SDS-PAGE and protein staining with colloidal Coomassie, the gels were destained with 
water and protein bands were excised. In order to further destain the protein bands, the gel 
pieces were incubated with 50 % acetonitrile (ACN) (v/v) for 5 min. This step was repeated until 
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the supernatant was not blue anymore. Subsequently, the gel pieces were dehydrated with ACN 
for 5 min and dried in a vacuum centrifuge (1,000 rpm, 40-60 °C). For protein reduction, 100 µl 
20 mM DTT (in 50 mM NH4HCO3) was added to the dried gel pieces and incubated for 30 min at 
55 °C. Afterwards, the gel pieces were washed with 100 µl 50 mM NH4HCO3 before proteins were 
alkylated by adding 100 µl 40 mM acrylamide solution (in 50 mM NH4HCO3). After protein 
alkylation for 30 min at RT, the gel pieces were washed with water, dehydrated by incubation 
with 50 % (v/v) and ACN and dried in a vacuum centrifuge like mentioned before. For protein 
digestion, the gel pieces were rehydrated in 50 mM NH4HCO3 containing 10 % ACN (v/v) and 
250 ng trypsin and incubated at 37 °C overnight. On the next day, the supernatant was 
transferred to a fresh 1.5 ml reaction vial and the gel pieces were washed with water for 5 min. 
The water was combined with the supernatant after digestion and peptides were extracted by 
sequentially incubating the gel pieces with 50 % ACN (v/v) and ACN for 5 min at RT. Finally, the 
peptide extracts were added to the mixture of water and digestion solution and dried in a 
vacuum centrifuge (1,000 rpm, 40-60 °C).  
 
4.8.2 Biotinylation via NHS-esters 
The reactivity of NHS-esters towards primary amine groups was used in order to biotinylate 
peptides and proteins in vitro.  
4.8.2.1 Sulfo-NHS-biotin 
Biotinylation of peptides and proteins via EZ-LinkTM sulfo-NHS-biotin (Thermo Fisher Scientific, 
Waltham, USA) was performed by incubating the sample with a 100-150 fold molar excess of 
sulfo-NHS-biotin in 20-60 mM TEAB (pH 8.5) or 1x PBS (pH 7.4) (for recipe see section 4.1.2) for 
30 min at RT. Remaining sulfo-NHS-biotin was quenched by incubating the reaction mixture for 
15 min with a 10-100 fold molar excess of hydroxylamine compared to the biotinylation reagent. 
Subsequent to this, samples were acidified and desalted by reversed phase chromatography 
4.8.2.2 Sulfo-NHS-LC-biotin 
Peptides were biotinylated with a 100-fold molar excess of EZ-LinkTM sulfo-NHS-LC-biotin 
(Thermo Fisher Scientific, Waltham, USA). For this purpose, 10 mM sulfo-NHS-LC-biotin solution 
(in H2O) was mixed with 0.5 µg peptides, dissolved in PBS. After incubation for 30 min at RT, 
samples were acidified with TFA and desalted by reversed phase chromatography.  
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4.8.2.3 NHS-biotin  
NHS-biotin (Sigma-Aldrich, St. Louis, USA) was dissolved in DMSO to achieve a final 
concentration of 0.1 M. Biotinylation of peptides was performed in 20 mM TEAB and 30 % DMSO 
with a 20-fold molar excess of NHS-biotin. After incubation for 30 min at RT, remaining NHS-
biotin was quenched by adding a 100-fold molar excess of hydroxylamine (compared to 
biotinylation reagent) to the mixture. Subsequently, the samples were acidified with TFA and 
directly used for strong cation exchange (SCX)-based sample clean up.  
 
4.8.3 Streptavidin incubation 
The high affinity between streptavidin and biotin was used to sequester biotinylated peptides. 
210 µl streptavidin sepharose® (GE Healthcare, Chicago, USA) was transferred to a fresh reaction 
tube and washed twice with 500 µl binding buffer (1 min, 500 x g). Afterwards, peptides 
dissolved in binding buffer were mixed with the streptavidin beads. The volume was adjusted to 
200 µl (with binding buffer) before the mixture was incubated for 1 h at RT on an orbital shaker 
(device parameters: orbital: 70 rpm, 5 s; Reciprocal: 45 deg., 5 s; Vibro/pause: 5°, 5 s). 
Subsequent to this, the samples were centrifuged for 1 min at 500 x g. The supernatant was 
transferred to a fresh reaction tube and the beads were washed once with 100 µl binding buffer. 
After centrifugation (1 min, 500 x g), the supernatant was combined with the previous one and 
desalted by reversed phase chromatography (“StageTip” procedure).  
Solution Volume Component  
Binding buffer (pH 7.5) 
1.6 ml 0.4 M NaH2PO4 
8.4 ml 0.4 M Na2HPO4 
3.33 ml 3 M NaCl 
6.67 ml H2O 
 
4.8.4 Phosphopeptide-enrichment 
Phosphopeptides were enriched by Titanium dioxide (TiO2) beads. Here, phosphopeptides were 
bound to the beads in an acidic environment and were eluted by raising the pH to an alkaline 
level (Pinkse et al. 2004; Larsen et al. 2005).  
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4.8.4.1 Phosphopeptide-enrichment from tryptic whole cell protein digest followed by 
SCX-based peptide fractionation 
20 mg TiO2 beads (GL Sciences, Torrance, USA) were suspended in 1 ml T-loading solution (TLS) 
and subsequently added to 2 mg dried, tryptic peptides from whole cell protein digest (1 mg 
TiO2 per 100 µg peptide). The mixture was incubated on an orbital shaker for 15 min (device 
parameters: orbital: 11 rpm, 1 s; Reciprocal: 45 deg., 6 s; Vibro/pause: 1°, 3 s). After centrifuging 
the samples for 30 s at 8,000 x g (RT), the supernatant was removed before the beads were 
washed with 500 µl TLS. The mixture was centrifuged again (30 s at 8,000 x g) and two additional 
washing steps with 1 ml 80 % ACN (v/v), 1 % TFA (v/v) were performed. Subsequent to this, the 
TiO2 beads were dried in a SpeedVac (40°C, 1000 rpm). Peptides were eluted by incubating the 
TiO2 beads with 200 µl freshly prepared 0.5 % NH4OH (v/v) solution (pH > 11) for 10 min at RT. 
The beads were pelletized by centrifugation at 8,000 x g for 30 s before the supernatant was 
removed and acidified with 5 µl FA. After acidification, peptides were desalted by reversed phase 
chromatography (“StageTip” procedure).  
The SCX columns were prepared by stamping out small pieces of EmporeTM Supelco® SCX 
material (3M, Saint Paul, USA) and placing them into a 200 µl pipette tip. Each column, 
comprising eight of these small SCX discs, were washed sequentially with 100 µl methanol, SCX 
elution buffer 5, water, SCX equilibration buffer, water and SCX loading buffer with 
centrifugation steps for 3 min at 3,000 x g in between. Phosphopeptides were re-dissolved in 
300 µl SCX loading buffer, sonicated for 2 min and loaded to the column. After centrifugation 
for 3 min at 3,000 x g, the flow through was kept as fraction 1. Five different SCX elution buffers 
with increasing KCl concentrations were sequentially added to the column (3 min at 3,000 x g in 
between) and the flow throughs were collected (factions 2-6). In the end, all fractions were 
desalted by reversed phase chromatography (“StageTip” procedure).  
 
Solution Concentration Component  
T-loading solution 
1 M glycolic acid 
80 % (v/v) ACN 
5 % (v/v) TFA 
SCX equilibration buffer (pH 7.5) 
50 mM KH2PO4 
500 mM NaCl 
SCX loading buffer (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
SCX elution buffer 1 (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
30 mM KCl 
SCX elution buffer 2 (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
60 mM KCl 
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Solution Concentration Component  
SCX elution buffer 3 (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
90 mM KCl 
SCX elution buffer 4 (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
120 mM KCl 
SCX elution buffer 5 (pH 2.65) 
7 mM KH2PO4 
30 % (v/v) ACN 
350 mM KCl 
 
4.8.4.2 Phosphopeptide-enrichment from protein digests of the lysosomal fractions 
Dried, tryptic peptides were re-dissolved in 50 µl TLS (for recipe see section 4.8.4.1) containing 
1 mg TiO2 beads (GL Sciences, Torrance, USA). The mixture was incubated for 15 min on an 
orbital shaker (device parameters: orbital: 11 rpm, 1 s; Reciprocal: 45 deg., 6 s; Vibro/pause: 1°, 
3 s). A column, consisting of a small piece of EmporeTM Supelco® C18 material (3M, Saint Paul, 
USA) plugged to a gel loading tip, was prepared. The column was equilibrated with 20 µl ACN 
before the peptide-TiO2 suspension was added. A syringe was used to force liquid through the 
column. The beads retained on top of the column were washed with 100 µl TLS and 35 µl 80 % 
ACN (v/v), 1 % TFA (v/v). Phosphopeptides were eluted by adding 30 µl 0.5 % NH4OH (v/v) to the 
beads/column. Afterwards, 5 µl 30 % ACN (v/v) were added in order to elute peptides bound to 
the C18 membrane. The eluate was acidified with 20 µl 25% FA (v/v) and dried in a vacuum 
centrifuge. 
 
4.8.5 Selective derivatization of peptide’s N-terminal amino group 
4.8.5.1 Reductive alkylation 
Reductive alkylation was performed according to the procedure described by Chen et al. (2017). 
In brief, 100 or 300 µg dried peptides were dissolved in 9.6 or 10 µl 25 mM citrate buffer pH 6.0 
(5 min, ultrasonic bath), respectively. Afterwards, the peptide solution was transferred to a glass 
vial and mixed with a fivefold molar excess of sodium cyanoborohydrate (dissolved in 25 mM 
citrate buffer, pH 6.0) and a twofold molar excess of benzaldehyde (diluted in DMSO). In case of 
the 300 µg peptide sample, 30.7 µl 25 mM citrate buffer (pH 6.0) were added. The mixtures were 
incubated for 5-6 h on a magnetic stirrer (500 rpm) before the samples were diluted with 74.1 
or 284 µl H2O, respectively. Subsequent to this, the peptide solution was desalted by reversed 
phase chromatography. 
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Solution Volume Component  
25 mM citrate buffer (pH 6.0) 
1.15 ml 25 mM Cirtric acid monohydrate 
8.85 ml 25 mM trisodium citrate dihydrate 
 
4.8.5.2 Acetylation and Propionylation 
Acetylation was performed according to the procedure described Mikami et al. (2012). The same 
principle was used for peptide propionylation. Prior to their derivatization, 0.5-20 µg dried 
peptides were dissolved in 12 µl 0.1 % (v/v) acetic acid (5 min, ultrasonic bath) and placed on ice 
for 1 min. Afterwards, 5 µl 0.5 M acetic acid anhydride or 0.5 M propionic acid anhydride (both 
diluted in ACN) were added to the peptide solution. The mixture was incubated in ice water for 
at least 5 min, snap-frozen in liquid nitrogen and dried by lyophilization.   
4.8.5.3 Transamination  
Transamination was performed according to the procedure mentioned by Sonomura et al. 
(2011). 0.5 µg dried peptides were dissolved in 4 µl H2O (5 min, ultrasonic bath). Derivatization 
was performed by adding 4 µl transamination solution containing 20 % pyridine (v/v), 
100 mM glyoxylic acid, 12 mM NiSO4 and 500 mM acetic acid to the peptide mixture. After 
incubation for 30 min at RT, peptides were desalted by reversed phase chromatography.  
 
4.8.6 Peptide sample clean-up via SCX chromatography 
In order to generate the SCX chromatography columns, small portions of EmporeTM Supelco® 
SCX material (3M, Saint Paul, USA) were stamped out and placed in a 200 µl tip. 20 of these SCX-
discs were used to prepare one column. Afterwards, the column was placed in a benchtop 
centrifuge. The SCX chromatography column was rinsed successively with 100 µl methanol, 
100 µl elution buffer (5 % NH4OH (v/v), 30 % methanol (v/v)) and 3 x 100 µl binding buffer (0.1% 
TFA (v/v), 30 % methanol (v/v)) (3 min, 3000 x g centrifugation in between). After loading the 
acidified sample, the column was centrifuged for 3 min at 3000 x g. The flow through was loaded 
again and the column was washed three times with 100 µl binding buffer. Peptides were eluted 
by adding two times 100 µl elution buffer to the column. Eluted peptides were dried in a vacuum 
centrifuge.  
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4.8.7 Peptide desalting via reversed phase chromatography 
Reversed phase chromatography is a common tool in MS sample preparation for peptide 
desalting prior to MS measurements. In an aqueous and acidic environment, peptides bind to 
the nonpolar stationary phase of the reversed phase chromatography column material and can 
be eluted by increasing the concentration of an organic solvent that has a lower polarity than 
water (Rappsilber et al. 2007).  
4.8.7.1 Gravity flow reversed phase chromatography columns 
For peptide desalting, the gravity flow reversed phase chromatography Oasis® columns (Waters, 
Milford, USA) were first equilibrated two times with 1 ml ACN. Afterwards, the column was 
washed three to four times with 1 ml 0.1 % FA (v/v). Columns used for peptide desalting after 
reductive amination were additionally rinsed with 1 ml 25 mM citrate buffer (pH 6). 
Subsequently, the peptide solutions were added and the column flow through was loaded again. 
Columns used for desalting after reductive amination were washed with 1 ml 25 mM citrate 
buffer (pH 6). Prior to peptide elution, the columns were rinsed three to four times with 1 ml 0.1 
% FA (v/v). Peptides were eluted either by adding two times 0.5 ml 80 % ACN (v/v), 0.1 % FA 
(v/v) or 70 % ACN (v/v) to the column. The eluates were dried in a vacuum centrifuged at 40-
60°C and 1,000 rpm.  
After single vial standard digestion of proteins in urea containing buffer, peptides were desalted 
by gravity flow reversed phase chromatography column Oasis® columns (Waters, Milford, USA). 
First, columns were equilibrated with 5 ml I. Subsequent to this, the columns were sequentially 
washed with 1 ml, 3 ml and 6 ml 0.1 % TFA (v/v) before the peptide mixtures were loaded. 
Afterwards, the columns were rinsed with 1 ml, 3 ml and 6 ml 0.1 % TFA (v/v) as well as with 
2 ml 0.1 % TFA (v/v) containing 5 % ACN (v/v). Peptides were eluted by adding three times 
2 ml 0.1 % TFA (v/v), 40 % ACN (v/v) to the column. The eluates were frozen for 5 h at -80 °C and 
subsequently dried by lyophilization. 
4.8.7.2 Millipore® ZipTip based sample purification 
C18 Millipore® ZipTips (Merck, Darmstadt, Germany) are pipette tips stuffed with reversed 
phase chromatography material. These columns were used for peptide desalting in the LysN 
digestion optimization experiment. Column conditioning was performed by aspirating 
10 µl 50 % ACN (v/v), 0.1 % TFA (v/v). Afterwards, the column was equilibrated three times with 
10 µl 0.1 % TFA (v/v) before aspirating and releasing the peptide solution for 5-10 times. After 
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three additional washing steps with 0.1 % TFA (v/v), peptides were eluted with 10 µl 50 % ACN 
(v/v), 0.1 % TFA (v/v). 
4.8.7.3 StageTip-based sample purification 
Phosphopeptides from whole cell protein digest after Titanium dioxide-based enrichment, LysN 
digested synthetic peptides (+/- NHS-biotin) and samples after streptavidin incubation were 
desalted by using the StageTip protocol published by Rappsilber et al. (2007) with slight 
adaptations. In brief, the column was prepared by placing 4-10 EmporeTM Supelco® C18 discs 
(3M, Saint Paul, USA) in a 200 µl pipette tip and equilibrated with 20 µl methanol (centrifugation 
for 1 min at 5,000 x g). Afterwards, the column was washed sequentially with 
20 µl 80 % ACN (v/v), 0.5 % acetic acid (AcOH) (v/v) and two times with 20 µl 0.5 % AcOH (v/v) 
(centrifugation for 1 min at 5,000 x g). The acidified sample was loaded and the column was 
centrifuged again for 1 min at 5,000 x g. Subsequent to this, the column was washed with 
100 µl 0.5 % AcOH (v/v) either by applying pressure with a syringe or by centrifugation for 3 min 
at 5,000 x g. Peptides were eluted by forcing two times 20 µl 80 % ACN (v/v), 0.5 % AcOH (v/v) 
through the column. For desalting of the LysN-digested synthetic peptides, 0.5 % AcOH (v/v) was 
substituted by 0.1 % TFA (v/v). Eluted peptides were dried in a vacuum centrifuge (40 °C at 
1,000 rpm). 
 
4.9 MS measurements 
4.9.1 LC-MS measurement with the LTQ Orbitrap Velos mass spectrometer 
Dried peptides were re-dissolved in 0.1 % FA (v/v). LC was performed by using a Dionex Ultimate 
3000 RSLC nano HPLC system equipped with an analytical C18 column either packed in-house 
(inner diameter 75 µm, length 15-25 cm, ReproSil-Pur 120 C18-AQ 1.9-3.0 µm (Dr. Maisch, 
Ammerbuch, Germany)) or purchased from NanoSeparations (Nieuwkoop, Netherlands) (inner 
diameter 75 µm, length 20 cm, C18 1.9 µm). Commercially acquired columns were used in 
combination with a PicoTip emitter (New Objective, Woburn, USA). LC was performed either 
with or without the presence of an upstream C18 pre-column (self-packed, length 2 cm, inner 
diameter 100 µm, ReproSil-Pur 120 C18-AQ 5.0 µm (Dr. Maisch, Ammerbuch, Germany)). 
Solvent A (0.1 % FA (v/v)) was used for loading peptides onto the column. The flow rate was set 
to 0.25-0.3 µl/min and peptide separation was performed by a linear gradient starting from 1-
6% and ranging to 35-45 % solvent B (90 % ACN (v/v), 0.1 % FA (v/v)). Gradient lengths between 
13 and 120 min were used. After elution, peptides were directed into a linear trap quadrupole 
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(LTQ) Orbitrap Velos mass spectrometer. The MS1 scan was performed in the Orbitrap detector 
at a range between 160-1600 or 200-1800 m/z and a resolution of 30,000-60,000 (maximal 
injection time 300-400 ms; AGC target 1 x 106). The 25 most intense peptide ions were selected 
for collision induced dissociation (CID) (normalized collision energy 35) and subsequently 
analyzed by a linear ion trap (maximal injection time 100 ms; AGC target 1 x 104). As 
phosphopeptide ions tend to loose phosphoric acid or phosphate (neutral losses), multistage 
activation (MSA) was used in order to analyze phosphoproteomic data sets. In this technique, 
ions with neutral losses detected in the MS2 scan are selected for further fragmentation, thus 
enhancing the detection of phosphorylated peptides. Once an MS2 spectrum was acquired, the 
corresponding precursor ion was excluded from repeated fragmentation for 12-30 seconds.  
 
4.9.2 LC-MS measurement via the Orbitrap Fusion Lumos mass spectrometer 
Dried peptides were re-dissolved in 0.1 % FA (v/v). LC was performed by using a Dionex system 
equipped with a self-pulled and packed analytical column (inner diameter 75 µm, length 26 cm, 
ReproSil-Pur 120 C18-AQ 1.9 µm (Dr. Maisch, Ammerbuch, Germany)). 0.1 % FA (solvent A) (v/v) 
was used for loading peptides onto the column. Peptides were separated at a flow rate of 
0.3 µl/min by using a linear gradient (90 min) ranging from 1-35% solvent B (90 % ACN (v/v), 
0.1 % FA (v/v)). The nano-LC was connected online to an Orbitrap Fusion Lumos mass 
spectrometer. Peptide precursor ions were scanned in the Orbitrap mass analyzer at a range 
between 330-1600 m/z and a resolution of 60,000 (maximal injection time 50 ms, AGC target 4 
x 105, cycle time 3 sec). Precursor ions with a charge state between 2-7 were isolated with an 
isolation window of 1.2 Da and fragmented by higher-energy collisional dissociation (HCD) 
(collision energy 30 %) in the top speed mode. MS2 spectra were acquired in the Orbitrap 
detector at a resolution of 30,000 and an AGC target of 5 x 104 (max injection time 54 ms). 
Fragmented precursor ions were excluded from repeated MS2 measurement for 30 seconds. 
 
4.9.3 MALDI-TOF measurement 
For matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry 
analysis, peptides were dissolved in 0.1 % FA (v/v) or 0.1 % TFA (v/v). The matrix was prepared 
by mixing α-cyano-4-hydroxycinnamic acid (HCCA) with 0.1 % TFA (v/v) or 0.1 % FA (v/v) 
containing 30-40 % ACN (v/v) in order to generate a saturated solution. Afterwards, 1 µl sample 
was mixed with 1 µl matrix supernatant directly on the ground steel target (Bruker Daltonik, 
Bremen, Germany). MALDI-TOF measurements of the dried samples were performed with an 
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Autoflex III TOF-TOF instrument. Prior to the measurement, the spectrometer was calibrated by 
using the Peptide Calibration Standard (Bruker Daltonik, Bremen, Germany). Data were acquired 
with a laser repetition rate of 200 Hz, a laser beam focus between 28-80 and a total number of 
shots between 845-6861. Spectral analysis was performed by using the flexAnalysis software 
3.3. 
 
4.10 MS data analysis 
4.10.1 Analysis of mass spectrometric data via Proteome Discoverer 
LC-MS data were analyzed with the Proteome Discoverer (PD) software (Version 2.2.0.338 or 
2.3.0.523). Database searches were performed by using an in-house Mascot server (2.6.1) 
(Matrix Science Ltd, London, UK). As far as not otherwise stated, human protein sequences from 
SwissProt (release 2018_07 or 2019_06) together with the common contaminants enlisted in 
the contaminant repository for affinity purification (cRAP) (modified) were used as reference 
databases (Mellacheruvu et al. 2013). MS2 data derived from investigations of synthetic 
peptides were search against the cRAP database modified with the according peptide sequence. 
The precursor mass tolerance was set to 9-10 ppm. MS2 spectra acquired with the Orbitrap mass 
analyzer were searched with a fragment mass tolerance of 20 mmu. In case of MS2 spectra 
acquisition in the linear ion trap, the mass tolerance was increased to 0.5 Da. The enzymes used 
in the data processing workflow were chosen according to the experiment and the maximum 
number of missed cleavages was set to 1-2. Propionamide (at Cysteine) was searched as a static 
modification. In case of experiments with isotopically labeled cells (SILAC), the “Quan Method” 
was adjusted accordingly. Oxidation (at methionine) and acetylation (at protein N-terminus) 
were set as standard dynamic modifications (except for data analysis of synthetic peptides). For 
data analysis after phospho-peptide enrichment, the list of dynamic modifications searched was 
extended by phosphorylation at serine, threonine, and tyrosine. The variable modifications set 
for analysis of raw data acquired during verification of the serial digestion and Nα-selective 
derivatization workflow (derivatization of primary amine group at amino-terminus) are listed in 
the corresponding data post-processing sections. The Percolator algorithm, implemented in 
Proteome Discoverer, was used by default for evaluating the Mascot results based on the q-
value or the posterior error probability (PEP) (strict false discovery rate (FDR) 0.01) (Käll et al. 
2007). Peptide spectrum matches (PSMs) derived from MS2 data analysis of the synthetic 
peptide samples were validated by the target-decoy approach (strict FDR 0.01). The mass 
tolerance for feature mapping between different raw files processed was either determined 
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automatically by the software or set to 5 ppm. Precursor quantification was performed based 
on the chromatographic peak area and the “total peptide amount” was used for normalization.  
 
4.10.2 Analysis of mass spectrometric data via MaxQuant 
SILAC-derived data searched for dynamic lysine modifications as well as raw files intended for 
comparison to such samples were analyzed by using the MaxQuant software and the 
implemented Andromeda search algorithm (Cox and Mann 2008; Cox et al. 2011).  
In case of data processing via the MaxQuant software (version 1.5.1.0 or 1.6.5.0), human 
(release 2018_08) or bovine protein sequences (release 2018_05) from SwissProt and the 
contaminant list implemented in MaxQuant were used as reference databases. The main MS1 
search was performed with a mass tolerance of 4.5 ppm. Fragment ion spectra were searched 
with an ion trap mass spectrometry (ITMS) MS/MS match tolerance of 0.5 Da. Database searches 
were performed with the respective enzymes and a maximum number of two missed cleavage 
sites. Propionamide (at Cysteine) was set as a static modification. If necessary, the labels for 
peptide quantification were adjusted according to the experiment. Oxidation (at methionine), 
acetylation (at protein N-terminus) and carbamylation (at lysine and peptide N-terminus) were 
searched by default as dynamic modifications. In case proteins were treated with NHS-biotin 
prior to the digestion, the list of variable modifications was extended by biotinylation (at lysine 
and peptide N-terminus). Together with the standard modifications mentioned above, 
phosphorylation (at serine, threonine and tyrosine) were allowed as dynamic modification for 
the analysis of phosphoproteomic samples. For identifications, FDR was set to 0.01. Most of the 
post-processing data analysis was performed based on the MaxQuant “Evidence” file. In this 
table, identical PSMs identified in the same raw file are combined into a single entry if they do 
not differ in their charge states or retention time window.  
 
4.10.3 Analysis of mass spectrometric data via PEAKS 
PTM searches were performed with the PEAKS software (version 10.0, PeaksPTM module) (Han 
et al. 2011). Human protein sequences retrieved from SwissProt (release 2018_08) and the cRAP 
contaminants list were used as reference databases. The enzyme selected for the database 
search was chosen according to the experimental settings (max. two missed cleavages). The 
precursor mass tolerance was set to 10 ppm. For MS2 spectra, a fragment ion mass tolerance of 
0.5 Da was used. In case of samples derived from the serial digestion workflow, acetylation (at 
protein N-terminus), oxidation (at methionine), and biotinylation (at lysine and peptide N-
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termini) were searched as dynamic modifications (max. three variable modifications per 
peptide). For the analysis of raw data after Nα-selective derivatization, the list of variable 
modifications was extended by single and double reductive alkylation (at lysine and peptide N-
termini). The precursor mass correction setting was enabled. PeaksPTM data were filtered for 
peptides with an FDR smaller than or equal to 1% and an Ascore of 20 or higher for PTM 
localization. Afterwards, the peptide table was exported and used for calculating the 
proportions of peptides containing the different PTMs. Here, only peptides with a quantification 
value were considered for data analysis.  
 
4.11 Post-processing of LC-MS2 data after database analysis 
4.11.1 Optimization of LysN digestion with a synthetic peptide (section 5.2.1.2) 
LC-MS2 data were analyzed by the Proteome Discoverer software (version 2.2.0.338) with the 
settings described in section 4.10.1. Oxidation at methionine was set as a dynamic modification. 
The chromatographic peak areas of high confident peptide groups were used to calculate the 
relative cleavage efficiency. Prior to these calculations, the abundances of peptides varying only 
in their oxidation status were summed up. Afterwards, the relative cleavage efficiency was 
calculated as the ratio of the abundances of the cleaved and the non-cleaved precursor peptide 
multiplied by a factor of 1000.  
 
4.11.2 LysN and LysArginase digestion of BSA and complex protein mixtures 
(section 5.2.1.3) 
After processing the LC-MS2 data of the BSA samples digested with LysN or LysArginase, the 
MaxQuant “Evidence” files were filtered for entries with a BSA protein accession and a PEP 
smaller than 0.01. For each raw file, the filtered entries were copied into a new Excel sheet. 
Redundant entries were removed based on the “Modified Sequence” column, thus generating 
the peptide table. Peptides with the same sequence only varying in the carbamylation and/or 
oxidation status were considered as one single entry. In contrast, peptides differing in their 
biotinylation- and acetylation-site (protein N-terminus) were kept separately. Subsequently, the 
modified peptide table was used for determining the number of biotinylated and non-
biotinylated peptides as well as the proportion of missed cleavage sites (MCS) in each sample. 
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For evaluation of the biotinylation position, the information given in the “Modified Sequence” 
and in the “Biotinylation [K] Probabilities” columns were used.  
In case of the complex HEK protein sample, only evidences (retrieved from MaxQuant 
“Evidence” file) with a quantification value in all three replicates/SILAC channels and a PEP 
smaller than 0.01 were considered for further data analysis. For each sample group, the filtered 
entries were copied to a new Excel sheet. Information about carbamylation and oxidation sites 
were removed in the sequence entries of the “Modified Sequence” column (e.g. KVTNLLM(ox)L 
was modified to KVTNLLML). In order to generate the peptide table, redundant entries were 
removed based on this column. Afterwards, this peptide table was used for data analysis similar 
to the procedure mentioned above. The boxplots depicting the median protein sequence 
coverage were generated in Excel by using the “Protein Groups” file. For each enzyme, only 
proteins identified with more than one unique peptide and with a quantification value in all 
three replicates of the NHS-biotin treated and non-biotinylated samples were used for data 
visualization.  
 
4.11.3 Evaluation of different derivatization methods regarding their reactivity, 
reproducibility and selectivity (section 5.2.2.2) 
Raw data were processes by using the Proteome Discoverer software (version 2.3.0.523) (see 
section 4.10.1). For each derivatization technique, the list of standard dynamic modifications 
was extended by single and double propionylation, acetylation or reductive alkylation (at lysine 
and peptide N-terminus). Peptides with a Percolator q-value smaller than 0.01 were used for 
further analysis. Post-processing was performed based on the PD “Peptide Isoforms” table by 
using a self-written R-script (R-Studio, R-packages: “dplyr” (version 0.8.3), “stringr” (version 
1.4.0)) (Hadley et al. 2019; Hadley 2019). Peptides featuring an “sp” entry in the “Master Protein 
Accession” column (contaminants) were removed. Afterwards, information about the 
derivatization site were fused to the peptide sequence thus yielding the “Modified Sequence” 
Column. For each replicate, redundant entries of the “Modified Sequence” column were 
removed. Subsequent to this, the non-redundant peptide lists were used in order to determine 
the reactivity, reproducibility and selectivity of the different derivatization methods.  
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4.11.4 Evaluation of the serial digestion and the Nα-selective derivatization workflow 
(section 5.2.1.4 and 5.2.2.3) 
Data processing was performed with the Proteome Discoverer software (version 2.2.0.338) 
according to the procedure described in section 4.10.1. Raw files belonging to the same step 
within the workflow were processed together. In addition to the standard settings, methylation 
at lysine and arginine were set as dynamic modifications. After NHS-biotin treatment, the list of 
variable modifications searched during data processing was extended by biotinylation (at lysine 
and peptide N-terminus). For Nα-selective derivatized samples, single and double alkylation (at 
lysine and peptide N-terminus) were searched as dynamic modifications.  
4.11.4.1 Investigation of the biotinylation efficiency  
PSMs (retrieved from PD “PSM” file) featuring a PEP smaller than 0.01 were used for evaluation 
of biotinylation efficiency. The percentages of biotinylated PSMs and those with at least one 
unmodified primary amine was determined. In case the samples were derivatized by reductive 
alkylation prior to the incubation with NHS-biotin, the proportion of alkylated PSMs was also 
investigated.  
4.11.4.2 Investigation of enhanced lysine and arginine PTM detection 
Peptide information were retrieved from the PD “Peptide Group” table. Data were filtered for 
peptides featuring a PEP smaller than 0.01 and information about the methylation sites were 
fused to the amino acid sequence (modified sequence column) by using a self-written R-script. 
Peptide species (entries of the modified sequence column) detected in the single 
samples/replicates were copied to separate Excel sheets. Non-assignable methylation sites were 
considered as ambiguous modifications. Based on the modified sequence column, redundant 
peptide entries were removed. Subsequent to this, the non-redundant entries of the modified 
sequence column were used to analyze the number of arginine and lysine methylation sites in 
each replicate and sample.  
Evaluation of the number of methylated PSMs was performed by using the PD “PSM” table. For 
this purpose, the position of the methylation site was deleted in the “Modifications” column. 
The table was filtered for PSMs featuring a PEP smaller than 0.01. Afterwards, the modified 
entries of the “Modifications” column were used for determining the number of arginine and 
lysine methylation sites in each raw file.  
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4.11.4.3 Investigation of the presence of C-terminal methylation sites after tryptic digestion 
(serial digestion workflow) 
The presence of methylation sites at the C-terminus after tryptic digestion was investigated 
based on the non-redundant peptide list used for determining the number of arginine and lysine 
methylation sites in samples of the two workflows (see section 4.11.4.2). 
4.11.4.4 Investigation of the number of lysine and arginine containing peptides in samples 
of the Nα-selective derivatization workflow 
The number of arginine and lysine containing peptides was determined by using the non-
redundant peptide lists generated for investigating the amount of methylation sites in the 
different samples/replicates of the two workflows (see section 4.11.4.2). 
4.11.4.5 Generation of Venn diagrams for sample comparison  
Proportional Venn diagrams were generated with R-studio by using the “eulerr” package 
(version 6.0.0) (Larsson 2019). The same software was used to create non-proportional Venn 
diagrams with the “VennDiagram” package (version 1.6.20) (Hanbo 2018). 
 
4.11.5 Analysis of phospho-data sets (section 5.1.2) 
4.11.5.1 Post-processing of MaxQuant phospho-data 
Post-processing of the MaxQuant data was performed with a self-written R-script. Evidences 
featuring a PEP smaller than 0.01 were retrieved from the MaxQuant “Evidence“ file. For singly 
phosphorylated evidences, the phosphorylation site with the highest probability (rounded to 
the first decimal) was fused to the amino acid sequence. In case the evidence was identified to 
be doubly phosphorylated, the two highest phospho-site probabilities (rounded to the first 
decimal) were considered. If the same probability was assigned to two or more phospho-sites, 
the information about all positions were kept. For each replicate, the evidences were split to 
separate tables. Afterwards, redundant entries were merged based on the phospho-site and 
probability containing sequence column previously generated. During this procedure, intensity 
values of redundant entries were summed up. Subsequently, the intensities of each channel 
were normalized on the median. In the end, the data in the single replicate tables were merged 
to one file and analyzed by the “qbaR” R-package (see section 4.11.5.3). Highly regulated 
phosphopeptides were determined by filtering the normalized data for peptides found in at least 
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two out of three DMSO replicates without any additional identification in the stimulated 
samples and vice versa. 
4.11.5.2 Post-processing of Proteome Discoverer phospho-data 
Phospho-data processed with PD were analyzed based on the “Peptide Isoform” table 
(maximum q-value 1%). Peptides featuring an “sp” entry in the “Master Protein Accession” 
column were removed. A self-written R-script was used in order to fuse the identified 
phosphorylation site to the amino acid sequence. Peptide entries without abundance value in 
all conditions/SILAC channels were removed. Afterwards, the data set was analyzed by the 
“qbaR” R-package (see section 4.11.5.3). Highly regulated phosphopeptides were determined 
according to the procedure described in section 4.11.5.1 . 
4.11.5.3 Statistical analysis of phospho-data 
For phosphoproteome comparison, statistical analysis was performed after filtering the data for 
phosphopeptides found in at least two out of three replicates of the treated samples and the 
control. In addition to that, the complete data set without further filtering was analyzed (see 
Appendix section 7.1). Statistics were performed with an R-script provided by Dr. Farhad Shakeri 
from the Core Unit for Bioinformatics Data Analysis of the University Hospital of Bonn (R-
packages: “qbaR” (version 1.2.3), “FactoMineR” (version 1.42), “ggplot2” (version 3.2.1), 
“data.table” (version 1.12.6), “tidyverse” (version 1.2.1)) (Lê et al. 2008; Wickham 2016, 2017; 
Dowle and Srinivasan 2019). In this workflow, the limma-package (version 3.40.6.) was used in 
order to correct p-values for multiple testing (Ritchie et al. 2015).  
 
4.11.6 Statistical analysis of proteome comparison data (section 5.1.5) 
Raw data from proteome comparison approaches were analyzed with PD (version 2.3.0.523) 
(see section 4.10.1). Grouped protein abundances were used to calculate protein ratios. 
Statistical analysis was performed by ANOVA (individual proteins) implemented in the PD 
workflow. Proteins identified with at least two unique peptides (maximum q-value 1 %) in more 
than one replicate of the wt and SNAPIN KO samples were used for data visualization. The 
volcano plot was generated with the R-software (R-packages: ggplot2, data.table). The PCA plot 
(see Appendix section 7.4) was retrieved from PD.  
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4.11.7 Analysis of Co-IP data (section 5.1.10) 
LC-MS2 data from the Co-IP experiment were processed with PD (version 2.3.0.523) according 
to the procedure mentioned in section 4.10.1. In addition to the standard databases, data were 
also searched against a protein list containing sequence information about the SNAPIN wt, 
S133E and S133A isoforms. In this additional database, the SNAPIN isoforms were listed without 
sequence information of the Myc-Tag and the linking region between the Tag and the protein. 
Non-normalized abundances of proteins found with at least two peptides (max. q-value 0.01) 
were used for post-processing data analysis.  
For each protein, the mean and standard deviation of the non-normalized abundances was 
calculated for the three replicates of the SNAPIN KO, SNAPIN S133E and SNAPIN S133A samples. 
Subsequent to this, the mean values were used to calculate the S133E/KO and S133A/KO ratios. 
In case the ratio could not be calculated due to missing values in the KO samples, a value of 200 
was set. Each protein with a ratio higher than 10 and found in at least two S133A or S133E 
replicates was assumed to be a potential interaction partner of the particular isoform. Data 
visualization was performed with the R-software (R-package: ggplot2). Here, the coefficient of 
variation (CV) (calculated as the standard deviation abundance divided by mean abundance) of 
each protein identified in more than one S133E or S133A replicate was plotted against its log2 
sample/KO ratio.  
In order to compare the abundances of the potential interaction partners shared between both 
isoforms, the protein levels of each channel and sample group were normalized on the 
corresponding SNAPIN quantities. Afterwards, the mean protein abundances of the different 
replicates were calculated and used to determine the S133A/S133E ratio. Data visualization was 
performed with R-studio (R-package: ggplot2). The ratios of the mean values were depicted as 
a bar chart. Abundance ratios determined for single replicates were indicated as dots.  
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5. Results 
 
5.1. Investigating cAMP mediated phosphorylations of lysosomal and 
lysosome-associated proteins 
cAMP is an important second messenger. Inside the cell, EPACs and the protein kinase A are two 
major cAMP sensors (Walsh et al. 1968; Tao et al. 1970; Kawasaki et al. 1998; Rooij et al. 1998).  
The peptide hormone glucagon, secreted as a starvation signal by pancreatic cells, is a well-
known trigger of the cAMP signaling machinery (Jelinek et al. 1993; reviewed by Habegger et al. 
2010). Once initiated, the cAMP pathway activates PKA which is associated with the degradation 
of glycogen, thus counteracting the starvation signal (reviewed by Unger 1985). Another process 
upregulated upon nutrient deprivation is the expression of genes encoding for lysosomal 
proteins which also results in an increased break-down of complex molecules (Sardiello et al. 
2009; Settembre et al. 2011). Based on their involvement in starvation-induced catabolism, one 
could hypothesize a functional relationship between PKA and lysosomes. For example, 
lysosomal membrane proteins might be regulated by PKA-dependent phosphorylation. So far, 
Mucolipin 1 is the only known lysosomal membrane protein phosphorylated by PKA 
(Vergarajauregui et al. 2008). Besides that, little is known about the functional impact of this 
kinase on lysosomes. In 2016, Rahman et al. demonstrated an effect of PKA in lysosome re-
acidification during investigations of the lysosomal pH upon depletion of soluble Acs (sAC). Here, 
the sAC knock-out (KO)-induced increase in lysosomal pH was rescued by the addition of cAMP 
to the media (Rahman et al. 2016). However, a combinatory treatment of the sAC-KO cells with 
cAMP and an PKA inhibitor was not associated with complete lysosome re-acidification, thus 
highlighting the role of PKA in re-adjusting the lysosomal pH (Rahman et al. 2016).  
The observations mentioned above suggest cAMP-mediated PKA activation as an important 
regulator for lysosomal function. Therefore, the present study aimed at investigating changes in 
the phosphorylation pattern of lysosomal and lysosome-associated proteins upon elevated 
intracellular cAMP levels, followed by the subsequent characterization of the targets. 
 
5.1.1. Validating the Forskolin and dibutyryl-cAMP induced stimulation of PKA  
In the course of this study, intracellular cAMP levels were raised by cultivating HEK 293 cells in 
medium containing forskolin (FSK), an AC stimulatory drug (dissolved in DMSO) (Seamon et al. 
1981), and dibutyryl-cAMP (db-cAMP), a cAMP analog. As the addition of FSK to the medium 
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resulted in a final DMSO concentration of 0.1 %, the same DMSO concentration was used in the 
stimulation control medium.  
The PKA activity was investigated in order to validate the treatment induced elevation of 
intracellular cAMP levels. After cell lysis, proteins were separated by SDS-PAGE and blotted onto 
a nitrocellulose membrane. Prior to immune detection, the membrane was cut horizontally 
between the 40 and 55 kDa marker protein. PKA stimulation was validated by antibody-based 
detection of a PKA targeted phosphorylation site (S133) of the cAMP-responsive element-
binding protein 1 (pCREB). In order to evaluate the influence of elevated cAMP levels on the 
CREB protein level, the same samples were investigated with an anti-CREB antibody. α-Tubulin 
detection served as a loading control. After densitometric quantification, pCREB and CREB 
signals were normalized to the α-Tubulin intensities. The experiment was performed in three 
biological replicates.  
By incubating the nitrocellulose membrane with the anti-CREB antibody, signals at approx. 
45 kDa were detected (Figure 5.1A, lower panel). As the position of those polypeptides match 
to the expected mass of cAMP-responsive element-binding protein 1, it is reasonable to assume 
that the signals obtained at 45 kDa corresponded to CREB. Except for the FSK/db-cAMP treated 
sample of the third replicate, the CREB signal intensities of the stimulated and non-stimulated 
samples as well as of the different replicates were comparable. Incubation of the membrane 
with an antibody directed against α-Tubulin was associated with a signal detection at approx. 
55 kDa (Figure 5.1A, upper panel). These signals match to the expected mass of α-Tubulin thus 
indicating the specificity of this antibody. Therefore, in the further course of this thesis, signals 
obtained at 55 kDa after immune detection with the anti-α-Tubulin antibody are assumed to 
derive from successful α-Tubulin detection. However, in this experiment, similar α-Tubulin signal 
intensities were observed among the different samples of the first two replicates. Compared to 
that, the signal intensities of the FSK/db-cAMP treated and non-stimulated samples of the third 
replicate were slightly reduced.  
The normalized CREB quantities were calculated as the ratio of the CREB and the α-Tubulin signal 
intensities determined for the single replicates of both sample groups. These relative CREB 
quantities are depicted as dots in figure 5.1B. Comparison of both conditions indicate a slightly 
lower CREB intensity in the FSK/db-cAMP treated samples. This tendency can also be observed 
when comparing the average relative CREB intensities of both groups shown as bar charts 
(Figure 5.1B, +/- standard deviation). However, the mean CREB intensity as well as the standard 
deviation detected in the FSK/db-cAMP stimulated sample was strongly influenced by the 
quantification value of the third replicate. As already shown in figure 5.1A, the CREB signal in 
this sample is noticeably lower compared to those observed for the other two replicates of this 
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group, thus strongly influencing the mean and standard deviation. Nevertheless, comparison of 
both sample groups by a two sample t-test indicates that the difference in the mean CREB 
intensities is not significant (homoscedastic, p-value 0.1328, significance threshold 0.05). 
Figure 5.1C (lower panel) shows the signals detected after incubating the membrane with an 
antibody directed against the phosphorylated S133 CREB motif (p-CREB). According to the 
information given by the antibody supplier, the signals detected at approx. 38 kDa correspond 
to a phosphorylated isoform of the cAMP-dependent transcription factor 1. However, based on 
the signals obtained by using the CREB antibody (Figure 5.1A), the polypeptides detected at 
approx. 45 kDa in figure 5.1C (lower panel) were ascribed to p-CREB. Compared to the controls, 
higher p-CREB signal intensities were observed in the FSK/db-cAMP treated samples among all 
three replicates. As the intensities of the α-Tubulin signals were similar between the different 
samples, it is reasonable to assume that this increase is rather caused by higher p-CREB levels 
present within the FSK/db-cAMP treated samples than by different protein amount loaded onto 
the gel. 
In order to determine the level of p-CREB within the different samples, p-CREB intensities 
obtained by immune detection were normalized to the corresponding α-Tubulin signals. Figure 
5.1D depicts the average α-Tubulin-normalized p-CREB intensity (+/- standard deviation) 
detected in the FSK/db-cAMP treated sample group as well as in the non-stimulated control. 
Additionally, the values of the single replicates are indicated as dots. Within the control group, 
the average relative p-CREB intensity amounted to 0.57 (standard deviation +/- 0.04). Compared 
to that, higher relative p-CREB levels were detected within all replicates of the FSK/db-cAMP 
stimulated samples. Here, an average p-CREB intensity of 0.96 (standard deviation +/- 0.05) was 
detected. Statistical analysis (two sample t-test) of the relative pCREB intensities revealed a 
significant difference between both sample groups (homoscedastic, p-value 0.0006, significance 
threshold 0.05)  
In summary, an increase in the pCREB signal intensity was observed when incubating the cells 
with FSK/db-cAMP whereas the CREB protein level was not significantly affected by this 
treatment. Therefore, it is reasonable to assume that PKA was successfully activated upon 
FSK/db-cAMP stimulation. 
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Figure 5.1:  In vitro investigation of the Forskolin and dibutyryl-cAMP induced activation of PKA.  
HEK 293 cells were cultivated in media containing either FSK and db-cAMP (PKA stimulation media) or DMSO (control). 
After cell lysis, proteins were separated by SDS-PAGE and transferred onto a nitrocellulose membrane. The influence 
of PKA activation on the CREB protein level was investigated by using an anti-CREB antibody (CREB: 30 s exposure; α-
Tubulin: 1 s exposure) (A). α-Tubulin-normalized CREB intensities are depicted in B. Here, the average relative CREB 
intensities (+/- standard deviation) are shown as a bar chart whereas the dots represent the quantification values 
observed for the single replicates (normalized to the α-Tubulin signals). An antibody directed against a PKA targeted 
phosphorylation site (S133) of CREB was used to evaluate PKA stimulation (CREB: 30 s exposure; α-Tubulin: 1 s 
exposure) (C). For both sample groups, the mean values (+/- standard deviation) of the relative p-CREB intensity 
(normalized to α-Tubulin signals) are shown as a bar chart (D). Additionally, the relative p-CREB intensities detected 
for the single replicates are indicated as dots. Statistical analysis was performed by a t-test. (A.U. = arbitrary units; 
n.s.: not significant (p-value >0.05); **** p-value < 0.001). 
 
5.1.2. Identification of significantly regulated phosphopeptides upon elevated 
intracellular cAMP levels 
After showing the successful activation of PKA by a combinatory FSK/db-cAMP stimulation, this 
treatment was used in order to investigate cAMP-dependent regulation of phosphorylation sites 
on whole cell and lysosomal level. Three biological replicates, using HEK 293 cells (light, medium 
and heavy labeled) in which the proteins were isotopically labeled according to the SILAC 
procedure, were analyzed. In each replicate, two of the three SILAC channels contained the 
FSK/db-cAMP stimulated cells and the corresponding DMSO control. The third SILAC label 
comprised of proteins from cells incubated with Torin1, a mechanistic target of rapamycin 
(mTOR) inhibitor (Thoreen et al. 2009). However, as only one significantly regulated 
phosphopeptide was identified in the mTOR data sets (see Appendix Figure 7.1, figure 7.3, figure 
7.5), the results mentioned in this section focus on phospho-sites found in the FSK/db-cAMP 
treated samples. 
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5.1.2.1. Phosphopeptide enrichment from whole cell lysate digest 
Prior to tryptic protein digestion, the lysates of stimulated, isotopically labeled cells were 
combined. Afterwards, titanium dioxide (TiO2)-based phosphopeptide-enrichment was 
performed followed by peptide fractionation via SCX chromatography. Non-phospho-enriched 
samples of the combined lysates were used for protein quantification in the starting material. 
The phospho-enriched and the input samples were analyzed by using a Dionex LC-system 
coupled to an LTQ Orbitrap Velos mass spectrometer. The MaxQuant software was used to 
search the raw data against a human reference database. Data analysis was performed with the 
information provided in the evidence table. In case of the enriched samples, the number of 
phospho-sites as well as the phosphorylation position with the highest probability were fused 
to the evidence sequence. For each replicate and SILAC channel, the peptide abundances were 
calculated by summing up all intensities of evidences with the same modified sequence. 
Subsequently, the peptide abundances were normalized by the median intensity determined for 
the different replicates and SILAC channels. Phosphopeptides found in at least two out of three 
replicates per condition were used for statistical analysis. The p-values were corrected for 
multiple testing by using the limma R-package. The protein quantities in the non-phospho 
enriched samples were calculated by summing up the evidence intensities belonging to the one 
UniProt accessions of a given channel and replicate. Subsequent to this, the ratio between the 
treated sample and the control was determined for each replicate. Finally, the mean and the 
standard deviation of the ratios of the three replicates were calculated.  
Fifty percent of the peptides identified after phospho-enrichment contained at least one 
phosphorylation site. In figure 5.2, the results of the statistical analysis of the phosphopeptides 
are visualized in a volcano plot, a special type of scatter plot. The p-value is plotted on the y-axis 
(-log10) whereas the abscissa contains information about the fold change (log2) between the 
FSK/db-cAMP stimulated sample group and the DMSO control. The red horizontal line indicates 
the adjusted p-value threshold of 0.05. Each point in the volcano plot represents a 
phosphopeptide identified within the study. The point color assigns each phosphopeptide to a 
specific data group. Significantly regulated phosphopeptides are colored in red and marked with 
their UniProt accession number, the peptide sequence, the number of phosphorylation events 
and the phospho-site position together with the localization probability. Compared to this, 
phosphopeptides with an adjusted p-value smaller than 0.05 and a log2 fold-change bigger than 
1 or smaller than -1 are colored in orange. The grey points represent the phosphopeptides with 
log2 fold-change between 1 and -1 and an adjusted p-value smaller than 0.05. Phosphopeptides 
found in at least two out of three FSK/db-cAMP-treated replicates but not in any DMSO sample 
and vice versa are considered as being highly regulated. However, as a statistical analysis of 
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those phosphopeptides is not possible due to the missing values either in the FSK/db-cAMP or 
DMSO sample group, they are not visualized in the volcano plot but listed in two separate tables 
(Table 5.2 and table 5.3). 
In the present data set, six significantly regulated phosphopeptides were identified (adjusted p-
value <0.05 and log2 fold change <1 or >1; figure 5.2, table 5.1). Additionally, eight 
phosphopeptides were found in at least two out of three DMSO replicates but not in any FSK/db-
cAMP stimulated sample, thus representing the highly downregulated phosphopeptides (Table 
5.3). Vice versa, the group of highly upregulated phosphopeptides contains 28 peptides. These 
peptides were detected in at least two FSK/db-cAMP treated replicates but not in the DMSO 
control (Table 5.2).  
As expected, FSK/db-cAMP treatment was associated with the upregulation of peptide 
phosphorylation. Known PKA target sites of the calcium/calmodulin dependent protein kinase 
kinase (CaMKK1; S475) (UniProt accession: Q8N5S9), the 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase 2 (PFKFB2; S466) (O60825) and the CAD protein (CAD) (P27708; S1406) were 
identified as being upregulated within the present study (Table 5.2) (PhosphoSitePlus online 
repository; phosphosite.org, retrieved 24.10.2019 (Hornbeck et al. 2015)) (Carrey et al. 1985; 
Okuno et al. 2001; Pozuelo Rubio et al. 2003). CaMKK1 and PFKFB2 were not detected in the 
non-phospho enriched starting material of this experiment. The abundance of the CAD protein 
was not influenced by the FSK/db-cAMP treatment. This indicates that the upregulation of the 
identified CAD phopsho-site was caused by cAMP mediated phosphorylation and not by an 
increase in the protein level upon stimulation. However, the detection of highly downregulated 
phosphopeptides also suggests an association of elevated intracellular cAMP levels with protein 
dephosphorylation or degradation. For example, such a downregulation was detected for two 
phospho-sites of the CREB-regulated transcription coactivator 3 (CRTC3) (Q6UUV7) (Table 5.3). 
The CRTC3 was not identified in the non-phospho enriched samples.  
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Figure 5.2:  Phosphopeptide enrichment from whole cell lysate digest.  
TiO2-based phosphopeptide enrichment was performed with peptides derived from tryptic digestion of whole cell 
lysate. Phosphopeptides were fractionated via SCX chromatography prior to LC-MS2 measurements. The experiment 
was performed in three biological replicates. Raw data were analyzed using the MaxQuant software. Statistical 
analysis (FSK/db-cAMP vs DMSO) was performed on phosphopeptides found in at least two out of three replicates 
(adjusted p-value threshold 0.05) by using the limma package implemented in an R-script. Significantly regulated 
phosphopeptides (adjusted p-value <0.05 and log2 fold change <1 or >1) are highlighted as red points. 
 
Table 5.1:  Significantly regulated phosphopeptides detected in the whole cell lysate digest after FSK/db-cAMP 
treatment.  
List of proteins corresponding to the six significantly regulated phosphopeptides (red points in figure 5.2) identified 
after statistical analysis of the phospho-data set derived from the whole cell digest (FSK/db-cAMP vs. DMSO). The 
mean ratios (+/- standard deviation) of the corresponding protein abundance (FSK/db-cAMP vs. DSMO) determined 
by MS analysis of the non-phospho-enriched samples are shown. 
Uniprot 
accession 
Protein name Log2 fold 
change 
Adj. p-value Mean protein ratio  
(FSK/db-cAMP vs. 
DMSO) 
O75396 Vesicle-trafficking protein 
SEC22b 
6.4 0.002 
 
0.98 (±0.09) 
P16949 Stathmin 2.8 0.006 0.99 (±0.08) 
Q2VPK5 Cytoplasmic tRNA 2-
thiolation protein 2 
-2.2 0.006 1.24 (±0.22) 
Q6IQ22 Ras-related protein Rab-12 -2.9 0.010 Found in less than 2 
replicates 
O94804 Serine/threonine-protein 
kinase 10 
-2.1 0.010 Not found 
Q9Y2I7 1-phosphatidylinositol 3-
phosphate 5-kinase 
2.3 0.038 Not found 
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Table 5.2:  Highly upregulated phosphopeptides detected in the whole cell lysate digest upon elevation of the intracellular cAMP level. 
List of phosphopeptides found to be highly upregulated in the whole cell lysate after FSK/db-cAMP treatment (found in at least two out of three FSK/db-cAMP replicates but not in any DMSO 
sample). For each phosphopeptide, the mean protein abundance ratios (+/- standard deviation) determined in the non-phospho-enriched samples are listed.  
Uniprot accession Modified sequence Protein name Mean ratio protein 
abundance  
(FSK/db-cAMP vs. DMSO) 
Q13206 APSLTNDEVEEFR_1xPhospho_S3_100 Probable ATP-dependent RNA helicase DDX10 1.47 (±0.75) 
P49792 KQSLPATSIPTPASFK_1xPhospho_S3_100 E3 SUMO-protein ligase RanBP2 1.03 (±0.07) 
Q96PK6 RLSESQLSFR_1xPhospho_S3_100 RNA-binding protein 14 0.94 (±0.11) 
Q9BXB4 SFSLASSSNSPISQR_1xPhospho_S3_90 Oxysterol-binding protein-related protein 11 1.30 (±0.06) 
Q9H3N1 SLGPSLATDKS_1xPhospho_S1_100 Thioredoxin-related transmembrane protein 1 1.03 (±0.05) 
P46019 SLNLVDSPQPLLEK_1xPhospho_S1_100 Phosphorylase b kinase regulatory subunit alpha, liver isoform Not found 
Q8N5S9 SMSAPGNLLVK_1xPhospho_S3_100 Calcium/calmodulin-dependent protein kinase kinase 1 Not found 
O43353 SPSLNLLQNK_1xPhospho_S3_100 Receptor-interacting serine/threonine-protein kinase 2 Not found 
Q7Z2W4 SSLGSLQTPEAVTTR_1xPhospho_S1_S2_50 Zinc finger CCCH-type antiviral protein 1 1.10 (±0.23) 
Q9Y4F5 AGSFTGTSDPEAAPAR_1xPhospho_S3_100 Centrosomal protein of 170 kDa protein B Not found 
P10412; P16403 KASGPPVSELITK_1xPhospho_S3_100 Histone H1.4; Histone H1.3; Histone H1.2 1.00 (±0.21); 0.99 (±0.19) 
Q9NPD8 KASQLVGIEK_1xPhospho_S3_100 Ubiquitin-conjugating enzyme E2 T 1.23 (±0.05) 
P35711 KGSLADVVDTLK_1xPhospho_S3_100 Transcription factor SOX-5; Transcription factor SOX-6 Not found 
P48634 KQSSSEISLAVER_1xPhospho_S3_100 Protein PRRC2A 0.92 (±0.21) 
Q9Y4H2 KSSEGGVGVGPGGGDEPPTSPR_1xPhospho_S2_60 Insulin receptor substrate 2 1.20 (±0.38) 
Q09666 LPSGSGAASPTGSAVDIR_1xPhospho_S3_100 Neuroblast differentiation-associated protein AHNAK 1.00 (±0.15) 
P52569 NLSSPFIFHEK_1xPhospho_S3_100 Cationic amino acid transporter 2 Not found 
O60825 NSFTPLSSSNTIR_1xPhospho_S2_100 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 Not found 
Q13610 NSSISGPFGSR_1xPhospho_S3_100 Periodic tryptophan protein 1 homolog 0.95 (±0.11) 
Q14671 RDSLTGSSDLYK_1xPhospho_S3_100 Pumilio homolog 1 1.16 (±0.15) 
P27708 RLSSFVTK_1xPhospho_S3_100 CAD protein 1.00 (±0.09) 
Q92794 RLSSQDVLR_1xPhospho_S3_100 Histone acetyltransferase KAT6A 0.95 (±0.06) 
Q9BXB4 SFSLASSSNSPISQR_1xPhospho_S1_90 Oxysterol-binding protein-related protein 11 1.30 (±0.06) 
A3KN83 SIDPDSIQSALLASGLGSK_1xPhospho_S1_100 Protein strawberry notch homolog 1 1.21 (±0.35) 
Q08AD1 SISNEGLTLNNSHVSK_1xPhospho_S1_S3_50 Calmodulin-regulated spectrin-associated protein 2 Not found 
Q9UPR0 SLEVIPEKANDETGE_1xPhospho_S1_100 Inactive phospholipase C-like protein 2 Not found 
Q96RR4 SLSAPGNLLTK_1xPhospho_S3_100 Calcium/calmodulin-dependent protein kinase kinase 2 Found in less than 2 replicates 
O60343 SLTSSLENIFSR_1xPhospho_S1_100   TBC1 domain family member 4 0.99 (±0.11) 
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Table 5.3:  Highly downregulated phosphopeptides detected in the whole cell lysate digest upon elevation of the intracellular cAMP level. 
List of phosphopeptides found to be highly downregulated in the whole cell lysate after FSK/db-cAMP treatment (found in at least two out of three DMSO replicates but not in any FSK/db-cAMP 
sample). For each phosphopeptide, the mean protein abundance ratios (+/- standard deviation) determined in the non-phospho-enriched samples are listed. 
Uniprot accession Modified sequence Protein name Mean ratio protein 
abundance  
(FSK/db-cAMP vs. DMSO) 
Q5SQI0 LLLAADPGGSPAQR_1xPhospho_S10_100 Alpha-tubulin N-acetyltransferase 1 Not found 
Q12830 NLSESPVITK_1xPhospho_S5_100 Nucleosome-remodeling factor subunit BPTF 1.25 (±0.17) 
Q7Z417 NLSSDEATNPISR_1xPhospho_S3_100 Nuclear fragile X mental retardation-interacting protein 2 1.12 (±0.05) 
Q6UUV7 SNPSIQATLNK_1xPhospho_S1_100 CREB-regulated transcription coactivator 3 Not found 
Q15758 GPAGDATVASEKESVM_1xPhospho_S10_100 Neutral amino acid transporter B(0) 0.95 (±0.06) 
Q6UUV7 LFSLSNPSLSTTNLSGPSR_1xPhospho_S5_80 CREB-regulated transcription coactivator 3 Not found 
Q9BXB4 SFSLASSSNSPISQR_1xPhospho_S10_100 Oxysterol-binding protein-related protein 11 1.30 (±0.06) 
Q9UKG1 VNQSALEAVTPSPSFQQR_1xPhospho_S12_100 DCC-interacting protein 13-alpha 1.10 (±0.15) 
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5.1.2.2. Phosphopeptide enrichment from lysosomal fractions 
Prior to lysosome enrichment, the lysates of stimulated, isotopically labeled cells were 
combined. Enriched lysosomes were further separated into a soluble and a membrane fraction. 
After tryptic digestion, phosphopeptides were enriched from the two lysosomal fractions by 
TiO2. Non-phospho-enriched peptides were used for MS-based protein quantification thus 
allowing conclusions about treatment-dependent changes of protein levels in the single 
fractions. The experiment was performed in three biological replicates. Phosphopeptides were 
analyzed by LC-MS2 either using the LTQ Orbitrap Velos (soluble fraction) or the Orbitrap Fusion 
Lumos mass spectrometer (membrane fraction). Raw data of the phospho- and non-phospho-
enriched samples were searched against a human reference database using the Mascot search 
engine implemented in the Proteome Discoverer software. The data of the phospho-data set 
were analyzed based on the peptide isoform table. Here, the number of phospho-sites as well 
as the position and localization probability of the phosphorylation event was fused to the 
peptide sequence. Statistical analysis of this data set was performed according to the procedure 
mentioned in section 5.1.2.1. For the non-phospho-enriched samples, the protein ratios enlisted 
in the “Protein” PD-output table were used without any further data modification. 
Within the soluble lysosomal fraction, 32 % of the peptides featured at least one 
phosphorylation site. However, no significantly regulated phosphopeptide was found in this 
sample group (see Appendix figure 7.4). Additionally, only one highly up- and one highly down-
regulated phospho-site was detected after FSK/db-cAMP treatment (highly upregulated: found 
in at least two out of three FSK/db-cAMP replicates but not in any DMSO sample; highly 
downregulated: found in at least two out of three DMSO replicates but not in any FSK/db-cAMP 
sample). These two phosphopeptides were derived from the Golgin subfamily B member 1- and 
the PRRC2A-protein. Nevertheless, 238 proteins found in at least two FSK/db-cAMP and DMSO 
replicates featured “lysosome” as a gene ontology (GO) annotation in the non-phospho-
enriched proteomic data set of the soluble fraction, thus indicating the presence of lysosomal 
proteins in the samples used for the phospho-enrichment.  
Similarly, 261 proteins with a “lysosome” GO annotation were identified in at least two out of 
three replicates of both, the control and FSK/db-cAMP treated samples of the lysosomal 
membrane fraction. After phospho-enrichment, 28 % of the peptides identified in the eluate 
contained at least one phosphorylation site. Figure 5.3 depicts the fold change and the p-value 
of phosphopeptides found in at least two out of three FSK/db-cAMP and DMSO replicates of the 
lysosomal membrane fraction. Twelve phosphopeptides were found to be significantly 
regulated upon elevation of the intracellular cAMP level (adjusted p-value <0.05 and log2 fold 
change <1 or >1; red points in figure 5.3). The protein names corresponding to those peptides 
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are listed in table 5.4. Besides that, 18 phosphopeptides were detected in at least two DMSO 
treated samples but not in any FSK/db-cAMP replicate, thus belonging to the highly 
downregulated peptide population (Table 5.6). The highly upregulated phospho-site group 
comprises peptides found in at least two FSK/db-cAMP replicates but not in any DMSO control. 
Within the present study, 23 phosphopeptides were found to be highly upregulated upon 
elevated intracellular cAMP levels (Table 5.5). 
Known PKA target sites of the CD44 antigen (S697) and the CAD protein (S1406) were identified 
as being upregulated in the lysosomal membrane fraction after FSK/db-cAMP treatment 
(PhosphoSitePlus online repository; phosphosite.org, retrieved 09.05.2019; note that the S697 
CD44 phospho-site corresponds to the S316 site described by Tzircotis et al. (2006) (Carrey et al. 
1985)). Here, an increase in the protein level was not detected. The upregulated phospho-site 
of the Vesicle-trafficking protein SEC22b, identified after phosphopeptide enrichment from the 
whole cell digest (Table 5.1), was also found as being significantly upregulated in the lysosomal 
membrane fractions (Figure 5.3, table 5.4). This demonstrates the comparability of the stimulus 
applied to the cells within the different experiments, although the starting material for 
phosphopeptide enrichment was different. The presence of non-lysosomal proteins among the 
regulated phosphopeptides in the membrane fraction indicate a certain impurity of the 
lysosome preparation. Highly or significantly regulated phospho-sites were identified for the 
lysosomal and lysosome-associated proteins regulatory-associated protein of mTOR (RPTOR), 
serine/threonine-protein kinase mTOR, run domain Beclin-1-interacting and cysteine-rich 
domain-containing protein (RUBCN), Mucolipin 1, and the SNARE-associated protein (SNAPIN). 
The protein levels of RPTOR, mTOR and Mucolipin 1 were not regulated in the lysosomal 
membrane fraction after FSK/db-cAMP treatment. Compared to that, RUBCN and SNAPIN were 
not detected in the non-phospho enriched samples thus hindering conclusions about the cAMP-
induced changes in protein levels within this lysosomal fraction. The phospho-sites identified for 
the lysosomal proteins are not assigned as PKA target sites in the PhophoSitePlus online 
repository (phosphosite.org, retrieved 09.05.2019). Compared to that, phosphorylation of 
SNAPIN (at S50) and Mucolipin 1 (at S557 and S559) have already been associated with PKA 
activity (Chheda et al. 2001; Vergarajauregui et al. 2008). Interestingly, the S133 phospho-site 
of SNAPIN identified within the present study was downregulated after FSK/db-cAMP 
treatment.  
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Figure 5.3:  Phosphopeptide enrichment from lysosomal membrane fraction.  
Lysosomes from isotopically labeled cells were enriched and subsequently separated into a water soluble and 
membrane fraction. After tryptic digestion, phosphopeptide enrichment was performed by TiO2. The experiment was 
performed in three biological replicates. Phosphopeptides derived from the membrane fractions were analyzed with 
an Orbitrap Fusion Lumos mass spectrometer. Raw data were searched against a human reference database by using 
the Mascot search engine. Statistical analysis (FSK/db-cAMP vs DMSO) was performed on phosphopeptides found in 
at least two out of three replicates (adjusted p-value threshold 0.05) by using the limma package implemented in an 
R-script. Significantly regulated phosphopeptides (adjusted p-value <0.05 and log2 fold change <1 or >1) are 
highlighted as red points. 
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Table 5.4:  Significantly regulated phosphopeptides detected in the lysosomal membrane fraction after FSK/db-
cAMP treatment.  
List of proteins corresponding to the twelve significantly regulated phosphopeptides (red points in figure 5.3) 
identified after statistical analysis of the phospho-data set derived from the lysosomal membrane fraction (FSK/db-
cAMP vs. DMSO). The ratios of the corresponding protein abundance (FSK/db-cAMP vs. control) determined by MS 
analysis of the non-phopho-enriched samples are shown.  
Uniprot 
accession 
Protein name Log2 fold 
change 
Adj. p-value Protein ratio  
(FSK/db-cAMP vs. 
DMSO) 
P52594 Arf-GAP domain and FG 
repeat-containing protein 1 
-2.7 0.0015 Not found 
O95295 SNARE-associated protein 
SNAPIN 
-1.8 0.0126 Not found 
Q4KMP7 TBC1 domain family member 
10B 
-1.8 0.0097 1.12 
O43521 Bcl-2-like protein 11 1.6 0.0161 Not found 
P13591 Neural cell adhesion molecule 
1 
2.5 0.0126 1.04 
O94887 FERM, ARHGEF and pleckstrin 
domain-containing protein 2 
2.8 0.0044 0.47 
Q9GZU1 Mucolipin 1 3.8 0.0002 1.14 
P07197 Neurofilament medium 
polypeptide 
4.0 0.0002 0.97 
O75396 Vesicle-trafficking protein 
SEC22b 
4.2 0.0036 Found in less than 2 
replicates 
Q7L9L4 MOB kinase activator 1B 2.7 0.0216 Not found 
P62753 40S ribosomal protein S6 2.9 0.0389 0.81 
Q9H2J7 Sodium-dependent neutral 
amino acid transporter 
B(0)AT2 
1.8 0.0307 0.93 
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Table 5.5:  Highly upregulated phosphopeptides detected in the lysosomal membrane fraction upon elevation of the intracellular cAMP level. 
List of phosphopeptides found to be highly upregulated in the lysosomal membrane faction after FSK/db-cAMP treatment (found in at least two out of three FSK/db-cAMP replicates but not in any 
DMSO sample). For each phosphopeptide, protein abundance ratios determined in the non-phospho-enriched samples are listed. 
Uniprot 
accession 
Modified sequence Protein name Protein ratio 
(FSK/db-cAMP vs. DMSO) 
Q12846 AIEPQKEEADENYNSVNTR_1xPhospho_[S15(100)] Syntaxin-4 1.21 
P54105 FEEESKEPVADEEEEDSDDDVEPITEFR_1xPhospho_[S17(100)] Methylosome subunit pICln 0.71 
Q8N122 GVHIHQAGGSPPASSTSSSSLTNDVAKQPVSR_1xPhospho_[S10(100)] Regulatory-associated protein of mTOR 1.01 
P55011 KESKGPIVPLNVADQK_1xPhospho_[S3(100)] Solute carrier family 12 member 2 0.82 
Q9BQG0 KGVLGKSPLSALAR_1xPhospho_[S7(100)] Myb-binding protein 1A 0.82 
Q8N7R7 KYSSCSTIFLDDSTVSQPNLR_1xPhospho_[Y/S/T] Cyclin-Y-like protein 1 Not found 
Q8N7R7 KYSSCSTIFLDDSTVSQPNLR_1xPhospho_[S/T/Y] Cyclin-Y-like protein 1 Not found 
P16070 LVINSGNGAVEDRKPSGLNGEASK_1xPhospho_[S16(100)] CD44 antigen 1.31 
O95297 SESVVYADIR_1xPhospho_[Y6(100)] Myelin protein zero-like protein 1 1.16 
P51610 ASAVSPANLPAVLLQPR_1xPhospho_[S5(100)] Host cell factor 1 Not found 
Q5VUB5 DQSTSMSHINLLFSR_1xPhospho_[T/S] Protein FAM171A1 Not found 
Q14789 KFSDAIQSKEEEIR_1xPhospho_[S3(100)] Golgin subfamily B member 1 1.00 
P13746 KGGSYTQAASSDSAQGSDVSLTACKV_1xPhospho_[S20(99.3)] HLA class I histocompatibility antigen, A-
11 alpha chain 
0.94 
Q9C0C9 KKSIPLSIK_1xPhospho_[S3(100)] E2 ubiquitin-conjugating enzyme Not found 
P49792 KQSLPATSIPTPASFK_1xPhospho_[S3(100)] E3 SUMO-protein ligase RanBP2 0.90 
Q9P2M7 KVSLVLEK_1xPhospho_[S3(100)] Cingulin 1.23 
P04920 NISAGSLGSLLGHHHGQGAESDPHVTEPLMGGVPETR_1xPhospho_[S3(100)] Anion exchange protein 2 1.00 
Q9Y2J2 RASALIDRPAPYFER_1xPhospho_[S3(100)] Band 4.1-like protein 3 0.76 
O95613 RESEVLDLKEQLEK_1xPhospho_[S3(100)] Pericentrin 1.17 
Q96II8 RISHEGSPVKPVAIR_1xPhospho_[S3(100)] Leucine-rich repeat and calponin 
homology domain-containing protein 3 
0.81 
P27708 RLSSFVTK_1xPhospho_[S3(100)] CAD protein 1.14 
Q86W92 RRPSDENTIAPSEVQK_1xPhospho_[S4(100)] Liprin-beta-1 Not found 
P42345 TRTDSYSAGQSVEILDGVELGEPAHKK_1xPhospho_[S5(98.4)] Serine/threonine-protein kinase mTOR 0.97 
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Table 5.6:  Highly downregulated phosphopeptides detected in the lysosomal membrane fraction upon elevation of the intracellular cAMP level. 
List of phosphopeptides found to be highly downregulated in the lysosomal membrane faction after FSK/db-cAMP treatment (found in at least two out of three DMSO replicates but not in any 
FSK/db-cAMP sample). For each phosphopeptide, protein abundance ratios determined in the non-phospho-enriched samples are listed. 
Uniprot 
accession 
Modified sequence Protein name Protein ratio 
(FSK/db-cAMP vs. DMSO) 
Q9BY89 AKLDPEPEKAAESPSPR_1xPhospho_[S15(99.5)] Uncharacterized protein KIAA1671 Not found 
P19634 IPSAVSTVSMQNIHPK_1xPhospho_[S9(100)] Sodium/hydrogen exchanger 1 Not found 
Q9H2J7 QSGSPTLDTAPNGR_1xPhospho_[S4(100)] Sodium-dependent neutral amino acid 
transporter B(0)AT2 
0.93 
O15439 SGIDFGSLLKKDNEESEQPPVPGTPTLR_1xPhospho_[T24(100)] Multidrug resistance-associated protein 4 0.54 
P52594 SLLGDSAPTLHLNKGTPSQSPVVGR_2xPhospho_[T16(100);_S20(100)] Arf-GAP domain and FG repeat-
containing protein 1 
Not found 
P52594 SLLGDSAPTLHLNKGTPSQSPVVGR_2xPhospho_[T/S] Arf-GAP domain and FG repeat-
containing protein 1 
Not found 
Q09666 TVIRLPSGSGAASPTGSAVDIR_1xPhospho_[S13(100)] Neuroblast differentiation-associated 
protein AHNAK 
1.04 
Q12933 AAASVTPPGSLELLQPGFSK_1xPhospho_[S4(99.2)] TNF receptor-associated factor 2 0.90 
O75427 AAAVAAPLAAGGEEAAATTSVPGSPGLPGRR_1xPhospho_[T/S] Leucine-rich repeat and calponin 
homology domain-containing protein 4 
Not found 
P20042 SGDEMIFDPTMSKK_1xPhospho_[S1(100)] Eukaryotic translation initiation factor 2 
subunit 2 
Not found 
Q5T1M5 DSGSDGHSVSSRDSAAPSPIPGADNLSADPVVSPPTSIPFK_2xPhospho_[S18(100);_S/T] FK506-binding protein 15 0.87 
Q9BXB5 HLSVGAPGVVTITHHKSPAAAR_1xPhospho_[S17(100)] Oxysterol-binding protein-related protein 
10 
Not found 
Q9H1B7 KASPEPPDSAEGALK_1xPhospho_[S3(100)] Probable E3 ubiquitin-protein ligase 
IRF2BPL 
Not found 
Q92622 KHESPLLVTK_1xPhospho_[S4(100)] Run domain Beclin-1-interacting and 
cysteine-rich domain-containing protein 
Not found 
Q2NKX8 RFPEAEALSPEQAAHYLR_1xPhospho_[S9(100)] DNA excision repair protein ERCC-6-like 0.71 
Q4KMP7 RHGAPAAPSPPPR_1xPhospho_[S9(100)] TBC1 domain family member 10B 1.13 
Q13427 RSETPPHWR_1xPhospho_[T4(99.6)] Peptidyl-prolyl cis-trans isomerase G Not found 
Q9BXB4 SFSLASSSNSPISQR_1xPhospho_[S10(99.6)] Oxysterol-binding protein-related protein 
11 
0.92 
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The current literature suggests important role of SNAPIN in the proper lysosome functionality 
(see section 2.5). Therefore, the present study aimed at further elucidating the importance of 
SNAPIN and the identified downregulated phospho-site at S133 in different processes such as 
the internalization and secretion of acidic hydrolases as well as lysosome positioning. 
 
5.1.3. Analyzing the influence of elevated intracellular cAMP concentrations on 
SNAPIN protein level, lysosomal association and phosphorylation status 
There are at least three explanations for the lower amounts of the SNAPIN S133 containing 
phosphopeptide detected in the lysosomal membrane fraction upon elevation of the 
intracellular cAMP level compared to the control. First, FSK/db-cAMP treatment could be 
associated with the activation of phosphatases which leads to the dephosphorylation of SNAPIN 
at S133. Second, cAMP-induced alterations in the PTM pattern of SNAPIN or an interacting 
protein could lead to a dissociation of SNAPIN from the lysosome. In this case, SNAPIN would 
not be co-purified during lysosome enrichment after FSK/db-cAMP treatment. Therefore, less 
SNAPIN peptides would be identified in the lysosomal fraction during MS analysis even though 
the phosphorylation status at S133 might be unaltered. Third, FSK/db-cAMP treatment could 
lead to a downregulation of SNAPIN expression or induce its degradation. Comparable to the 
second possibility, this would be associated with a reduced number of detectable total SNAPIN 
peptides in the lysosomal fractions and would not necessarily involve a cAMP-mediated 
dephosphorylation at S133.  
5.1.3.1. Investigating the influence of FSK/db-cAMP treatment on SNAPIN protein level 
The influence of FSK/db-cAMP treatment on whole cell SNAPIN protein level was investigated 
by Western Blot and immune detection. The experiment was performed in three biological 
replicates. Prior to protein detection, the nitrocellulose membrane was cut horizontally. The 
upper part of the membrane was incubated with an antibody directed against α-Tubulin 
whereas the lower half was used for immune detection of SNAPIN. For signal quantification, 
SNAPIN intensities were normalized to the α-Tubulin signals. 
After incubating the nitrocellulose membrane with an antibody directed against SNAPIN, signals 
at 15 kDa were observed (Figure 5.4A). Considering its expected mass, these signals can be 
assigned to the SNAPIN protein. Based on this specificity, signals obtained by using this antibody 
will be considered as a successful SNAPIN detection in the further course of this thesis. α-Tubulin 
was detected at 55 kDa on the upper part of the membrane. Similar SNAPIN and α-Tubulin signal 
intensities were observed for the FSK/db-cAMP treated samples and the controls (Figure 5.4A). 
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This was consistent among all replicates. Figure 5.4B shows the quantitative analysis of the 
Western Blot signals. For each replicate and condition, the SNAPIN intensity was normalized on 
the α-Tubulin signal. Afterwards, the means of the relative SNAPIN intensities were calculated 
and plotted as a bar chart for both conditions. The variability among the replicates is shown by 
the standard deviation. Additionally, the relative SNAPIN intensities of the single replicates are 
indicated as dots. By comparing the FSK/db-cAMP treated sample with the control, no difference 
in the mean relative SNAPIN intensity was observed. A two sample t-test revealed no significant 
differences in the relative SNAPIN intensities obtained for the PKA-stimulated and the non-
stimulated group (homoscedastic, p-value 0.7898, significance threshold 0.05). Therefore, the 
results indicate that the SNAPIN protein level was not affected by the treatment.  
 
 
Figure 5.4:  Investigating the influence of FSK/db-cAMP treatment on SNAPIN protein level.  
Cells were either incubated for 30 min with FSK/db-cAMP or DMSO (control). The experiment was performed in 
triplicates (n=3). Whole cell proteins were separated by SDS-PAGE and transferred onto a nitrocellulose membrane. 
SNAPIN detection was performed by using an anti-SNAPIN antibody (10 s exposure) (A). α-Tubulin signals were used 
as a loading control (1 s exposure) (A). For each condition and replicate, SNAPIN intensities were normalized on the 
corresponding α-Tubulin signals. The relative SNAPIN intensities of the FSK/db-cAMP treated sample group and the 
control are depicted as bar charts (B). The variability among the replicates is shown by the standard deviation (B). 
Additionally, the relative SNAPIN intensities of the single replicates are indicated as dots (B). Statistical analysis was 
performed by a t-test (p-value 0.7898). (A.U.: arbitrary units; n.s.: not significant (p-value > 0.05)) 
 
5.1.3.2. Investigating SNAPIN’s association to the lysosomes upon FSK/db-cAMP treatment 
In phosphoproteomic studies, protein levels within the starting material are usually quantified 
by investigating the non-phospho-enriched fraction of the sample. Especially after organelle 
enrichment, stimulation dependent changes in the subcellular protein localization might be 
misinterpreted as phospho-site regulation although the phosphorylation status of the whole 
protein population remains unaltered. Within the present study, SNAPIN was not detected in 
the non-phospho enriched proteomic data set of the membrane lysosomal fractions (see table 
5.4). In order to investigate cAMP-mediated changes in lysosome association of SNAPIN, 
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HEK 293 cells were either treated with FSK/db-cAMP or DMSO. Afterwards, the lysosomes were 
enriched before proteins present in the lysosomal fraction were separated via SDS-PAGE and 
subsequently transferred onto a nitrocellulose membrane. The experiment was performed in 
three biological replicates. SNAPIN levels were investigated by immune detection. The signals 
obtained after incubating the membrane with an antibody directed against the lysosomal 
protease Cathepsin D (CTSD) were used for normalizing the SNAPIN level to the amounts of 
lysosomes present within the different samples after the enrichment procedure. For the heavy 
chain of mature CTSD, a mass of approx. 31-35 kDa was expected (Huang et al. 1979; Hasilik and 
Neufeld 1980).  
SNAPIN was detected at 15 kDa in all samples (Figure 5.5A). After incubating the upper part of 
the membrane with the anti-CTSD antibody, signals at approx. 35 kDa were observed. These 
signals were attributed to the heavy chain of CTSD. Figure 5.5B depicts the results of the signal 
quantification. For each replicate, SNAPIN intensities were normalized to the CTSD signal 
(indicated as dots). The average SNAPIN intensities identified for the two sample groups are 
shown as bar charts (+/- standard deviation). By comparing the FSK/db-cAMP treated sample 
group with the control, the SNAPIN level tends to be reduced in the lysosomal fraction upon 
elevation of the intracellular cAMP level. However, when applying statistical analysis (two 
sample t-test), the difference is not significant (homoscedastic, p-value 0.1095, significance 
threshold 0.05). It is reasonable to assume that the insignificance is predominantly caused by 
the relative SNAPIN intensity observed in the first replicated of the non-stimulated group (1.1). 
Compared to the other two replicates of the control, the relative SNAPIN intensity detected in 
this sample is strongly reduced, thus lowering the mean value and increasing the standard 
deviation in the non-stimulated group.  
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Figure 5.5:  Investigating the influence of elevated intracellular cAMP levels on the lysosome-association of 
SNAPIN.  
Lysosomes were enriched from HEK 293 cells, treated with FSK/db-cAMP or DMSO (control). Proteins present within 
the lysosomal fractions were separated by SDS-PAGE and blotted onto a nitrocellulose membrane. Afterwards, 
SNAPIN (15 s exposure time) and CTSD signals (2 s exposure time) were visualized by immune detection (A). For signal 
quantification, SNAPIN intensities of each replicate were normalized to the corresponding CTSD signals (B; indicated 
as dots). The average relative SNAPIN intensity for the stimulated and non-stimulated sample group are depicted as 
bar charts (B). Statistical analysis was performed by a t-test (p-value 0.1095). (A.U.: arbitrary units; n.s.: not significant 
(p-value > 0.05)) 
 
5.1.3.3. Investigating cAMP-mediated SNAPIN dephosphorylation with 2D-gel 
electrophoresis 
cAMP-mediated changes in the SNAPIN phosphorylation status were investigated by 2D-gel 
electrophoresis. In the first dimension, proteins were separated according to their isoelectric 
point (PI). As protein phosphorylation lowers the PI, these proteoforms migrate further to the 
anode (acidic pH) during IEF compared to their less-phosphorylated counterpart. After IEF, 
proteins were further separated via SDS-PAGE and subsequently transferred onto a 
nitrocellulose membrane. A SNAPIN specific antibody was used for the detection of the different 
proteoforms. In addition to the FSK/db-cAMP treated sample and the DMSO control, a non-
stimulated protein lysate was incubated with calf intestine alkaline phosphatase in order to 
visualize the migration behavior of dephosphorylated SNAPIN isoforms during 2D-gel 
electrophoresis. The experiment was performed in two biological replicates.  
Figure 5.6A depicts the SNAPIN isoforms detected at 15 kDa after incubating the samples of the 
first replicate with the SNAPIN antibody. The signals corresponding to the highest 
phosphorylated proteoforms are indicated by the open arrowheads. Five distinct SNAPIN 
isoforms were observed after FSK/db-cAMP treatment. Compared to that, six proteoforms were 
detected in the DMSO control. Changes in the relative signal intensities were observed for the 
first (open arrowheads) and the third (arrow) isoform. In case of the FSK/db-cAMP treated 
sample, the intensity of the third proteoform is higher compared to the first one. By comparing 
these two isoforms in the DMSO control, a slightly stronger signal intensity of the first 
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proteoform was detected. Additionally, the signal pattern of the isoform with the highest PI is 
less distinct in the DMSO control compared to the FSK/db-cAMP sample. The proteoform 
pattern observed in the phosphatase treated sample was similar to that obtained upon elevation 
of the intracellular cAMP levels.  
The signals obtained in the second replicate are shown in figure 5.6B. Compared to the first 
replicate, the background signal is higher thus making the precise detection of the different 
SNAPIN isoforms more difficult. However, when comparing the first and the third SNAPIN 
proteoforms in both conditions, the isoform with the highest phosphorylation status seemed to 
be more abundant in the DMSO control. In case of the phosphatase treated sample, the third 
isoform was not detected in the second replicate. 
The different relative signal intensities of the first and the third SNAPIN proteoform identified in 
both samples and replicates indicate that SNAPIN is dephosphorylated after FSK/db-cAMP 
treatment. This finding is further supported by the pattern observed in the phosphatase treated 
sample of the first replicate in which the third isoform is also highly abundant. Nevertheless, the 
absence of the third isoform in the phosphatase treated sample of the second replicate indicates 
that the dephosphorylation in the first replicate was not complete. The detection of at least two 
proteoforms after phosphatase treatment indicates the existence of two non-phosphorylated 
SNAPIN isoforms (expected unmodified SNAPIN PI = 9.35; phosphosite.org, retrieved 
09.05.2019). In addition to these findings, SNAPIN also seems to be phosphorylated upon 
FSK/db-cAMP treatment as the signal pattern of the proteoforms with the highest PI appears to 
be less blurry compared the DMSO control.  
 
 
Figure 5.6:  Investigating changes in the abundance of different SNAPIN proteoforms after FSK/db-cAMP treatment 
by 2D-gel electrophoresis.  
Cells were either incubated in medium containing FSK/db-cAMP or DMSO. Cell lysate treated with calf intestine 
alkaline phosphatase was used in order to identify the migration behavior of dephosphorylated isoforms. Proteins 
were first separated according to their PI and subsequently based on their molecular mass. Afterwards, proteins were 
transferred onto a nitrocellulose membrane followed by immune detection of SNAPIN. The signals shown in this figure 
were obtained at different exposure times (biological replicate 1 (A): FSK/db-cAMP 3 min; DMSO 5min(for the same 
exposure time of the FSK/db-cAMP and DMSO sample of the first replicate see Appendix; Phosphatase 1 min) 
(biological replicate 2 (B): FSK/db-cAMP 3 min; DMSO 3min; Phosphatase 3 min). Furthermore, the contrast 
(black/white value) between background and signal was adjusted for the signals of the second replicate.  
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5.1.4. SNAPIN gene knock out with the CRISPR-Cas9 method 
In order to investigate the cellular function of SNAPIN, HEK 293 and HeLa knock-out cell lines 
were generated via the CRISPR-Cas9 method. For this purpose, cells were co-transfected with 
the SNAPIN crRNA, a tracrRNA and a plasmid containing the gene encoding for the Cas9 
endonuclease and a puromycin resistance cassette. Cells carrying the Cas9 plasmid were 
selected by adding puromycin to the medium. Afterwards, monoclonal cell populations were 
prepared and the SNAPIN gene knock out was validated by next generation sequencing (NGS). 
The sequencing data were analyzed by the “outknocker” web tool (Schmid-Burgk et al. 2014). 
Figure 5.7A shows the output after analyzing the NGS data with “outknocker”. Each pie chart 
represents one monoclonal colony and is labeled according to the well position of the 96-well 
plate in which the cells were grown. The pie chart size corresponds to the number of sequencing 
reads whereas the different colors indicate the results of the alignment of the sequenced DNA 
strand compared to the reference sequence. Here, the shades of red represent different types 
of detected out of frame insertions or deletions (indels). As the frame shift leads to non-sense 
mutations or to a premature stop of translation, pie charts completely colored in red might 
indicate monoclones featuring a functional gene knock out. Detailed information about the 
alignment can be obtained by clicking on the single pie charts in the web interface (see Appendix 
Figure 7.8 and figure 7.9).  
In case of all HEK 293 monoclones investigated by NGS, some sequencing reads could not be 
aligned to the uploaded reference sequence (white parts of pie chart). The highest proportion 
of out-of-frame indels was observed for the HEK 293 clones A2, A3, A4, A7, A12, B1, B2, B10 and 
B11. Nevertheless, small blue parts, indicating the detection of some in-frame indel mutations, 
can also be detected in the pie charts of these nine clones. Such a mutation would not be 
associated with a frame shift and a functional gene knock out. However, as these reads are not 
displayed in the alignment list, the in-frame mutations were detected in less than 2 % of the 
reads, thus being considered as false positive identifications (below the 2% indel threshold). 
Therefore, the NGS data indicate a functional SNAPIN KO for the HEK 293 clones A2, A3, A4, A7, 
A12, B1, B2, B10 and B11. Except for clone B5, in-frame-mutations above the 2 % indel threshold 
were not observed in the HeLa NGS data set. Here, five potential HeLa SNAPIN KO clones (A9, 
A12, B1, B3, B4) have been identified.  
In order to verify the functional gene knock-out identified in the NGS data set, the potential 
HEK 293 and HeLa SNAPIN KO clones were investigated by Western Blot and immune detection 
of SNAPIN. Wildtype (wt) HEK 293 and HeLa cells served as controls. Detection of α-Tubulin was 
used to control the amount of protein loaded onto the gel.  
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SNAPIN was detected at 15 kDa in the HEK 293 and HeLa wt samples when incubating the 
nitrocellulose membranes with the SNAPIN antibody (Figure 5.7B). At the same height, weak 
signals were observed in the lanes of the different HEK 293 SNAPIN KO samples. However, as 
the same signal pattern was detected in the secondary antibody control (sec. AB ctrl), the signals 
might rather be derived from unspecific binding of the secondary antibody to HEK proteins than 
from SNAPIN detection in the KO samples. Compared to that, no signals were observed in the 
lanes containing the HeLa SNAPIN KO samples after incubation with the SNAPIN antibody. The 
uniformity of the α-Tubulin signals indicates that similar protein amounts were loaded onto the 
gels. Therefore, the missing SNAPIN signal in the HEK 239 and HeLa KO samples indicates an 
impaired SNAPIN protein production within these clones, thus supporting the observations 
made in the NGS data set.  
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Figure 5.7:  Validation of SNAPIN KO generated with the CRISPR-Cas9 method in HEK 293 and HeLa cells.  
Genetic modifications in the SNAPIN gene of monoclonal cell populations after CRISPR-Cas9 was investigated by NGS. 
Data analysis was performed by the “outknocker” web tool (Schmid-Burgk et al. 2014). Sequencing results for the 
different monoclones are depicted as pie charts (A). Nine potential HEK 293 and five HeLa SNAPIN KO monoclonal cell 
populations were identified. The functional gene knockout was further validated by Western Blot and immune 
detection of SNAPIN (B) (HEK α-Tubulin: 1 s exposure; HEK SNAPIN + sec. AB ctrl.: 3 min exposure; HeLa α-Tubulin: 3 s 
exposure; HeLa SNAPIN + sec. AB ctrl.: 4 min exposure).  
 
5.1.5. Proteomic comparison of HEK 293 wt and HEK 293 SNAPIN KO cells 
SNAPIN KO mediated changes in the proteome were investigated by bottom up mass 
spectrometry. For this purpose, whole cell lysates of isotopically labeled HEK 293 wt and HEK 
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293 SNAPIN KO cells were mixed. The third SILAC channel comprised HEK 293 wt cells starved 
for 50 min but these samples are not further discussed in this thesis. After SDS-PAGE, proteins 
were digested by in-gel digestion. Tryptic peptides were analyzed by LC-MS2 using a Dionex LC-
system coupled to an LTQ Orbitrap Velos mass spectrometer. Data analysis was performed with 
the Proteome Discoverer software. Based on the protein abundances in the SNAPIN KO and wt 
group, the protein ratios were calculated. For statistical analysis, the analysis of variance 
(ANOVA) (individual proteins) setting was used.  
The data of the HEK 293 SNAPIN KO and HEK 293 wt proteome comparison are visualized in a 
volcano plot (Figure 5.8). Here, the log2 fold change and the p-values of the individual proteins 
are shown. Proteins with a log2 fold change higher than 0.75 or lower than -0.75 are depicted as 
blue points. Out of these, proteins with a p-value smaller than 0.05 (-log10 p-value >1.3) are 
labeled with their UniProt accession. The protein names corresponding to these accessions are 
listed in table 5.7. After adjusting the p-value for multiple testing, no significantly regulated 
protein was detected. The serine/threonine-protein kinase TAO1 (UniProt accession Q7L7X3) 
was found in two SNAPIN KO but not in any wt sample.  
The lysosome annotated cation-independent mannose-6-phosphate receptor (MPR300) was 
identified as being slightly downregulated in HEK 293 SNAPIN KO cells. Although this 
downregulation was not ascribed as being significant after p-value correction for the whole data 
set, detailed analysis of the processing results highlighted the reliability of the MPR300 
identification and the consistency of the MPR300 quantification values detected for the 
different samples among the replicates. In order to validate the MS results, MPR300 quantity in 
SNAPIN KO and wt cells was investigated by Western Blot and immune detection.  
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Figure 5.8:  Quantitative proteome comparison of HEK 293 SNAPIN KO and HEK 293 wt cells. 
Proteins of isotopically labeled HEK 293 SNAPIN KO and HEK 293 wt cells were mixed, separated via SDS-PAGE and 
digested by in-gel digestion. Tryptic peptides were analyzed by LC-MS2. The experiment was performed in three 
biological replicates. MS spectra were searched against a human reference database. Protein ratios were calculated 
based on their abundance in the different sample group. Statistical analysis was performed by an ANOVA test 
(individual proteins). Data are visualized in a volcano plot. Proteins with a log2 fold change higher than 0.75 or lower 
than -0.75 are shown as blue points. Among those, proteins with a p-value smaller than 0.05 are labeled with their 
UniProt accession. 
 
Table 5.7:  Protein names corresponding to the UniProt accessions depicted in figure 5.8.  
Uniprot 
accession 
Protein name Log2 fold 
change 
p-value 
P13797 Plastin-3 -0.79 0.0003 
Q9H0F7 ADP-ribosylation factor-like protein 6 -0.88 0.0046 
Q9ULT8 E3 ubiquitin-protein ligase HECTD1 -0.78 0.0245 
P11717 Cation-independent mannose-6-phosphate receptor -0.94 0.0260 
Q8TEM1 Nuclear pore membrane glycoprotein 210 -1.31 0.0291 
Q00534 Cyclin-dependent kinase 6 -0.78 0.0289 
O75376 Nuclear receptor corepressor 1 0.92 0.0096 
P07305 Histone H1.0 0.82 0.0161 
Q9UHW5 GPN-loop GTPase 3 1.38 0.0263 
 
5.1.6. Investigating the MPR300 level in SNAPIN KO cells 
Changes in the MPR300 level after SNAPIN KO were investigated in HeLa and HEK 293 cells by 
Western blotting and immune detection. MPR300 was detected by using an antiserum directed 
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against the third domain of the receptor previously made in the laboratory. α-Tubulin detection 
was used as a loading control. In order to verify the SNAPIN KO, the samples were also probed 
by the anti-SNAPIN antibody. The experiment was performed in two biological replicates. 
HEK 293 wt and SNAPIN KO cell lysates of the first replicate were derived from a stimulation 
experiment. Here, the wt and the KO cells were treated with DMSO for 30 min prior to cell lysis. 
However, as both samples of the first HEK 293 replicate were treated the same way, the MPR300 
intensities obtained for these two lysates were assumed to be comparable. The other samples 
used in this experiment were not treated with DMSO before cell lysis. 
The SNAPIN signals observed for the different cell lines and genotypes are shown in figure 5.9A 
(lower panel). Here, no SNAPIN signal was detected in any SNAPIN KO sample thus indicating a 
functional gene knock out in these cell lines. In case of the wt samples, SNAPIN was detected as 
a 15 kDa signal. Compared to the HeLa cells, stronger SNAPIN signals were observed in the 
HEK 293 samples. Similar α-Tubulin signal intensities were detected among the different cell 
lines and genotypes (Figure 5.9A, upper panel). Therefore, the stronger SNAPIN signal observed 
in the HEK 293 wt cells might be assignable to higher SNAPIN amounts present within this cell 
type.  
Figure 5.9B (upper panel) depicts the signals obtained after incubating the membrane with the 
anti-MPR300 antiserum. Here, strong signals at approx. 300 kDa were detected. As these signals 
match to the expected mass of the MPR300, they were assigned to this receptor. Comparing 
both cell types, the MPR300 signals observed in the HEK samples were more focused. Especially 
in the HeLa SNAPIN KO cells, the MPR300 bands were less sharp. α-Tubulin was detected at 
approx. 50 kDa with similar intensities among all samples (Figure 5.9A, lower panel). Only for 
the HeLa SNAPIN KO sample of the first replicate and the HEK 293 SNAPIN KO samples of the 
second replicate, slightly stronger α-Tubulin signals were observed.  
The relative MRP300 intensities calculated based on the signals obtained after immune 
detection are shown in figure 5.9C. Here, the MPR300 signal of each sample was normalized to 
the corresponding α-Tubulin intensity. In comparison to the wt samples, a lower relative 
MPR300 signal intensity was detected in the SNAPIN KO cells for both cell lines. This observation 
was consistent among all replicates. However, when comparing the abundances of the receptor 
within the wt and KO cells, a higher variability in the MPR300 levels was detected among the 
two replicates of the SNAPIN KO cell lysates. As a result of this, the MPR300 KO/wt-fold change 
varied between 0.44 and 0.63 in the HEK 293 samples and between 0.54 and 0.69 in the HeLa 
cell lysates. Nevertheless, the results described in this section support the previously detected 
downregulation of MPR300 in SNAPIN KO cells compared to their wt counterpart observed in 
the MS-based proteome comparison approach (Figure 5.8, table 5.7). 
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Figure 5.9:  Immune detection-based investigations of the MPR300 level in wt and SNAPIN KO cells.  
Proteins derived from HeLa and HEK 293 wt and SNAPIN KO cells were separated by SDS-PAGE and transferred onto 
a nitrocellulose membrane. SNAPIN levels of the different samples were investigated by immune detection using a 
protein specific antibody (A) (α-Tubulin: 1 s exposure; SNAPIN: 10 s exposure). MPR300 signals were visualized by 
using an antiserum directed against the third domain of this receptor (B) (α-Tubulin + MPR300: 1 s exposure). α-
Tubulin detection was used as a loading control (A+B). The relative MPR300 intensities of the different samples were 
calculated by normalizing the MPR300 signal to the corresponding α-Tubulin intensity (C).  
 
5.1.7. Investigating the effect of elevated intracellular cAMP levels on endocytosis in 
HEK 293 wt and SNAPIN KO cells  
The MPR300 has been described as an important receptor for the transport of lysosomal 
enzymes from the trans-Golgi network (TGN) to endosomes as well as for the internalization of 
mannose-6-phosphate containing and non-glycosylated proteins from the extracellular space 
(reviewed by Braulke and Bonifacino 2009). In order to investigate whether the MPR300 
downregulation detected in the SNAPIN KO cells influences endocytosis, an internalization 
experiment with the lysosomal enzyme ASA was performed. Additionally, the effect of elevated 
intracellular cAMP levels on ASA endocytosis was analyzed. For this purpose, HEK 293 wt and 
SNAPIN KO cells were incubated with biotinylated ASA in the presence or in the absence of 
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FSK/db-cAMP. Here, biotinylated ASA was used in order to be distinguishable from its 
endogenous counterpart. After cell lysis, the amount of internalized biotinylated ASA was 
quantified by an ELISA and normalized to the protein concentration of the corresponding lysate.  
Figure 5.10 shows the relative amounts of internalized, biotinylated ASA (in ng/µg) identified 
within the single replicates of the different sample groups (indicated as dots). The corresponding 
mean values (+/- standard deviation) are depicted as bar charts.  
For both cell types, no differences in the endocytosis of biotinylated ASA was detected when 
comparing the FSK/db-cAMP treated samples with the non-stimulated controls. Analysis of the 
cell lysates by Western Blotting and pCREB immune detection indicates a successful FSK/db-
cAMP-dependent activation of PKA in the wt cells (data not shown). Compared to that, 
inconclusive results regarding the stimulation-induced activation of PKA were obtained for the 
SNAPIN KO cells (data not shown).  
However, comparison of the HEK 293 wt and the SNAPIN KO cells indicate a treatment-
independent reduction of ASA internalization in the KO samples. Statistical analysis was 
performed by using a one-way ANOVA (p-value 0.0055) followed by a Tukey honest significant 
difference (HSD) post hoc test (homoscedastic, homogeneity of variance was tested by a Brown-
Forsythe test (p-value 0.5633)). By comparing the mean values of the non-stimulated HEK 293 
wt and SNAPIN KO cells, a p-value of 0.014 was obtained. A similar p-value was calculated for 
the comparison of the means of the two cell types after FSK/db-cAMP-treatment (p-value 
0.046).  
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Figure 5.10:  Investigation of the internalization of biotinylated ASA in HEK 293 wt and SNAPIN KO cells upon 
elevated intracellular cAMP levels.  
Endocytosis of a lysosomal hydrolase was investigated by incubating HEK 293 wt and SNAPIN KO cells with 
biotinylated ASA and FSK/db-cAMP. DMSO treated cells served as a control. The amount of internalized, biotinylated 
ASA was analyzed by an ELISA and subsequently normalized to the protein concentration of the lysate. For each 
sample group, the relative biotinylated ASA amounts detected in the single replicates are indicated as dots. The 
corresponding mean values are depicted as bar charts (+/- standard deviation). Statistical analysis was performed by 
a one-way ANOVA (p-value 0.0055) followed by Tukey HSD post hoc test (p-valuewt control-KO control 0.014; p- valuewt FSK/db-
cAMP-KO FSK/db-cAMP 0.046). (n.s.: not significant (p-value > 0.05), * p-value < 0.05). 
 
5.1.8. Investigating the spatial distribution of LAMP-2 in HeLa wt and SNAPIN KO cells 
after FSK/db-cAMP treatment 
SNAPIN is part of BORC, a complex known to be involved in lysosome positioning (Pu et al. 2015). 
In order to investigate changes in the subcellular distribution of lysosome/LE upon elevating the 
intracellular cAMP levels, the spatial distribution of lysosome-associated membrane 
glycoprotein 2 (LAMP-2) in HeLa wt and SNAPIN KO cells treated with FSK/db-cAMP or DMSO 
was analyzed. After stimulation, cells were fixed and stained with an antibody directed against 
LAMP-2. The DAPI containing ProLongTM Diamond was used for mounting the cover slips to the 
glass slides. Images were acquired as Z-stacks by using an LSM 980 confocal microscope 
equipped with an Airyscan 2 detector (Zeiss). In order to obtain comparable signal intensities 
among the different samples, the laser gain was kept constant during image acquisition. For 
each sample, the same adjustments of the black and white values were made in the histogram 
of the LAMP-2 channel in order to obtain an optimal contrast. Afterwards, the single images of 
one Z-stack were combined by a maximum intensity projection. 
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Figure 5.11 depicts the signals obtained by incubating the different samples with an anti-LAMP-
2 antibody. Although LAMP-2 was detected within the whole cell, a slight accumulation of the 
signal in the perinuclear region was observed for the HEK wt cells. However, by comparing the 
FSK/db-cAMP-treated wt sample and the corresponding control, no difference in the signal 
distribution was identified. In DMSO treated HeLa SNAPIN KO cells, punctate LAMP-2 signals 
were distributed homogenously. Compared to that, a slight LAMP-2 accumulation adjacent to 
the nucleus was observed in case of the FSK/db-cAMP treated KO cells.  
The strongest difference in the LAMP-2 signal pattern was identified between the two cell types. 
Whereas relatively large structures were detected by the LAMP-2 antibody in the HeLa wt cells, 
the signals observed in the SNAPIN KO samples were smaller and more dispersed across the 
cells. Reliable conclusions about differences in the summed LAMP-2 intensity between these 
two cell types cannot be drawn, as such an analysis requires a bigger sample size.  
 
 
Figure 5.11:  Investigation of the LAMP-2 signal distribution in FSK/db-cAMP treated HEK 293 wt and SNAPIN KO 
cells as well as in the corresponding controls.  
HEK 293 wt and SNAPIN KO cells, either incubated with FSK/db-cAMP or DMSO, were stained with an antibody 
directed against LAMP-2. Images were acquired as Z-stacks by using the same laser gain for the different samples. 
After image acquisition, the single images of one Z-stack were combined by maximum intensity projection. 
Scale bar = 10 µm. 
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5.1.9. Investigation of cAMP-dependent changes in the exocytosis of lysosomal 
enzymes in HeLa wt and SNAPIN KO cells 
SNAPIN has been demonstrated to be involved in tethering insulin granules to the plasma 
membrane in pancreatic beta cells (Somanath et al. 2016). HeLa wt and SNAPIN KO cells were 
used in order to investigate the impact of SNAPIN and elevated intracellular cAMP levels on the 
exocytosis of lysosomal enzymes (three biological replicates). For this purpose, the cells were 
treated with FSK/db-cAMP for 20 min. HeLa cells incubated with DMSO served as a control. 
Exocytosis was triggered by replacing the stimulating medium with an isosmotic buffer 
containing either FSK/db-cAMP or DMSO as well as CaCl2 and ionomycin as an ionophore. 
Buffers without ionomycin, CaCl2 or both supplements were used as controls in the exocytosis 
experiments. After 10 minutes of incubation, the release of lysosomal proteins was analyzed by 
measuring the activity of β-hexosaminidase (β-Hex) in the supernatant. In addition to that, the 
β-Hex activity assay was also performed for the different cell lysates. The total β-Hex activity of 
a sample was calculated as the sum of the activity determined in the lysates and the 
supernatant. For comparison of the different samples, the β-Hex activities were normalized to 
the protein amounts measured in the corresponding cell lysates.  
The bar charts depicted in figure 5.12 show the mean β-Hex activities (+/- standard deviation) 
determined in the supernatants (A) and the total fractions (B). Additionally, the activities of the 
single replicates of each sample are indicated as dots. Single sample types were compared 
statistically by a t-test. 
When evaluating the release of β-Hex in the different FSK/db-cAMP treated HeLa wt samples, 
the highest mean activity was measured after incubating the cells with ionomycin and CaCl2 
(Figure 5.12A). Nevertheless, as a high variability among the single replicates of the non-
ionomycin and non-CaCl2 containing sample was observed, reliable conclusions about the effect 
of these two supplements on β-Hex exocytosis cannot be drawn for this sample group. In case 
of the DMSO treated HeLa wt cells, similar average β-Hex activities were measured in the 
different media, thus indicating that exocytosis was not triggered by adding ionomycin and CaCl2 
to the cultivation medium. Compared to that, an ionomycin/CaCl2-dependent increase in the 
release of β-Hex was observed for the HeLa SNAPIN KO cells. Here, no difference in the β-Hex 
activity was detected in the supernatant of the FSK/db-cAMP treated samples and the control. 
However, when comparing the β-Hex release of the two cell types, higher mean activities were 
detected in all sample groups of the HeLa SNAPIN KO cells. A significant difference was detected 
between the FSK/db-cAMP, ionomycin and CaCl2 treated samples of these two cell types 
(homoscedastic, p-value 0.0047, significant threshold 0.05). Furthermore, comparison of the β-
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Hex secretion between the wt and SNAPIN KO cells of the DMSO stimulation control without 
ionomycin and CaCl2 treatment revealed a significant difference (homoscedastic, p-value 0.022, 
significant threshold 0.05). In addition to that, the difference in the β-Hex release observed by 
comparison of the DMSO treated HeLa wt and SNAPIN KO cells, incubated with ionomycin and 
CaCl2, were also significant (homoscedastic, p-value 0.0113, significant threshold 0.05).  
Figure 5.12B depicts the sum of the β-Hex activity detected in the supernatant and the lysate. 
Similar total β-Hex activities were observed for the different HeLa wt samples. In case of the KO 
cell line, a high variability in the β-Hex activity was detected between the single replicates of 
some conditions. Nevertheless, similar mean β-Hex activities were observed between the 
different samples of the HeLa SNAPIN KO cells. Comparison of the two cell lines indicates a lower 
total β-Hex activity within the HeLa wt cells. A significant difference (two sample t-test) was 
observed when comparing the β-Hex activities of the two cell lines detected for the FSK/db-
cAMP, ionomycin and CaCl2 treated samples (homoscedastic, p-value 0.0034, significance 
threshold 0.05). Similarly, the differences in the total β-Hex activities detected for the wt and 
SNAPIN KO cells in the DMSO (homoscedastic, p-value 0.0137, significance threshold 0.05) as 
well as in the FSK/db-cAMP (homoscedastic, p-value 0.0431, significance threshold 0.05) 
controls without ionomycin and CaCl2  were statistically significant (two sample t-test).  
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Figure 5.12:  Investigation of cAMP-mediated exocytosis of a lysosomal protein in HeLa wt and SNAPIN KO cells.  
The experiment was performed in three biological replicates. cAMP levels were elevated by adding FSK/db-cAMP to 
the medium. Cells treated with DMSO served as a control. Exocytosis was triggered by replacing the medium with a 
buffer containing CaCl2 and ionomycin. Buffers without CaCl2, ionomycin or both supplements were used as controls 
of the exocytosis experiment. The release of lysosomal enzymes was investigated by measuring the β-Hex activity in 
the supernatant (A). The total β-Hex activities of the different samples were calculated as the sum of the activity 
determined in the supernatant and the cell lysate (B). For data comparison, β-Hex activities were normalized to the 
protein amount determined for the corresponding lysates (A+B). Mean normalized β-Hex activities are shown as bar 
charts (+/- standard deviation). The activities measured for the single replicates are indicated as dots. Statistical 
analysis was performed by a t-test. (* p-value < 0.05; *** p-value <0.005, n.s.: not significant) 
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5.1.10. Co-immunoprecipitation with phosphomimetic SNAPIN variants  
The replacement of an amino acid residue at a potential phospho-site by an acidic amino acid 
such as glutamate is intended to mimic a permanent phosphorylation whereas its substitution 
by alanine imitates the non-phosphorylated isoform. These phosphomimetic substitutions are 
often used in order to investigate the biological function of a certain phosphorylation site.  
Compared to the control, the SNAPIN peptide containing the S133 phospho-site has been 
identified to be less abundant in the lysosomal membrane fraction when treating the cells with 
FSK/db-cAMP (section 5.1.2.2). Potential interaction partners of the S133 phosphorylated and 
non-phosphorylated SNAPIN isoform were investigated by a phosphomimetic study. For this 
purpose, co-immunoprecipitation was performed with isotopically labeled HEK 293 SNAPIN KO 
cells stably transfected with a plasmid encoding for a Myc-tagged SNAPIN variant either 
containing a serine to alanine (S133A) or a serine to glutamate (S133E) substitution at position 
133. Precipitation of the SNAPIN variants was achieved by using Myc-Trap-beads. Non-
transfected HEK 293 SNAPIN KO cells served as a control for unspecific protein binding to the 
beads. The experiment was performed in three biological replicates.  
The protein lysate (input) used for the IP as well as the supernatant after the pull-down assay 
were investigated by SDS-PAGE, Western Blotting and immune detection.  
Figure 5.13 shows signals detected after incubating the nitrocellulose membrane with 
antibodies directed against SNAPIN and α-Tubulin. α-Tubulin was detected as a 55 kDa signal. 
Except for the SNAPIN S133A Rep1 and the SNAPIN S133E Rep2 samples, the α-Tubulin signal 
intensities were similar between the lysates (Input IP). Signals at approx. 20 kDa were detected 
in case of all SNAPIN S133A and S133E input samples when incubating the corresponding 
membrane with the anti-SNAPIN antibody. These signals match with the expected molecular 
mass of the Myc-tagged SNAPIN variants. A slightly higher signal intensity was detected for the 
SNAPIN S133E samples compared to SNAPIN S133A lysate. However, no signals were observed 
for the HEK 293 SNAPIN KO samples further substantiating the KO genotype of these cells.  
Compared to the input, lower amounts of α-Tubulin were detected in the supernatant after IP 
which was a consequence of diluting the cell lysate prior to the pull-down assay. Additionally, 
varying α-Tubulin signals were observed in the supernatants with the lowest amount detected 
in the SNAPIN KO samples. This suggests an increased unspecific binding of this protein to the 
beads when the antigen is not present. However, SNAPIN was also detected in the supernatant 
after IP indicating an incomplete pull-down. Normalization of the SNAPIN signals was not 
possible as the α-Tubulin signals were inconsistent. In addition to the 20 kDa SNAPIN 
polypeptide, one or two signals with a smaller molecular mass were detected in the 
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supernatants by the anti SNAPIN antibody. These might correspond to SNAPIN versions 
expressed from a small proportion of plasmids containing the genetic information of a truncated 
SNAPIN proteoform. Some of these signals were also observed for higher exposure times of the 
membrane containing the input samples (data not shown).  
 
 
Figure 5.13:  Immune detection of SNAPIN and α-Tubulin in the IP input and the IP supernatant samples.  
HEK 293 SNAPIN KO cells were stably transfected with a plasmid carrying a gene either encoding for the 
phosphomimetic SNAPIN S133E or the non-phophorylatable SNAPIN S133A isoform. After isotopic labeling of the 
cells, immunoprecipitation was performed by using Myc-Trap beads directed against the Myc-tag of the SNAPIN 
proteoforms. Untransfected SNAPIN KO cells served as a control. The experiment was performed in triplicates. 
Proteins were separated according to their molecular mass by SDS-PAGE and subsequently transferred onto a 
nitrocellulose membrane. Immune detection of the SNAPIN variants and α-Tubulin was performed by using anti-
SNAPIN and anti- α-Tubulin antibodies (α-Tubulin + SNAPIN input IP: 2 s exposure; α-Tubulin supernatant IP: 5 s 
exposure; SNAPIN supernatant IP: 20 s exposure).  
 
After immunoprecipitation, eluted proteins from the SNAPIN S133A, S133E and KO samples 
belonging to the same replicate were mixed and loaded to an SDS gel. Proteins from gel slices 
were digested and analyzed by LC-MS2. MS raw data were searched against a database 
containing the SNAPIN sequences of the wt, S133A and S133E isoforms (without Myc-tag) as 
well as against a database comprising human reference protein sequences. This search was 
implemented in a Proteome Discoverer workflow.  
Calculation of the SNAPIN S133A/KO and the SNAPIN S133E/KO ratio was performed with non-
normalized protein abundances. First, the mean abundance of the three replicates for the 
SNAPIN KO, SNAPIN S133A and SNAPIN S133E sample group was calculated for each protein. 
Afterwards, these mean abundances were used for determining the SNAPIN S133A/KO and the 
SNAPIN S133E/KO ratio for the single proteins. In case the ratio could not be calculated because 
of a missing value in the KO sample group, a value of 200 was set. Furthermore, the coefficient 
of variation (CV) was calculated for the non-normalized abundances. For this purpose, the 
standard deviation of the abundances was divided by their mean values. This calculation was 
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performed for each protein and allowed a conclusion about the variance of the abundances 
among the replicates of one sample group. For both SNAPIN proteoforms (S133A and S133E), 
proteins found in at least two out of three replicates were used for data visualization. 
Figure 5.14 shows the scatter plots generated for the SNAPIN S133A (A) and S133E (B) sample 
group. Here, the CV (in percent) of a single protein is plotted against its log2 abundance ratio of 
the S133A or S133E sample group and the SNAPIN KO control (log2 ratio (SNAPIN proteoform-
KO)). For both SNAPIN proteoforms (S133A and S133E), most of the proteins had a higher mean 
abundance in the SNAPIN KO sample group thus representing unspecific pull-downs. However, 
proteins with a log2 abundance ratio (S133A or S133E sample group – KO sample group) higher 
than 3.3 (10-fold enrichment in the specific IP sample) were assumed as potential interaction 
partners. Within the scatter plots, this threshold is indicated by the green, dashed line.  
SNAPIN S133A was identified with a log2 abundance ratio of 5.7 in the S133A sample group 
indicating its identification in the SNAPIN KO control (Figure 5.14, blue point). However, these 
identifications were only based on feature mapping of precursor ions probably corresponding 
to certain SNAPIN S133A peptides but without evidence on MS2 level. Similar observations were 
made in the SNAPIN S133E sample group (Figure 5.14B, blue point). Here, SNAPIN S133E 
peptides were also found in the SNAPIN KO samples without any PSM assigned to its features. 
As a result of the missing MS2 evidence, the identification of both SNAPIN proteoforms in the 
control could also be due to a false feature alignment on MS1 level. This becomes more apparent 
when considering that the SNAPIN isoforms were not found by immune detection in the KO IP 
input and the KO IP supernatant samples (Figure 5.13).  
The peptide comprising the S133E substitution was found in the S133A samples and vice versa. 
Comparable to the MS-based SNAPIN detection in the KO cells, these identifications were only 
based on MS1 feature mapping without evidence on PSM level. Therefore, it is reasonable to 
assume that this identification might have been also caused by false MS1 precursor alignment, 
similar to the findings mentioned above. 
According to the criteria applied in this study, nine proteins were identified as potential 
interaction partners of the SNAPIN S133A proteoform (Figure 5.14A). Among those, two proteins 
were uniquely found in this sample group whereas seven proteins were also identified to be at 
least 10 times more abundant in the S133E sample group compared to the KO control. 
Additionally, five proteins were found as possible interaction partners specific to the SNAPIN 
S133E proteoform (Figure 5.14B). For both SNAPIN proteoforms (S133A and S133E), unique 
potential interaction partners are indicated as red points together with their UniProt accession 
number in the scatter plots of figure 5.14. The corresponding protein names and the MS 
identification levels are listed in table 5.8. In this context, a MS1 identification level indicates 
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that no MS2 spectra was assigned to any peptide found for the particular protein in this sample 
group. Here, the assignments are solely based on matching of the precursor mass and retention 
time to an otherwise identified peptide. In contrast, protein identifications based on peptides 
with at least one PSM are annotated with an MS2 identification level.  
 
 
Figure 5.14:  Data analysis of the proteins identified in the IP eluate by LC-MS2. 
Calculations were based on non-normalized abundance values. For each protein identified in at least two out of three 
SNAPIN S133A (A) or S133E (B) pull-down experiments, the CV is plotted against the log2 abundance ratio of the 
samples and the KO control. Proteins with a sample/KO ratio higher than 10 (log2 > 3.3, green dashed line) were 
considered as potential interaction partners. Proteins uniquely identified in the SNAPIN S133A or S133E co-IP are 
shown as red dots. The blue point represents the bait of the particular pull-down experiment.  
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Table 5.8:  Description and MS identification levels corresponding to the proteins identified as potential unique 
interaction partners of the SNAPIN S133A or the SNPAIN S133E proteoform (red dots in figure 5.14).  
 Uniprot accession Protein name MS identification level 
Identified 
SNAPIN S133A 
interaction 
Q96PU5 E3 ubiquitin-protein ligase 
NEDD4-like 
MS1 (2/3 Rep) 
Q96TA1 Protein Niban 2 MS1 (2/3 Rep) 
Identified 
SNAPIN S133E 
interaction 
Q6P1Q9 Methyltransferase-like protein 
2B 
MS1 + MS2 (2/3 Rep) 
O43237 Cytoplasmic dynein 1 light 
intermediate chain 2 
MS1 (2/3 Rep) 
Q12834 Cell division cycle protein 20 
homolog 
MS1 + MS2 (2/3 Rep) 
Q9UL45 Biogenesis of lysosome-related 
organelles complex 1 subunit 6 
MS2 (2/3 Rep) 
Q9Y676 28S ribosomal protein S18b, 
mitochondrial 
MS1 (2/3 Rep) 
 
Direct comparison between the protein abundances of the SNAPIN S133A and the SNAPIN S133E 
sample group is difficult as the quantity of the recombinantly produced protein might vary after 
stable transfection with different constructs. When using transfected cells for pull-down 
experiments, such variations in the bait concentration might influence the quantity of co-
immunoprecipitated interaction partners. In order to overcome this variability, the protein 
abundances of each channel and sample group have been normalized on the according SNAPIN 
quantities.  
Figure 5.15 shows the abundance ratios of the seven proteins found as potential interaction 
partners in the SNAPIN S133A and the SNAPIN S133E sample group (based on normalized 
abundances). The corresponding protein names as well as the MS identification levels are listed 
in table 5.9. In figure 5.15, abundance ratios of single replicates are indicated as dots. The bars 
depict the ratios of the mean abundances determined from all relevant replicates. Here, the 
mean protein abundance of one sample group was calculated prior to the ratio determination. 
Compared to the calculation of the mean ratio based on the single replicate ratios, this considers 
a higher number of quantification values as one protein found in two out of three replicates 
might not have been always identified in the same replicate among the S133E and S133A sample 
groups. In this case, only one single replicate ratio would be calculated whereas the second 
quantification value identified for each sample group would be lost (see figure 5.15, Protein 
Q8IY63 and Q96FH0).  
By comparing the normalized abundance ratios of the proteins found in the SNAPIN S133A and 
S133E sample group, no mutation induced differences in the interaction of the SNAPIN 
proteoforms and the co-immunoprecipitated proteins were detected (Figure 5.15). Except for 
the biogenesis of lysosome-related organelles complex 1 (BORC) subunit 2 (Accession Q6QNY1), 
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a high variability of the single replicate ratios was detected, thus indicating high variations in the 
protein abundances between the replicates.  
 
 
Figure 5.15:  Comparison of the normalized abundance ratios of proteins identified as potential interaction 
partners in the SNAPIN S133A and S133E pull down experiments (min. found in 2/3 replicates).  
The dots represent the ratios determined for the single replicate. The bars indicate the ratios of the mean abundances 
determined from all relevant replicates. Here, the mean protein abundance of one sample group was calculated prior 
to the ratio determination.  
 
Table 5.9:  Description and MS identification levels corresponding to the proteins identified as potential 
interaction partners of both SNAPIN proteoforms (Figure 5.15).  
Uniprot 
accession 
Protein name MS identification 
level S133A sample 
group 
MS identification 
level S133E sample 
group 
P78537 Biogenesis of lysosome-related 
organelles complex 1 subunit 1 
MS2 (3/3 Rep) MS2 (3/3 Rep) 
Q15291 Retinoblastoma-binding protein 5 MS1 (3/3 Rep) MS1 (2/3 Rep) 
Q6QNY1 Biogenesis of lysosome-related 
organelles complex 1 subunit 2 
MS2 (3/3 Rep) MS2 (3/3 Rep) 
Q8IY63 Angiomotin-like protein 1 MS1 + MS2 
(2/3 Rep) 
MS1 + MS2 
(2/3 Rep) 
Q96B45 BLOC-1-related complex subunit 7 MS1 + MS2 
(3/3 Rep) 
MS2 
(3/3 Rep) 
Q96FH0 BLOC-1-related complex subunit 8 MS1 + MS2 
(2/3 Rep) 
MS1 + MS2 
(2/3 Rep) 
Q9NPJ6 Mediator of RNA polymerase II 
transcription subunit 4 
MS1 + MS2 
(3/3 Rep) 
MS2 (3/3 Rep) 
 
SNAPIN is a known subunit of the BORC and the BLOC-1 complex (Starcevic and Dell'Angelica 
2004; Pu et al. 2015). Among the proteins precipitated by the SNAPIN S133A and S133E 
proteoforms, four other subunits either belonging to BORC or the BLOC-1 complex were found 
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(P78537, Q6QNY1, Q96B45, Q96FH0) (Starcevic and Dell'Angelica 2004; Pu et al. 2015). 
However, as the abundance ratios of these proteins were not consistently changed between the 
replicates, the precipitation between these subunits and the two SNAPIN isoforms seems to be 
independent from the substitution of serine at position 133. Interestingly, BLOC-1 subunit 6 
(BLOC1S6), another member of BLOC-1, has been identified as a possible unique interaction 
partner of the SNAPIN S133E proteoform (Figure 5.14B). This might suggest a charge dependent 
interaction between these two proteins which might also occur when the serine 133 is 
phosphorylated. Nevertheless, as the CV of this protein was rather high, the unique interaction 
of BLOC1S6 with SNAPIN S133E needs to be further analyzed in order to draw reliable 
conclusions. 
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5.2. Method development for the detection of different lysine PTMs in a 
single MS experiment 
Protein lysine modifications are prominent PTMs in eukaryotic cells responsible for the 
regulation of protein degradation, gene expression, signaling pathways and other cellular 
processes (Ciechanover et al. 1980; Hershko et al. 1980; Hebbes et al. 1988; Gu and Roeder 
1997; Strahl et al. 1999; Chen et al. 2001; Huang et al. 2006; Wang et al. 2008; Kaimori et al. 
2016; Elkouris et al. 2016; Fischer et al. 2017). Peptide centric bottom up mass spectrometry is 
a common tool used for identifying these PTMs. Prior to the MS analysis, lysine modification 
containing peptides are often enriched by immunoprecipitation using PTM-specific antibodies 
(Choudhary et al. 2009; Guo et al. 2014). Based on the specificity of the antibody, studies aiming 
at identifying the diversity of lysine modifications within the cells require the utilization of 
several of these immunoaffinity-based approaches thus making the investigations expensive 
and laborious. Additionally, the ability to investigate lysine modification containing peptides by 
this method depends on the quality and availability of a proper antibody which might hinder 
investigations of rare or novel lysine modifications. Another drawback of the antibody-based 
enrichment techniques is the requirement of a high amount of sample which might be a problem 
when dealing with limited amounts of starting material such as enriched organelles. 
The present studies aimed at developing a non-antibody-based technique for enhancing the 
identification of multiple different lysine PTM containing peptides from low abundant complex 
samples. As depicted in figure 5.16, two different methods were tested. Based on the procedure, 
the methods are called the serial digestion technique and the selective derivatization-based 
method. The common starting point of both techniques is the tryptic digestion of the protein 
mixture (Figure 5.16, step 1). Here, the protease trypsin cleaves proteolytically after lysine and 
arginine residues (Olsen et al. 2004). As trypsin is assumed to be sensitive towards lysine 
modifications such as acetylation, a missed cleavage site might be introduced next to these 
modified amino acid residues (Smith et al. 2003; Peters et al. 2003; Freitas et al. 2004; 
Burlingame et al. 2005).  
In case of the serial digestion technique, tryptic peptides are first biotinylated with NHS-biotin, 
a primary amine reactive reagent leading to biotinylation of peptide N-termini and the side chain 
of lysines (Figure 5.16, step 2.1). Lysines already modified by PTMs remain unbiotinylated. The 
next step within the workflow requires the ability of a protease to cleave adjacent to different 
endogenous PTM-containing lysine residues. LysN, a protease cleaving N-terminal to lysine 
residues, has already been described to cleave next to mono- and dimethylated lysines (Nonaka 
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et al. 1995; Taouatas et al. 2010). Similar properties have been published for the proteinase 
LysArginase which cleaves N-terminal to lysine and arginine residues (Tallant et al. 2006; Tallant 
et al. 2007; Huesgen et al. 2015). It is assumed that these enzymes might have an expanded 
cleavage capability which is why they are used for the digestion of PTM containing peptides 
within the serial digestion-based workflow (Figure 5.16, step 3.1). Here, the capability of the 
enzymes to cleave adjacent to PTM containing lysine residues would result in the removal of the 
biotinylated, N-terminal amino acid groups from the modified peptide. This cleavage is crucial 
as the last step of the serial digestion workflow comprises the incubation of the double digested 
samples with streptavidin (Figure 5.16, step 4.1). In this step, the strong affinity of biotin to 
streptavidin is used to remove any biotinylated peptide from the supernatant, thus leaving the 
PTM-containing peptides in the supernatant (Figure 5.16, step 4.1). Nevertheless, due to the 
specificity of trypsin, peptides with both, an internal PTM-containing as well as a C-terminal 
unmodified lysine residue might be generated during the first digestion of the protein sample 
(see figure 5.16, step 1, succinylated peptide). After incubation with NHS-biotin, this C-terminal 
lysine residue is biotinylated and needs to be separated from the PTM containing part of the 
peptide in order to prevent the loss of this PTM site during streptavidin incubation (see figure 
5.16, step 2.1, succinylated peptide). Therefore, a cleavage capability of LysN and LysArginase 
next to biotinylated lysine residues would further enhance the efficiency of this method, as 
biotin-containing lysine residues could be removed from the C-terminus of post translationally 
modified tryptic peptides (see figure 5.16, step 3.1, succinylated peptide).  
The second technique starts with the selective derivatization of the α-amino group present at 
the N-terminus of the tryptic peptides in order to block these groups from NHS-based 
modifications (Figure 5.16, step 2.2). Afterwards, NHS-biotin is used for biotinylation of 
unmodified lysine residues (Figure 5.16, step 3.2). Incubation with streptavidin leads to a 
depletion of biotinylated peptides, thus leaving only peptides comprising a C-terminal arginine 
in the supernatant (Figure 5.16, step 4.2). As non-lysine PTM containing peptides are depleted 
during this workflow, the reduced complexity could also be associated with an improved 
identification of arginine modifications. 
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Figure 5.16:  Schematic overview of the two different workflows tested for enhancing the identification of lysine 
PTM containing peptides.  
In both techniques, proteins are digested with trypsin. For the serial digestion workflow (branch 2.1), tryptic peptides 
are biotinylated and subsequently incubated with LysN or LysArginase. Biotinylated peptides are removed by 
incubating the mixture with streptavidin. In case of the derivatization-based method (branch 2.2), α-amino groups at 
the N-terminus of the tryptic peptides are modified (indicated by X). Afterwards, the derivatized peptides are 
biotinylated and incubated with streptavidin. Abbreviations: Sc = succinylation; di-Me = di-methylation; Cr = 
crotonylation  
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5.2.1. Serial digestion workflow  
 
5.2.1.1. Single peptide-based evaluation of LysN’s cleavage property next to biotinylated 
lysines 
The ability of LysN in cleaving adjacent to mono- and dimethylated lysine residues has already 
been described (Taouatas et al. 2010). As mentioned earlier, the efficiency of the serial 
digestion-based workflow would be enhanced if LysN is also able to cleave next to biotinylated 
lysine residues. In order to evaluate this capability, a synthetic peptide was biotinylated with 
sulfo-NHS-biotin, digested with LysN and subsequently analyzed by MALDI-TOF MS (Figure 
5.17A). In these MS-based approaches, biotinylation events via NHS-biotin can be identified by 
a mass shift of 226 m/z.  
The MALDI-TOF spectra acquired by the analysis of the reaction products are shown in figure 
5.17B. NHS-biotin incubation was associated with biotinylation of the synthetic precursor 
peptide (1531.7 m/z) at two to three positions (1983.9 m/z & 2210.0 m/z). The digestion of the 
non-biotinylated peptide with LysN yielded a peak at 1039.5 m/z, corresponding to the peptide 
C-terminus after N-terminal cleavage of the precursor at position K5. When incubating the 
biotinylated peptide with LysN, a peak at 1265.6 m/z was detected. This signal was not observed 
in any other sample. The 1265.6 m/z peak matches the expected mass of the biotinylated 
KHLEDLER peptide. However, in two similar experiments, the 1265.6 m/z peak was also observed 
in the biotinylated, non-digested sample (data not shown).  
The biotinylation of the precursor peptide at three positions indicates at least one unspecific 
biotinylation event. Reliable conclusions about the ability of LysN to cleave adjacent to 
biotinylated lysine residues is not possible, as the 1265.6 m/z peak was also observed in the 
NHS-biotin treated, non-digested sample in two similar, independent experiments. Assuming 
that the peak detected at 1265.6 m/z corresponds to the biotinylated KHLEDLER peptide, the 
weak intensity of this signal compared to its non-biotinylated counterpart (1039.5 m/z) could 
either be assigned to an impaired LysN digestion at the modified lysine residue or to changes in 
the ionization behavior during MALDI. However, the incompleteness of the LysN digestion as 
indicated by the prominent 1531.7 m/z peak of the non-biotinylated sample suggests the 
necessity of optimizing the digestion conditions irrespective of lysine’s biotinylation status.  
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Figure 5.17:  LysN digestion of a biotinylated, synthetic peptide.  
A synthetic peptide was biotinylated and subsequently incubated with LysN (A). Non-biotinylated and/or non-
digested peptides served as controls. Reaction products were analyzed by MALDI-TOF MS (B).  
 
5.2.1.2. Optimization of LysN digestion with a non-biotinylated synthetic peptide 
As the LysN digestion of the non-biotinylated sample was incomplete (see figure 5.17B), the 
conditions for the enzymatic reaction should be optimized. The improvement of the digestion 
conditions was assumed to also enhance the cleavage of the biotinylated peptides. The 
characteristics of LysN have been investigated by Nonaka et al. in 1995. Within that study, the 
authors highlighted the importance of divalent cations such as Mn2+, Zn2+ and Mg2+ for the 
enzyme activity (Nonaka et al. 1995). Thus, the synthetic peptide MHTGHANAKHIAGLSR was 
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incubated in the presence of different divalent cations. This peptide has been designed with the 
intention to yield a high LysN cleavage efficiency. The sequence was chosen based on the 
predicted influence of lysine-adjacent amino acids on the frequency of LysN cleavages published 
by Gershon (2014). In addition to testing the influence of cations, the effect of different 
peptide:LysN mass ratios on the cleavage efficiency was investigated. Analysis of the reaction 
products was performed by LC-MS2 measurements using a Dionex LC-system coupled to a LTQ 
Orbitrap Velos mass spectrometer. Database searches were performed by using the Mascot 
search engine implemented in the Proteome Discoverer software. The relative cleavage 
efficiency was calculated as the ratio of chromatographic peak areas of the cleaved and the non-
cleaved precursor peptide multiplied by a factor of 1000 to yield a reasonable number. 
Figure 5.18A shows the influence of different peptide:LysN ratios on the relative cleavage 
efficiency of the protease (without cations). The highest number of cleavage events was 
observed when using a peptide:LysN mass ratio of 25:1. Further reduction of the peptide:LysN 
ratio led to a tremendous reduction in the cleavage efficiency.  
Within the present study, two different concentrations of ZnCl2, MnCl2 and MgCl2 were tested 
(Figure 5.18B). Among those, the samples containing 0.1 mM MgCl2 and those without 
additional cations featured the highest LysN cleavage efficiency but also the biggest variance 
between the two technical replicates (tr). Compared to that, the addition of 0.1 mM ZnCl2 and 
0.1 mM MnCl2 seemed to reduce LysN activity. No cleavage was observed for the sample 
containing 1 mM ZnCl2 in the digestion buffer. The effects of the addition of 1 mM MgCl2 and 
1 mM MnCl2 to the reaction seemed to be comparable to those detected for the 0.1 mM MgCl2 
sample.  
LysN digestion can be optimized by adjusting the peptide:LysN ratio to 25:1. Compared to that, 
the effect of the different cations investigated within the study is inconclusive. Incubation of 
NHS-biotin treated peptides with LysN in presence of 0.1 mM MgCl2 (peptide:LysN ratio 25:1) 
was not associated with the detection of the biotinylated, C-terminal cleavage product in MALDI-
TOF MS (data not shown). Nevertheless, as the data presented here might suggest an increase 
in LysN’s cleavage efficiency of the non-biotinylated peptide in presence of 0.1 mM MgCl2, this 
condition was used together with a peptide:protease ratio of 25:1 in further LysN digestion 
experiments. 
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Figure 5.18:  Optimizing the LysN cleavage of non-biotinylated peptides.  
The relative protease cleavage efficiencies (in arbitrary units) were calculated as the ratio of the chromatographic 
peak area of the C-terminal product and the precursor peptide (x1000) (A+B). Different peptide:LysN mass ratios (A) 
as well as the influence of the addition of divalent cations to the digestion buffer (B) were tested regarding their effect 
on the cleavage efficiency.  
 
5.2.1.3. Protein-based evaluation of LysN’s and LysArginase’s cleavage property next to 
biotinylated lysines 
LysArginase, a protease cleaving N-terminal of lysine and arginine residues, might be useful as a 
substitute of LysN in the serial digestion workflow (Tallant et al. 2006; Tallant et al. 2007; 
Huesgen et al. 2015). Comparable to LysN, its cleavage ability adjacent to methylated lysines has 
already been described (Huesgen et al. 2015).  
Detailed investigations of LysN’s and LysArginase’s cleavage capability next to biotin-modified 
lysine residues was performed by using biotinylated BSA and cell lysate as substrates. Although 
the serial digestion workflow described in figure 5.16 comprises the LysN digestion of tryptic, 
biotin-containing peptides, utilization of denatured, biotinylated proteins was assumed in being 
sufficient for evaluating enzyme’s cleavage capability at biotin-modified lysine residues. This 
assumption was made in order to simplify data analysis. Successful LysN and LysArginase 
cleavage of a biotinylated, tryptic peptide would lead to a loss of the biotin-containing lysine 
and could therefore only be determined indirectly. Compared to that, enzymatic cleavage at a 
biotin containing lysine residue on protein level leads to the formation of peptides containing a 
biotinylation at the N-terminal side chain which can easily be assessed by LC-MS2.  
 
5.2.1.3.1. Proteolytic cleavage of biotinylated BSA by LysN and LysArginase  
BSA was biotinylated with NHS-biotin und subsequently digested by LysN or LysArginase (Figure 
5.19A). As depicted in the previous section, a protein:LysN ratio of 25:1 and a concentration of 
0.1 mM MgCl2 might lead to an increase of cleavage efficiency. Therefore, these conditions were 
used for the LysN digestion of the biotinylated BSA. LysArginase digestion was performed with 
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the same protein:protease ratio but with 10mM CaCl2 present in the digestion buffer. The 
experiment was performed in three technical replicates (tr1-tr3). Digestion products were 
investigated by LC-MS2 measurements (LTQ Orbitrap Velos mass spectrometer). Raw data 
analysis was performed by using the MaxQuant software. 
Figure 5.19B depicts the number of biotinylated and non-biotinylated peptides identified for 
both enzymes. Approx. 80 peptides were identified when digesting the non-biotinylated BSA 
with LysN or LysArginase. Roughly the same number of biotinylated peptides were detected 
when incubating the NHS-Biotin treated samples with LysN. Compared to that, digestion of the 
biotinylated BSA with LysArginase yielded approx. 20 biotin-containing peptides. 
The reproducibility of the enzymatic digestion of biotinylated BSA across the three replicates is 
shown in figure 5.19C. Out of the approx. 80 biotinylated peptides detected after LysN digestion 
of the NHS-biotin treated sample, 62 peptides were found in all three replicates. LysArginase 
digestion of the biotinylated BSA only yielded an overlap of 11 biotin-containing peptides across 
the replicates.  
The biotinylated peptides identified after LysN and LysArginase digestion were used for 
investigating the position of the biotin-containing lysine residue within the amino acid sequence. 
In this case, peptides containing the biotinylated lysine at the N-terminus indicate a successful 
enzymatic cleavage adjacent to the modified lysine residue. Figure 5.19D shows the proportion 
of the different modification sites among the biotinylated peptides. Almost 100 % of the 
peptides identified after LysArginase digestion of the NHS-Biotin treated BSA featured their 
biotinylation site at an internal lysine residue. In case of the LysN digestion, approx. 58 % of the 
biotin-containing peptides comprised its modification at the N-terminal lysine side chain. 
Besides that, 40 % of the peptides in this sample group featured the biotin modification at an 
internal lysine residue and in 2 % of the cases, the biotinylation site could not be clearly assigned.  
Figure 5.19E depicts the mean percentages of the numbers of missed cleavage sites (MCS) 
identified among the three technical replicates. Compared to the control (-NHS-Biotin), 
biotinylation of BSA was associated with an increased proportion of MCS after LysN digestion. 
In case of LysArginase, only a slight increase in the percentage of peptides featuring a missed 
cleavage site was observed when comparing the NHS-Biotin treated and non-biotinylated 
sample.  
Summarizing the results described in this section, LysN seems to be able to cleave adjacent to 
biotinylated lysine residues but its cleavage capability is impaired. This leads to an increased 
proportion of peptides with missed cleavages. Compared to that, biotinylation is only associated 
with a slight increase in the percentage of MCS in the LysArginase digested samples. This might 
be a combinatory effect of LysArginase’s ability to also cleave N-terminal of arginine residues 
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and the fact, that this enzyme already featured a higher proportion of MCS in the control sample. 
Additionally, cleavage of LysArginase next to biotinylated lysine residues might lead to peptides 
with a reduced charge state after electrospray ionization as these hydrolysis products would 
only feature one primary amine group at the N-terminus. Singly charged peptides were not 
fragmented with the MS settings used in this study which would explain the low number of 
identifications with an N-terminal biotinylated lysine residue in the LysArginase sample group. 
However, in order to further investigate the cleavage capability of these two enzymes, similar 
investigations were performed with a complex biotinylated protein mixture.  
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Figure 5.19:  Proteolytic cleavage of biotinylated BSA by LysN and LysArginase.  
BSA was biotinylated with NHS-biotin, digested with LysN or LysArginase and subsequently analyzed by LC-MS2 (A). 
Non-biotinylated samples served as controls. The experiment was performed in three technical replicates (tr1-tr3). 
The number of biotinylated and non-biotinylated peptides identified in the different sample groups and replicates are 
depicted as a bar graph (B). The Venn diagrams indicate the overlap of the biotinylated peptides detected across the 
single replicates (C). For both sample groups, the mean percentages (+/- standard deviation) of peptides either with 
an N-terminal, internal or ambiguous biotinylation sites are shown in D. The pie charts represent the mean proportion 
of the numbers of missed cleavage sites detected for the peptides of the different samples (standard deviation less 
than 4%) (E). 
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5.2.1.3.2. Proteolytic cleavage of biotinylated proteins from HEK lysates by LysN and 
LysArginase 
In order to investigate the cleavage capability of LysN and LysArginase adjacent to biotinylated 
lysines, isotopically labeled proteins from HEK cell lysate (light, medium and heavy labeled) were 
incubated with NHS-biotin and subsequently digested. The experiment was performed in 
biological triplicates. Prior to the LC-MS2 measurement (LTQ Orbitrap Velos mass 
spectrometer), isotopically labeled peptides of the three replicates belonging to one sample 
group were combined. Raw data were processed by using the MaxQuant software. Only 
peptides found in all three replicates and featuring a posterior error probability (PEP) smaller 
than 0.01 were used for data analysis.  
Figure 5.20A shows the number of biotinylated and non-biotinylated peptides identified within 
the different sample groups. Biotinylation of the protein mixtures prior to LysN and LysArginase 
digestion was associated with a reduced number of identified peptides in case of both enzymes. 
Unlike the observations made in the experiment using biotinylated BSA as a substrate (Figure 
5.19B), similar proportions of biotin-containing peptides were detected after digesting the NHS-
Biotin treated protein mixture with LysN or LysArginase, respectively (approx. 35-36 %).  
More than 80 % of the biotinylated peptides identified after LysN digestion featured their 
modification at an internal lysine (Figure 5.20B). In contrast to the LysN results obtained in the 
BSA experiments (Figure 5.19D), a biotin-containing N-terminal lysine residue was only detected 
for 7 % of the modified peptides. For this enzyme, roughly the same proportions of non-
assignable modification sites and biotinylated protein N-termini were observed. Compared to 
that, only 2 % of the LysArginase derived biotinylated peptides featured an N-terminal 
biotinylated lysine residue whereas the majority (90 %) comprised an internal modification site. 
The dependency between protein biotinylation and the proportion of the different number of 
MCS is depicted in figure 5.20C. In case of both enzymes, the proportion of missed cleavages 
was increased when proteins are biotinylated prior to the digestion. However, like the results 
obtained in the BSA experiment (Figure 5.19E), only a slight increase in the proportion of MCS 
was observed in the biotinylated and non-biotinylated LysArginase sample groups.  
The effect of the digestion of biotinylated samples on the protein sequence coverage was 
investigated. Figure 5.20D shows the boxplots of the sequence coverage (in percent) for the 
different sample groups. Protein biotinylation followed by digestion with LysN or LysArginase 
was associated with a lower median sequence coverage compared to the non-biotinylated 
samples.  
The results obtained in this section indicate an impaired ability of LysN to cleave adjacent to 
biotinylated lysine residues in the complex protein mixture. However, the observation made for 
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the LysArginase digested biotinylated HEK samples are comparable to those described in section 
5.2.1.3.1. Therefore, a reduced charge state of LysArginase-derived biotinylated peptides cannot 
be excluded as a reason for the low identification rate of peptides featuring a biotinylation at 
the N-terminal lysine residue in this sample group.  
 
 
Figure 5.20:  Proteolytic cleavage of biotinylated proteins from HEK 293 cell lysate with LysN and LysArginase.  
Isotopically labeled proteins were modified with NHS-biotin, digested with LysN or LysArginase and analyzed by LC-
MS2. Non-biotinylated protein samples served as controls. The experiment was performed in triplicates. Only 
peptides identified in all three replicates of one sample group and those featuring a PEP smaller than 0.01 were used 
for data analysis. The number of biotinylated and non-biotinylated peptides in the different sample groups are shown 
in a bar graph (A). For both sample groups, the percentages of peptides either with a protein N-terminal, peptide N-
terminal, internal or ambiguous biotinylation sites are depicted in B. The pie charts represent the proportion of the 
numbers of missed cleavage sites detected for the peptides of the different samples (C). The median sequence 
coverages for proteins are depicted as boxplots (blue line within the box: median; box: 25/75% quartile; end of black 
lines: min/max values) 
 
5.2.1.4. Investigating the capability of the serial digestion workflow for enhancing the 
identification of lysine modified peptides 
HEK protein lysate was used as a starting material for investigating the capability of the serial 
digestion workflow to enhance the identification of lysine modified peptides (see figure 5.16). 
Proteins were digested with trypsin before peptides were biotinylated with NHS-biotin. Non-
biotinylated samples served as controls. Remaining NHS-biotin was quenched and subsequently 
removed by an SCX chromatography-based peptide clean-up step. For the second digestion, 
biotinylated peptides were either incubated with LysN or LysArginase. Afterwards, biotinylated 
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amino acids and peptides were precipitated by incubating the mixtures with streptavidin beads, 
potentially leaving the lysine PTM containing peptides in the supernatant. The experiment was 
performed in three technical replicates. After each step of the workflow, a sample was taken as 
a control. Each sample was analyzed in a single LC-MS2 run using a Dionex LC-system coupled to 
an LTQ Orbitrap Velos mass spectrometer.  
In classical MS data analysis approaches, peptide modifications must be specified prior to the 
database search, thus hindering the identification of non-defined PTMs. However, several non-
restrictive search algorithms have been reported, allowing the detection of non-specified 
modifications. Within the present study, the PeaksPTM algorithm, implemented in the PEAKS 
software, was used in order to identify such unspecified modifications present in the 
supernatants of the different samples after streptavidin incubation (Han et al. 2011). The five 
most abundant peptide modifications (based on their proportions on total peptide 
identifications) reported by the PeakPTM software for the NHS-biotin treated samples are listed 
in table 5.10. Pyroglutamate formation from glutamine was found as a frequent modification in 
the biotinylated, LysN digested sample group (approx. 12 % of peptides). Compared to that, less 
pyroglutamate formation was detected in the NHS-biotin treated, LysArginase digested samples 
(approx. 6 %). Here, oxidation at methionine was identified as the most abundant modification 
(approx. 13-14 %). Besides that, methylmalonylation at serine, acetylation at the protein N-
terminus as well as deamination at asparagine and glutamine were reported in both sample 
groups after biotinylation. Methylation at lysine and arginine residues were annotated as one 
modification entry by the PeaksPTM algorithm. These PTMs were only detected in minor 
proportions in the samples incubated with streptavidin (0.3-0.5%). Here, all lysine methylation 
sites were found in the non-biotinylated samples. Nevertheless, no other lysine modification 
was found to be more abundant when considering all streptavidin incubated samples analyzed 
by PeaksPTM at once. Compared to the lysine methylated peptides, a similar number of 
methylarginine containing peptides was identified in these samples. Therefore, methylation at 
lysine and arginine were set as dynamic modifications in the Proteome Discoverer software 
when re-analyzing the samples with a classical database search. 
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Table 5.10:  PeaksPTM analysis of peptide samples after streptavidin incubation (serial digestion workflow).  
Percentage of different peptide modifications identified by analyzing the streptavidin incubated samples with the 
PeaksPTM algorithm implemented in the PEAKS X software (only NHS-biotin treated samples are shown). Besides the 
expected variable modifications, the PeaksPTM search also allows the identification of unspecified PTM present in 
the Unimod database and added manually prior to data processing.  
 +NHS-biotin  
+LysN digestion 
+NHS-biotin  
+LysArginase digestion 
 tr1 tr2 tr3 tr1 tr2 tr3 
Pyro-glu from Q 12.1 % 13.8 % 9.9 % 5.3 % 7.0 % 6.4 % 
Acetylation (Protein N-term) 15.3 % 10.4 % 7.2 % 5.0 % 6.6 %  6.4 % 
Methylmalonylation (S) 12.6 % 10.1 % 10.2 % 5.3 % 7.5 % 5.8 %  
Oxidation (M) 9.3 % 14.1 % 9.9 % 13.9 % 14.5 % 13.0 % 
Deamidation (NQ) 3.3 % 2.1 % 2.0 % 1.8 % 2.2 % 2.4 %  
 
PTM profiling by algorithms such as PeaksPTM might be prone to false discoveries as the 
increase in search space also increases the frequency of false data assignments. Therefore, the 
data of the streptavidin incubated samples were reprocessed in a classical database search using 
the Mascot algorithm accessed from the Proteome Discoverer software. Acetylation at protein 
N-termini, oxidation at methionine, biotinylation at peptide N-termini and lysine as well as 
methylation at lysine and arginine were set as dynamic modifications. The same settings were 
used for analyzing the samples taken after each step of the serial digestion workflow. For data 
processing, raw files belonging to the same step within the workflow (e.g. +NHS-biotin & -NHS-
biotin) were processed together. The false-discovery rate (FDR) was controlled with the help of 
the Percolator algorithm (Käll et al. 2007). In order to analyze the data on peptide level, 
information about methylation sites were fused to the amino acid sequence. Afterwards, 
redundant sequence entries were removed for each replicate and sample group.  
Table 5.11 comprises the average number (+/- standard deviation) of peptides and PSMs 
identified in the different sample groups. Additionally, the percentages of methylated peptides 
and PSMs are shown. On average, approx. 14,000 peptides and 21,000 PSMs were detected in 
the trypsin digested samples. Here, less than 0.1 % of the peptides were methylated. Compared 
to that, biotinylation of tryptic peptides followed by SCX chromatography peptide purification 
led to a strong decrease in peptide and PSM identifications. A similar tendency was observed for 
the non-biotinylated (-NHS-biotin control (ctrl.)), SCX chromatography purified peptides, 
although the decrease is lower compared to the NHS-biotin treated samples. However, in 
comparison to the tryptically digested samples without any further treatment, peptide 
biotinylation combined with SCX chromatography-based sample clean-up was associated with a 
strong increase in the detection of arginine methylated peptides (1.8 %) whereas only a slightly 
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higher proportion of lysine methylation was observed (0.14 %). The highest percentage of 
peptide lysine methylation was detected in the non-biotinylated, SCX chromatography purified 
sample group (3 %). Incubation of the biotinylated peptides with LysN was associated with a 
slight decrease in peptide and PSM identifications accompanied with a reduced detection of 
methylation sites (0.5 % methylated arginines). This effect was even higher for the non-
biotinylated, LysN digested samples. Here, the proportion of lysine methylated peptides 
amounted only to 0.2 %. Similar tendencies were observed when incubating the biotinylated 
and non-biotinylated peptides with LysArginase. In case of the NHS-biotin treated, LysArginase 
digested sample group, 0.42 % of the peptides featured a methylated arginine residue. 
Compared to that, the percentages of peptide arginine and lysine methylation amount to 0.48 % 
and 0.58 % respectively in the non-biotinylated, LysArginase digested samples. Incubation of the 
non-biotinylated, LysN/LysArginase digested samples with streptavidin was associated with a 
further reduction of the average number of peptides and PSMs identified during data analysis. 
The lowest peptide identification rate was observed for the NHS-biotin treated, 
LysN/LysArginase digested and streptavidin incubated samples. Here, the average number of 
PSMs was lower compared to the number of identified peptides. This indicates that the 
identification of several peptides in this sample group was based on MS1 feature mapping to 
PSMs found in other raw files processed together with the biotinylated, LysN/LysArginase 
digested and streptavidin incubated samples. However, by comparing the biotinylated and non-
biotinylated streptavidin incubated samples, almost no difference in the proportion of 
methylated peptides was detected. Therefore, complete sample processing by the serial 
digestion workflow was not associated with an increased identification of methylation sites.  
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Table 5.11:  Average number and standard deviation of peptides and PSMs found in the different sample groups of the serial digestion workflow (n=3) (first part of table).  
The percentage of methylated peptides/PSMs compared to the total number of peptides/PSMs is given in parenthesis. * biotinylated and non-biotinylated peptides before second digestion with 
the particular enzyme. Table continues on the next page. 
   # total pep. 
# meth. pep. 
[K] 
# meth. pep. 
[R] 
# meth. pep. 
[K+R] 
# total PSMs 
# meth. 
PSMs [K] 
# meth. 
PSMs [R] 
# meth. 
PSMs [K+R] 
Tryptic 
peptides 
  13935 ± 66 
7 ± 1 
(0.05 %) 
9 ± 1 
(0.07 %) 
2 ± 1 
(0.02 %) 
21046 ± 352 
26 ± 2 
(0.13 %) 
42 ± 1 
(0.20 %) 
6 ± 1 
(0.03 %) 
Biotinylated 
peptides 
before 
LysN* 
+NHS-Biotin 4223 ± 207 
6 ± 1 
(0.14 %) 
76 ± 9 
(1.80 %) 
1 ± 1 
(0.03 %) 
5397 ± 372 
2 ± 1  
(0.04 %) 
94 ± 15 
(1.73 %) 
1 ± 1 
(0.02 %) 
-NHS-Biotin ctrl 7127 ± 270 
212 ± 3 
(2.97 %) 
101 ± 4 
(1.42 %) 
2 ± 1 
(0.02 %) 
9946± 424 
375 ± 24 
(3.77 %) 
176 ± 4 
(1.77 %) 
2 ± 1 
(0.02 %) 
before 
LysArg* 
+NHS-Biotin 4181 ± 277 
6 ± 1 
(0.15 %) 
73 ± 12 
(1.74 %) 
2 ± 1 
(0.04 %) 
5442 ± 539 
2 ± 1 
(0.04 %) 
98 ± 30 
(1.77 %) 
1 ± 1 
(0.01 %) 
-NHS-Biotin ctrl 7005 ± 303 
206 ± 9 
(2.95 %) 
97 ± 10 
(1.38 %) 
1 ± 1 
(0.02 %) 
9731 ± 573 
341 ± 44 
(3.50 %) 
171 ± 34 
(1.75 %) 
2 ± 2 
(0.02 %) 
Double 
digested 
peptides 
LysN 
+NHS-Biotin 3191 ± 89 
4 ± 1 
(0.11 %) 
15 ± 2 
(0.47 %) 
1 ± 0 
(0.03 %) 
3271 ± 351 
1 ± 1 
(0.02 %) 
19 ± 2 
(0.59 %) 
1 ± 2 
(0.01 %) 
-NHS-Biotin ctrl 3782 ± 14 
8 ± 1 
(0.20 %) 
26 ± 3 
(0.68 %) 
1 ± 1 
(0.02 %) 
4798 ± 533 
15 ± 3 
(0.32 %) 
56 ± 7 
(1.18 %) 
0 
(0.00 %) 
LysArg 
+NHS-Biotin 2696 ± 233 
2 ± 1 
(0.06 %) 
11 ± 2 
(0.42 %) 
1 ± 0 
(0.04 %) 
2767 ± 337 
1 ± 1 
(0.05 %) 
16 ± 3 
(0.59 %) 
1 ± 0 
(0.04 %) 
-NHS-Biotin ctrl 3575 ± 209 
21 ± 1 
(0.58 %) 
17 ± 3 
(0.48 %) 
0 ± 0 
(0.00 %) 
4297 ± 468 
38 ± 5 
(0.89 %) 
26 ± 4 
(0.62 %) 
0 
(0.00 %) 
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Table 5.11 (second part):  Average number and standard deviation of peptides and PSMs found in the different sample groups of the serial digestion workflow (n=3).  
The percentage of methylated peptides/PSMs compared to the total number of peptides/PSMs is given in parenthesis. * biotinylated and non-biotinylated peptides before second digestion with 
the particular enzyme. 
   # total pep. 
# meth. pep. 
[K] 
# meth. pep. 
[R] 
# meth. pep. 
[K+R] 
# total PSMs 
# meth. 
PSMs [K] 
# meth. 
PSMs [R] 
# meth. 
PSMs [K+R] 
Streptavidin 
incubated 
peptides 
LysN 
+NHS-Biotin 623 ± 214 
2 ± 2 
(0.28 %) 
4 ± 1 
(0.60 %) 
0 ± 0 
(0.00 %) 
122 ± 28 
0 
(0.00 %) 
1 ± 2 
(0.95 %) 
0 
(0.00 %) 
-NHS-Biotin ctrl 2588 ± 855 
6 ± 1 
(0.23 %) 
12 ± 4 
(0.48 %) 
0 ± 0 
(0.00 %) 
3750 ± 503 
7 ± 3 
(0.18 %) 
40 ± 3 
(1.07 %) 
0 
(0.00 %) 
LysArg 
+NHS-Biotin 557 ± 103 
1 ± 0 
(0.18 %) 
3 ± 2 
(0.60 %) 
0 ± 0 
(0.00 %) 
230 ± 65 
0 
(0.00 %) 
3 ± 2 
(1.43 %) 
0 
(0.00 %) 
-NHS-Biotin ctrl 2819 ± 270 
11 ± 2 
(0.40 %) 
10 ± 1 
(0.35 %) 
0 ± 0 
(0.00 %) 
3419 ± 462 
21 ± 4 
(0.62 %) 
23 ± 1 
(0.69 %) 
0 
(0.00 %) 
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Insufficient peptide biotinylation could be a reason for the low amount of peptide methylation 
identified in the streptavidin incubated samples. Although the reduced number of peptides and 
PSMs detected in the NHS-biotin treated samples indicate a successful biotinylation, incomplete 
peptide modification after treatment with the NHS-ester could lower the effectiveness of the 
workflow. In order to evaluate the efficiency of peptide biotinylation prior to the second 
digestion, the percentage of biotinylated PSMs as well as of PSMs with unmodified primary 
amines was investigated (Figure 5.21). Approx. 95 % of the PSMs detected in the NHS-biotin 
treated samples were biotinylated whereas approx. 5 % featured at least one unmodified 
primary amine within their sequence. Compared to that, such unmodified primary amines were 
observed within 99 % of the PSMs identified in the non-biotinylated control. In this sample 
group, less than 1 % of the PSMs were biotinylated.  
The results indicate a nearly complete biotinylation of the primary amines present within the 
peptides after incubation with the NHS-biotin. 
 
 
Figure 5.21:  Investigation of the percentage of biotinylated PSMs in different sample groups of the serial digestion 
workflow. 
Percentage of biotinylated PSMs as well as of PSMs with unmodified primary amines after incubation of tryptic 
peptides with NHS-biotin. Non-biotinylated samples served as a control. The samples were taken prior to the second 
digestion with LysN or LysArginase, respectively.  
 
As the number of detected methylated peptides and PSMs decreased after the second digestion 
(Table 5.11), the methylation position within the sequence before incubation with LysN and 
LysArginase was investigated. The capability of both enzymes to cleave N-terminal of 
methylated lysine residues has already been described (Taouatas et al. 2010; Huesgen et al. 
2015). Additionally, LysArginases’ cleavage property adjacent to methylated arginines has been 
published (Huesgen et al. 2015). Therefore, if the methylation site is located at the C-terminus 
of the peptides after tryptic digestion, incubation with LysN or LysArginase might remove the 
methylated amino acid, thus lowering the number of detected methylated peptides. 
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Table 5.12 comprises the average numbers and percentages of peptides with C-terminal and 
non-C-terminal methylation sites. Prior to the LysN and LysArginase digestion, the total number 
of methylated peptides detected in the non-biotinylated control was more than four times 
higher compared to the NHS-biotin treated samples. 74-78 % of the methylated peptides 
identified in the +NHS-biotin sample group featured their methylation site at the C-terminal 
amino acid before incubation with the second proteolytic enzyme. This proportion was lower in 
the corresponding non-biotinylated controls (59-60 %).  
The high proportion of methylation at the C-terminal amino acid prior to the second digestion 
indicates that trypsin was able to cleave adjacent to methylated lysine and arginine residues. 
Therefore, the reduction of methylated peptides detected in the double digested samples might 
have been caused by the removal of the modified amino acid after incubation with LysN and 
LysArginase.  
 
Table 5.12:  Average numbers (+/- standard deviation) and percentages of peptides with a C-terminal and non-C-
terminal methylation site.  
   
# total meth. 
pep. 
# pep. meth.  
C-terminus 
# pep. meth. 
not C-terminus 
Biotinylated 
peptides 
before 
LysN 
+NHS-Biotin 85 ± 9 
63 ± 5 
(74 %) 
22 ± 4 
(26 %) 
-NHS-Biotin ctrl 354 ± 10 
214 ± 9 
(60 %) 
141 ± 16 
(40 %) 
before 
LysArg 
+NHS-Biotin 82 ± 12 
64 ± 10 
(78 %) 
18 ± 4 
(22 %) 
-NHS-Biotin ctrl 343 ± 25 
203 ± 6 
(59 %) 
140 ± 19 
(41 %) 
 
 
 
 
 
 
 
 
5 Results 
122 
 
5.2.2. Derivatization-based method – Investigations of Nα-selective peptide 
derivatization 
The second workflow tested for enhancing the identification of lysine PTM containing peptides, 
is based on the selective derivatization of the alpha amino group present at peptides’ N-termini 
after tryptic digestion. Figure 5.22 shows an overview of the four different derivatization 
techniques used in the initial experiment within the present study. N-terminal selective 
transamination was performed according to the procedure published by Sonomura et al. (2011). 
Here, the N-terminal amino group of the peptide was substituted by a carbonyl group derived 
from glyoxylic acid. For Nα-selective acetylation, peptides were incubated with acetic acid 
anhydride like described by Mikami et al. (2012). N-terminal propionylation was performed 
similarly. According to the method published by Chen et al. (2017), selective reductive alkylation 
of the N-terminal amino group was performed by incubating the peptides with benzaldehyde at 
pH 6.1 in the presence of cyanoborohydride as a reducing agent.  
 
 
Figure 5.22:  Overview of the chemical reactions used for Nα-selective derivatization of peptide N-termini.  
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5.2.2.1. Single peptide-based evaluation of different Nα-selective derivatization techniques 
In order to evaluate the mass shifts obtained by the Nα-selective derivatization methods, a 
synthetic peptide containing an internal lysine residue was modified by the different techniques. 
After its modification, the peptide was incubated with NHS-LC-biotin or NHS-biotin in order to 
detect remaining free primary amine groups within the sequence (Figure 5.23A). Here, 
biotinylation with NHS-LC-biotin led to a mass shift of 339 m/z whereas utilization of NHS-biotin 
was associated with a mass shift of 226 m/z. Peptide analysis on MS1 level was performed by 
MALDI-TOF MS.  
Figure 5.23B shows the peaks detected for the transaminated sample group. Single (1870.9 m/z) 
and double biotinylation (2209.9 m/z) was observed when incubating the precursor peptide 
(1531.7 m/z) with NHS-LC-Biotin. Transamination of the non-biotinylated peptide was 
associated with the expected mass shift of -1 m/z (1530.7 m/z). However, a second, unexpected 
peak at 1604 m/z was detected within this sample, thus indicating the occurrence of a side 
reaction. Like the transaminated peptide, this side product was singly biotinylated after 
incubation with NHS-LC-Biotin (1869.6 m/z and 1943.8 m/z). 
In case of the acetic acid anhydride treated sample, mass shifts of 42 m/z and 84 m/z, 
corresponding to the singly (1573.7 m/z) and doubly acetylated (1615.7 m/z) precursor peptide, 
were detected (Figure 5.23C). Biotinylation of this sample was associated with the detection of 
a singly acetylated, biotin-containing peptide at 1912.8 m/z. 
Comparable to the acetic acid anhydride treated sample, single (1587.7 m/z) and double 
propionylation (1643.7 m/z) was observed when incubating the precursor peptide with 
propionic acid anhydride (mass shifts of 56 m/z and 112 m/z) (Figure 5.23D). After NHS-LC-Biotin 
based biotinylation of the anhydride treated sample, a peptide, featuring a single propionylation 
and biotinylation site was detected (1926.9 m/z).  
Single (1757.8 m/z) and double biotinylation (1983.9 m/z) was observed when incubating the 
precursor peptide with NHS-Biotin (Figure 5.23E). Reductive alkylation of the precursor peptide 
was associated with the expected mass shift of 90 m/z (1621.6 m/z). However, a second peak 
detected at 1711.8 m/z within this sample indicates a double alkylation of the precursor peptide. 
Incubation of the alkylation-modified sample with NHS-biotin was associated with the detection 
of a singly alkylated, biotin-containing peptide at 1847.8 m/z.  
The detection of doubly acetylated, propionylated and alkylated peptides indicates a non-
selective modification of the peptide N-terminus and the lysine side chain by the different 
derivatization techniques. Although the possibility of a double alkylation at the peptide N-
terminus has been described by Chen et al. (2017), such a peptide would be biotinylatable by 
NHS-biotin at the internal lysine residue. A peak corresponding to a double alkylated and 
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biotinylated peptide was not observed thus further highlighting peptide alkylation at the N-
terminus and the lysine side chain.  
Even though the derivatization techniques might not be 100 % selective, reliable conclusion 
about the reaction stoichiometry cannot be drawn based on the mass spectrometry data as 
differences in the ionization behavior between the peptide species influence the signal intensity. 
Additionally, the findings described here for the synthetic model peptide might not be easily 
transferrable to other peptides. Therefore, the acetylation-, propionylation- and alkylation-
based Nα-selective derivatization techniques were also tested on complex peptide mixtures. 
Combined with LC-MS2 measurements, these investigations were assumed to yield a more 
detailed perspective regarding the reaction selectivity and in allowing a more representative 
evaluation of the different methods. The transamination technique was not further investigated 
as formation of unknown reaction side products would interfere with proper peptide 
identification during analysis of the MS data.  
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Figure 5.23:  Investigation of different Nα-selective derivatization techniques at single peptide level.  
The synthetic peptide was derivatized and subsequently biotinylated by NHS-LC-biotin or NHS-Biotin in order to identify remaining primary amine groups present within the sequence (A). The X 
indicates the derivatized amino group. The transamination- (B), acetylation- (C), propionylation- (D) and reductive alkylation derivatization method (E) were tested regarding their selectivity towards 
peptides’ alpha amino group. MS1 data acquisition was performed by MALDI-TOF MS. 
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5.2.2.2. Nα-selective derivatization of a complex protein mixture 
For investigating the different derivatization techniques regarding their selectivity towards the 
peptide N-terminus in a complex sample, HEK proteins were digested with trypsin. Afterwards, 
the tryptic peptides were derivatized by Nα-selective acetylation, propionylation and reductive 
alkylation (Figure 5.24A). The experiment was performed in technical triplicates (tr1-3). Peptide 
analysis was performed by LC-MS2 using a Dionex LC-system coupled to an LTQ Orbitrap Velos 
mass spectrometer. The Mascot search engine implemented in the Proteome Discoverer 
software was used to search raw data against a human reference database with the single 
derivatizations set as variable modifications according to the sample.  
In LC-MS2 data analysis, only mass shifts defined as variable modifications will appear in the final 
output of the processing results. This hinders the identification of side products occurring during 
the chemical derivatization processes of peptides, as any undefined mass shift will not be 
identified as a PSM by the search algorithm. Nevertheless, the occurrence of such side products 
with a high frequency/abundance increases the probability that these peptides will be 
fragmented in the data-dependent MS data acquisition mode. Therefore, the number of MS2 
spectra increases but as these fragment ions do not match to any expected peptide feature, the 
number of PSMs will not rise. As a result of that, the percentage of matched MS2 spectra can be 
used as indication for the occurrence of highly abundant side products during the derivatization 
process. Table 5.13 shows the number of MS2 spectra and PSMs identified by a combined 
analysis of the three replicates for each sample group. For all derivatization techniques, 59 to 
60 % of the MS2 spectra were assigned to a certain peptide feature. This indicates that 
unexpected side reactions were not highly abundant, as the same percentage of identifications 
was observed for the non-derivatized sample (input).  
 
Table 5.13:  Number of MS2 spectra and PSMs identified for the different derivatization techniques as well as for 
the input.  
HEK 293 proteins were digested and subsequently derivatized by acetylation, propionylation or reductive alkylation. 
A non-derivatized samples served as a control (input). The experiment was performed in three technical replicates. 
The peptide mixtures were analyzed by LC-MS2. Raw data were searched against a human reference database with 
the different derivatizations set as variable modifications  
 # MS2 spectra # PSMs % matched spectra 
input (w/o derivatization) 122,645 72,702 59 
acetylation 121,951 73,546 60 
propionylation 121,566 73,057 60 
red. alkylation 125,268 73,881 59 
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For data analysis on peptide group level, information about the derivatization sites were fused 
to the amino acid sequence. Afterwards, redundant sequence entries were removed in the 
single replicates.  
Figure 5.24B shows the number of derivatized and underivatized peptides identified in each 
replicate of the different sample groups. No distinction was made between modifications 
occurring at the N-terminus or the lysine residue. Approx. 16,000 peptides were detected in the 
different replicates of the non-derivatized peptide sample (input). Compared to that, roughly 
18,000 peptides were obtained in the acetylated sample group. Among those, 44 % (approx. 
8,000 peptides) were identified as being acetylated. These 44 % also comprise endogenous 
protein N-terminal acetylation sites as this modification cannot be distinguished from peptide 
derivatization caused by the incubation with the acetic anhydride. Nevertheless, as only 76-80 
acetylated peptides derived from protein N-termini were identified in the acetic anhydride 
treated samples, their contribution to the total number of acetylation sites is rather low. In the 
propionylated sample group, a total number of approx. 18,000 peptides were detected in the 
single replicates. Here, approx. 33 % of the peptides were propionylated. A slightly lower 
number of total peptides were identified in the reductive alkylation sample group (approx. 
17,400 peptides). However, this sample group contained the highest proportion of derivatized 
peptides (88 %).  
 
 
Figure 5.24:  Number of derivatized and underivatized peptides in the different sample groups. 
Proteins were digested and subsequently derivatized (A). The X indicates the derivatized amino group. The different 
numbers of derivatized and underivatized peptides identified in the replicates of the different sample groups are 
shown in B.  
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In order to investigate the reproducibility of the derivatization techniques, the overlap of 
derivatized peptides identified in the single replicates of the different sample groups are shown 
in a Venn diagram (Figure 5.25). The size of the Venn diagrams reflects the total number of 
derivatized peptides detected for the different sample groups. In case of peptide acetylation by 
acetic anhydride, 71 % of the acetylated peptides were found in all three replicates 
(6,676 peptides). Compared to that, 4,688 derivatized peptides were identified in all replicates 
of the propionylated sample group (67 %). The highest number of derivatized peptides were 
detected after reductive alkylation. Here, 68 % of the alkylated peptides were found in all 
replicates (12,199).  
 
 
Figure 5.25:  Overlap of the derivatized peptides identified in the single replicates of the different sample groups.  
The size of the Venn diagram reflects the total number of derivatized peptides found for the different derivatization 
techniques.  
 
Nα-selectivity of the different techniques was investigated by analyzing the derivatization site of 
peptides identified in all three replicates (Figure 5.26). The highest proportion of N-terminal 
peptide derivatization was detected for the reductive alkylation sample group (92 %). However, 
comparable Nα-selectivity was observed for the acetylation- and propionylation-based 
techniques (88 % and 85 %). In case of these two derivatization methods, approx. 10 % of the 
peptides featured their modification in the side chain of lysine. Compared to that, a 
derivatization of the lysine residue was only detected for 3 % of the alkylated peptides. A 
modification of both, the peptide N-terminus and the lysine side chain, was identified for 5 % of 
the derivatized peptides of the reductive alkylation and propionylation sample group. Among 
the acetylated peptides, such a double modification was only detected for 2 % of the peptides.  
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Figure 5.26:  Proportion of derivatization sites detected for peptides found in all three replicates of the different 
sample groups.  
The X indicates the position of the derivatized amino group. 
 
A high Nα-selectivity was observed for all derivatization techniques tested within this study. 
Nevertheless, the results indicate that utilization of the reductive alkylation-based technique in 
the Nα-selective derivatization workflow might be advantageous as this method yields the 
highest number of derivatized peptides combined with a good derivatization reproducibility. 
Therefore, this technique was used for investigating the capability of the derivatization-based 
workflow to enhance the identification of lysine PTM-containing peptides.  
5.2.2.3. Validating the Nα-selective derivatization workflow for enhancing the identification 
of lysine modified peptides  
The usability of the Nα-selective derivatization workflow for increasing the identification of lysine 
modified peptides was investigated by using HEK protein lysate as a starting material. After 
tryptic digestion, peptide’s N-termini were selectively derivatized by reductive alkylation. 
Subsequently, remaining primary amines were biotinylated with NHS-biotin. The last step of the 
workflow comprised the streptavidin-based depletion of biotinylated peptides. After each step 
of the workflow, a sample was taken as a control. The experiment was performed in three 
technical replicates. Samples were analyzed by LC-MS2 using a Dionex-LC system coupled to an 
LTQ Orbitrap Velos mass spectrometer. Note that the reductive alkylated samples investigated 
in section 5.2.2.2 were used as a starting material in this experiment.  
The MS data of the derivatized peptide samples incubated with streptavidin were processed 
with the PeaksPTM algorithm implemented in the PEAKS X software. As mentioned in the 
section 5.2.1.4, this algorithm enables the identification of unspecified modifications. Table 5.14 
5 Results 
130 
 
comprises modifications in NHS-biotin treated samples identified for more than 1 % of the 
peptides. More than 80 % of the peptides identified in the biotinylated samples featured an 
alkylation at the peptide N-terminus or the side chain of lysine. Double alkylation either at the 
lysine residue or the peptide N-terminus was observed for approx. 12 % of the peptides detected 
in the biotinylated samples. Additionally, more than 9 % of the peptides were modified by 
oxidation at methionine or propionamide at cysteine due to alkylation of thiol groups with 
acrylamide in these sample groups. Methylation at lysine and arginine was annotated as one 
modification entry by the PeaksPTM algorithm. In the NHS-biotin treated samples, 1.3-1.5 % of 
the peptides were reported as being methylated at lysine or arginine residues. The vast majority 
of these methylation sites were found at arginine side chains. Compared to that, lysine 
methylations were almost exclusively identified in the non-biotinylated samples. 
 
Table 5.14:  PeaksPTM analysis of peptide samples after streptavidin incubation (Nα-selective derivatization 
workflow). 
Percentage of different peptide modifications identified by analyzing the derivatized and streptavidin incubated 
samples with the PeaksPTM search implemented in the PEAKS software (only NHS-biotin treated samples are shown). 
Besides the expected variable modifications, the PeaksPTM search also allows the identification of unspecified PTM 
present in the Unimod database and added manually prior to the data processing.  
 Technical replicate 1 Technical replicate 2 Technical replicate 3 
Alkylation (K/N-term)) 83.2 % 81.3 % 80.8 % 
Oxidation (M) 19.4 % 20.2 % 19.2 % 
2x Alkylation (K/N-term) 12.0 % 13.4 % 14.0 % 
Propionamide (C) 10.6 % 9.7 % 11.0 % 
Deamidation (NQ) 1.5 % 1.4 % 1.5 % 
Methylation (KR) 1.3 % 1.5 % 1.5 % 
 
Non-restrictive search algorithms such as PeaksPTM might be prone to false discoveries due to 
the increased search space. Therefore, based on the modifications identified by the PeaksPTM 
software, the raw data of the streptavidin incubated samples were reprocessed using the 
Mascot search engine. Here, alkylation (at K/N-term), double alkylation (at K/N-term), 
acetylation (at protein N-term), oxidation (at methionine), biotinylation (at K/N-term) as well as 
methylation (at R/K) were set as variable modifications. Samples taken during the different steps 
of the workflow were analyzed accordingly. For data processing, raw files belonging to the same 
step within the workflow (e.g. +NHS-biotin & -NHS-biotin) were processed together. The 
Percolator algorithm was used in order to control the FDR (<0.01) (Käll et al. 2007). 
Figure 5.27 depicts the percentage of reductive alkylated and biotinylated PSMs as well as of 
PSMs with unmodified primary amines detected in the biotinylated and non-biotinylated 
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samples prior to streptavidin incubation. More than 90 % of the PSMs identified in the NHS-
biotin treated sample and the non-biotinylated control featured a reductive alkylation site. 
Nevertheless, approx. 65 % of the PSMs in the non-biotinylated control featured at least one 
unmodified primary amine within their sequence. Compared to that, the proportion of 
unmodified primary amines detected in the NHS-biotin treated samples was strongly reduced 
(less than 3 %). In contrast, approx. 40 % of the PSMs identified in this sample group comprised 
at least one biotinylated amino acid thus suggesting a successful peptide biotinylation after NHS-
biotin treatment.  
 
 
Figure 5.27:  Investigation of the percentage of biotinylated and reductive alkylated PSMs in different sample 
groups of the Nα-selective derivatization workflow. 
Percentages of biotinylated and reductive alkylated PSMs as well as of PSMs with unmodified primary amine detected 
in NHS-biotin treated sample and the non-biotinylated control prior to streptavidin incubation are depicted.  
 
Data analysis on peptide group level was performed by fusing information about methylation 
sites to the amino acid sequence. Afterwards, redundant sequence entries were removed for 
each replicate and sample group.  
Figure 5.28 shows the average number (+/- standard deviation) of arginine and lysine containing 
peptides detected in the single steps of the Nα-selective derivatization workflow. The highest 
number of peptide identifications was detected after tryptic digestion of the HEK protein lysate. 
Compared to that, less peptides were found in the samples derivatized by reductive alkylation 
(second bar, without SCX chromatography-based sample clean-up). Each additional step of the 
workflow was associated with a further loss of identifications. Interestingly, the identification 
loss is not uniform throughout the different peptide species. Whereas the number of arginine 
containing peptides stayed nearly constant among the first three steps of the workflow, the 
percentage of lysine containing peptides decreased in the NHS-biotin treated samples compared 
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to the peptide population detected after reductive alkylation. After streptavidin incubation of 
the biotinylated samples, an increase in the proportion of arginine containing peptides was 
observed. In this sample group, only 10 % lysine containing peptides were detected. Therefore, 
the results indicate a shift in the peptide population towards arginine containing features after 
NHS-biotin treatment.  
 
 
Figure 5.28:  Number of lysine and arginine containing peptides in the different sample groups of the Nα-selective 
derivatization workflow.  
Average number of lysine and arginine containing peptides (+/- standard deviation) detected in the single steps of Nα-
selective derivatization workflow. Note that the reductive alkylated, non-biotinylated samples (second bar) were not 
purified by SCX chromatography. 
 
The average number of methylated peptides and PSMs (+/- standard deviation) detected in the 
different sample groups of the Nα-selective derivatization workflow are listed in table 5.15. Here, 
the tryptic digested sample group is the same as the one analyzed in the serial digestion 
workflow (see section 5.2.1.4). Less than 0.1 % of the peptides detected after tryptic digestion 
were methylated. Similar proportions were observed after reductive alkylation, although the 
total number of peptides identified in this group was reduced compared to the tryptic digested 
samples. SCX chromatography-based sample clean-up of the biotinylated and non-biotinylated 
peptides was associated with a further reduction in the number of peptide identifications. Here, 
the peptide loss was higher in the NHS-biotin treated samples compared to the non-biotinylated 
controls. In contrast to the tryptic digested and alkylated sample groups, NHS-biotin treatment 
followed by SCX chromatography-based sample clean-up was associated with an increased 
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identification of PSMs featuring a methylated arginine residue (191 ± 10). Here, also higher 
numbers of arginine methylated peptides (118 ± 5) were detected. In comparison, a slightly 
lower amount of methylarginine containing peptides was observed in case of the non-
biotinylated, SCX chromatography purified samples. However, this group featured the highest 
number of lysine methylated peptides (155) and PSMs (299) among all samples taken during the 
derivatization workflow. Compared to the corresponding non-depleted sample group, 
incubation of the biotinylated peptides with streptavidin was associated with a slight reduction 
in the total amount of PSMs and peptides detected during LC-MS2 analysis. Whereas the 
number of identified methylated peptides remained nearly unaltered in the biotinylated and 
streptavidin incubated samples, an increase in the proportion of peptides featuring an arginine 
methylation was observed. A slight decrease in the total number of peptides and PSMs was 
detected when incubating the non-biotinylated samples with streptavidin. Here, streptavidin 
incubation was also associated with a loss of lysine methylated peptides (109).  
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Table 5.15:  Average number and standard deviation of peptides and PSMs found in the different sample groups of the Nα-selective derivatization workflow (n=3).  
The percentage of methylated peptides/PSMs compared to the total number of peptides/PSMs is given in parenthesis. * indicates mean values of samples groups comprising only two technical 
replicates. For these sample groups, the standard deviation was not calculated.  
  # total pep. 
# meth. pep. 
[K] 
# meth. pep. 
[R] 
# meth. pep. 
[K+R] 
# total PSMs 
# meth. 
PSMs [K] 
# meth. 
PSMs [R] 
# meth. 
PSMs [K+R] 
Tryptic peptides  13935 ± 66 
7 ± 1  
(0.05 %) 
9 ± 1  
(0.07 %) 
2 ± 1 
(0.02 %) 
21046 ± 352 
26 ± 2 
(0.13 %) 
42 ± 1 
(0.20 %) 
6 ± 1 
(0.03 %) 
Red. alk. Peptides  11381 ± 112 
11 ± 1 
(0.09 %) 
11 ± 1 
(0.10 %) 
3 ± 0 
(0.03 %) 
21729 ± 328 
29 ± 6 
(0.13 %) 
38 ± 4 
(0.17 %) 
8 ± 1 
(0.04 %) 
Biotinylated 
peptides 
+NHS-Biotin 7348 ± 220 
15 ± 2 
(0.20 %) 
118 ± 5 
(1.60 %) 
1 ± 0 
(0.01 %) 
11113 ± 623 
4 ± 1 
(0.04 %) 
191 ± 10 
(1.72 %) 
2 ± 1 
(0.02 %) 
-NHS-Biotin ctrl 8666* 
155* 
(1.78 %) 
99* 
(1.14 %) 
1* 
(0.01 %) 
14017* 
299* 
(2.13 %) 
184* 
(1.31 %) 
1* 
(0.01 %) 
Streptavidin 
incubated peptides  
+NHS-Biotin 6475 ± 66 
11 ± 4 
(0.17 %) 
117 ± 7 
(1.80 %) 
1 ± 0 
(0.02 %) 
8883 ± 174 
3 ± 1 
(0.03 %) 
201 ± 22 
(2.26 %) 
4 ± 0 
(0.05 %) 
-NHS-Biotin ctrl 8469* 
109* 
(1.28 %) 
111* 
(1.31 %) 
3* 
(0.04 %) 
12704* 
196* 
(1.55 %) 
135* 
(1.06 %) 
3* 
(0.02 %) 
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Data analysis of the Nα-selective derivatized, biotinylated samples indicate an increased 
identification of arginine methylated peptides independent of streptavidin incubation. Similar 
observations were made for methylation at lysine residues in the SCX chromatography purified, 
non-biotinylated sample groups. The population of lysine and arginine methylated peptides 
identified in the single groups were compared in two Venn diagrams (Figure 5.29). Here, amino 
acid specific methylations found in two out of two replicates (-NHS-Biotin ctrl) or in at least two 
out of three replicates (+NHS-Biotin) were used for the comparison.  
The highest number of unique lysine methylations was observed in the non-biotinylated and 
non-streptavidin incubated sample group. Compared to that, 43 methylated lysine residues 
were detected after incubating the non-biotinylated peptides with streptavidin. Additionally, an 
overlap of 39 lysine methylated peptides was identified between these two sample groups. In 
contrast, no unique lysine methylation was observed for the NHS-biotin treated samples. 
However, peptide biotinylation was associated with an increased identification of arginine 
methylations. Here, incubation of the NHS-biotin treated sample with streptavidin was linked to 
an unique identification of 34 methylations at arginine residues. In comparison, 43 unique 
arginine methylated peptides were detected in the non-streptavidin incubated samples. 11 and 
13 unique arginine methylated peptides were observed in the two non-biotinylated sample 
groups, respectively. In total, 32 arginine methylation sites were shared between all samples.  
 
 
Figure 5.29: Comparison of methylated peptides detected in different samples groups of the Nα-selective 
derivatization workflow.  
Methylated peptides found in two out of two replicates (-NHS-biotin ctrl) or in at least two out of three replicates 
(+NHS-biotin) were used for generating the Venn diagrams.  
5 Results 
136 
 
In order to evaluate the reproducibility of PTM-identifications with the Nα-selective 
derivatization workflow, the methylated peptide populations detected in the three biotinylated 
and streptavidin incubated replicates were compared (Figure 5.30). Here, 65 % (105 peptides) 
of the methylated peptides were found in all replicates thus indicating the reproducibility of the 
identification of peptide methylations by this workflow.  
 
 
Figure 5.30:  Comparison of the methylated peptides identified in the three replicates after biotinylation and 
streptavidin-based depletion.  
 
5.2.3. Comparison of methylated peptides identified after SCX chromatography-
based sample clean-up in both workflows 
The data obtained during the investigations of the two workflows suggest an SCX 
chromatography-based increase of methylated peptides. However, as the N-termini of the 
peptides are alkylated prior to biotinylation and SCX chromatography-based sample clean-up 
within the Nα-selective derivatization workflow, the populations of methylated peptides might 
differ compared to those detected after SCX chromatography-based peptide purification during 
the serial digestion workflow. The overlaps within the populations of methylated peptides 
identified in the different samples are depicted by two Venn diagrams (Figure 5.31). For both, 
the LysN- and the LysArginase-based serial digestion workflow, three NHS-biotin treated and 
three non-biotinylated samples were prepared. The data of these six samples were combined 
prior to the comparison. Here, methylated peptides detected in at least four out of six replicates 
were used. In case of the SCX chromatography purified samples obtained during the Nα-selective 
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derivatization workflow, the comparison was based on methylated peptides found in two out of 
two (-NHS-Biotin ctrl) or in at least two out of three replicates (+NHS-Biotin).  
The highest number of unique lysine methylation was detected for the non-derivatized and non-
biotinylated samples (157 peptides). Within the derivatized, non-biotinylated sample group, 88 
unique methyllysines were identified. Compared to that, unique lysine methylated peptides 
were not detected in the two NHS-biotin treated sample groups. In contrast, peptide 
biotinylation was associated with an increased number of uniquely identified methylated 
arginine residues compared to the non-biotinylated samples. Therefore, the results indicate a 
complimentary identification of methylated peptides among the different sample groups.  
 
 
Figure 5.31:  Comparison of methylated peptides detected after SCX chromatography-based sample clean-up in 
the serial digestion and the Nα-selective derivatization workflow.  
In case of sample groups derived from the serial digestion workflow, methylated peptides found in at least four out 
of six replicates were used for the comparison. For the Nα-selective derivatized sample groups, methylated peptides 
found in two out of two (-NHS-biotin ctrl) or in at least two out of three replicates (+NHS-biotin) were used for 
generating the Venn diagrams.  
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6. Discussion 
 
6.1. SNAPIN, a multifunctional protein with altered phosphorylation 
pattern upon elevation of cAMP levels 
 
Inside the cell, cAMP is generated by Acs in response to the activation of stimulatory GPCR. 
Glucagon, a peptide hormone secreted by pancreatic cells at low plasma glucose levels, is a 
known ligand mediating the activation of this pathway (Jelinek et al. 1993; reviewed by 
Habegger et al. 2010). The elevation of intracellular cAMP levels leads to an activation of protein 
kinase A (Walsh et al. 1968; Tao et al. 1970). In turn, PKA triggers the production of free glucose 
inside the cells by stimulating processes such as glycogenolysis, thus playing a key role in the 
cellular response machinery after sensing deprivation of this monosaccharide (reviewed by 
Unger 1985).  
The expression of genes encoding for lysosomal proteins is another process triggered under 
nutrient deprivation which correlates with an increase in macromolecule degradation (Sardiello 
et al. 2009; Settembre et al. 2011). Based on their contribution in starvation-induced catabolic 
processes, one could hypothesize a functional relationship between PKA and lysosomes. So far, 
Mucolipin 1 is the only known lysosomal membrane protein getting phosphorylated upon PKA 
activation (Vergarajauregui et al. 2008). In order to further investigate the influence of elevated 
intracellular cAMP levels on lysosomal processes, the initial part of the present study aimed at 
identifying cAMP-mediated changes in the phosphorylation status of lysosomal membrane and 
lysosome associated proteins.  
 
6.1.1. FSK/db-cAMP treatment triggers PKA activation 
FSK/db-cAMP mediated PKA activation was monitored by detecting the phosphorylation status 
at S133 of CREB. This amino acid residue of CREB has been shown to be a direct target of PKA 
(Montminy and Bilezikjian 1987; Gonzalez and Montminy 1989). Its phosphorylation is 
associated with the activation of this transcription factor thus mediating transcription of cAMP 
responsive genes (Montminy and Bilezikjian 1987; Gonzalez and Montminy 1989).  
Within the present study, FSK/db-cAMP stimulation was associated with a strong increase in the 
p-CREB (S133) signal intensity compared to the non-treated control (Figure 5.1). As the CREB 
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protein level was not significantly affected by the treatment, the p-CREB signal observed after 
cell stimulation with FSK/db-cAMP was caused by phosphorylation of CREB at S133.  
Besides PKA, several kinases such as PKB and the calcium/calmodulin-dependent protein kinase 
(CaMK) I & II have been demonstrated to mediate CREB phosphorylation at S133 (Sheng et al. 
1991; Du and Montminy 1998). However, in order to mediate CREB phosphorylation upon 
FSK/db-cAMP treatment, kinase activity must be regulated by cAMP. In 2005, Delghandi et al. 
investigated the ability of several kinases directly or indirectly regulated by cAMP and Ca2+ (PKA, 
PKB, mitogen-activated protein kinase p38 (MAPK p38), CaMKII) to phosphorylate CREB at S133 
upon FSK treatment in NIH 3T3 cells. Among those, PKA was the only kinase directly catalyzing 
CREB phosphorylation whereas p38 triggered CREB-induced transcription in a PKA-dependent 
manner (Delghandi et al. 2005). Although these results suggest a rather specific activation of 
PKA upon increased intracellular cAMP levels, one has to keep in mind that kinase signaling 
networks are highly interlaced, thus potentially hampering the assignment of a modification site 
to a specific pathway. In addition to the crosstalk of different kinase signaling pathways, the 
discovery of EPACs as intracellular cAMP sensors further demonstrates the complexity of the 
networks affected by this second messenger (Kawasaki et al. 1998; Rooij et al. 1998). Although 
Delghandi et al. (2005) demonstrated that CREB phosphorylation is not affected by EPAC 
activation, other proteins and processes might also be regulated by synergistic or antagonistic 
action of cAMP sensors. Therefore, the assignment of one phospho-site as a PKA target also 
requires investigations of changes in the phosphorylation pattern upon PKA-specific inhibition 
when using elevated intracellular cAMP levels as a stimulus.  
 
6.1.2. Elevation of intracellular cAMP levels leads to the identification of regulated 
phospho-sites 
After demonstrating the successful activation of PKA upon FSK/db-cAMP treatment, cAMP-
dependent changes in protein phosphorylation patterns were investigated. When analyzing 
whole cell lysates, the detection of an altered phospho-site abundance can either result from 
the activation of kinases and phosphatases or from changes in the protein degradation and 
expression. Here, a shift in protein homeostasis after cell treatment implies the activation of 
important regulatory processes. If the increase of the protein abundance correlates with an 
upregulation of one of its phospho-sites, kinase activation needs to mediate both, the elevation 
of the protein level as well as the phosphorylation of the raised number of the particular 
modification-site compared. Similarly, downregulation of phospho-sites caused by a treatment-
induced reduction of protein expression or increased degradation might also require further 
modulation of kinase and phosphatase activity. Whether this modulation is needed depends on 
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the turnover rate of the affected protein. A short treatment-independent cellular half-life time 
or a stimulation-induced degradation of phosphoproteins diminish the abundance of 
phosphopeptides without modulating phosphatase activity.  
Within the present study, PKA/EPAC were stimulated by increasing the intracellular cAMP level 
during a 30 min treatment of the cells with FSK/db-cAMP. Although the turnover rates are highly 
variable, a half-life of less than 5 hours in cell cycle arrested HeLa cells was only reported for a 
minority of proteins (Cambridge et al. 2011). This suggests that only few proteins will undergo 
significant turnover during the 30 min treatment applied in this study. Nevertheless, PKA as one 
of the major intracellular cAMP sensors has already been demonstrated to stimulate gene 
expression by phosphorylating the CREB transcription factor (Montminy and Bilezikjian 1987; 
Gonzalez and Montminy 1989). A detailed study about PKA induced changes in gene expression 
was performed by Zambon et al. (2005). Here, RNA analysis identified more than 700 genes as 
being at least 1.5 fold up- and downregulated upon treatment of murine lymphoma cells with a 
cAMP analog for two hours compared to the 0 hour control group (Zambon et al. 2005). Besides 
influencing the protein level by regulating gene expression, elevations of cAMP levels have also 
been shown to induce degradation of short-lived proteins via the ubiquitin-proteasome pathway 
(Lokireddy et al. 2015). Considering these effects of cAMP on modulating protein levels, the 
necessity of monitoring protein abundances when investigating cAMP-dependent changes in 
phosphorylation events in a long-term treatment becomes apparent. However, protein levels 
were not assumed to be altered during the 30 minute FSK/db-cAMP treatment applied within 
this study. 
Known PKA target sites of CaMKK1, PFKFB2 and CAD were identified as being upregulated in 
phosphopeptides from the whole cell lysate upon FSK/db-cAMP treatment (PhosphoSitePlus 
online repository; phosphosite.org, retrieved 24.10.2019) (Carrey et al. 1985; Okuno et al. 2001; 
Pozuelo Rubio et al. 2003) (Table 5.2). This indicates the successful activation of PKA by the 
stimulus applied in this experiment. 
Besides these known PKA target sites, several phosphopeptides, so far unknown to be regulated 
upon PKA activation, were identified (according to PhosphoSitePlus, retrieved 24.10.2019) 
(Figure 5.2, table 5.1, table 5.2, table 5.3). For example, the phosphatidylinositol 3-phosphate 5-
kinase (PIKFYVE) phospho-site detected as being upregulated after FSK/db-cAMP treatment has 
been previously identified as an AMP-activated protein kinase and PKB target (Berwick et al. 
2004; Liu et al. 2013). In these two studies, contradictory results regarding the impact of the 
phosphorylation on PIKFYVE activity were obtained. Whereas Liu et al. (2013) demonstrated that 
phosphorylation at S307 did not affect the activity of the enzyme, Berwick et al. (2004) observed 
6 Discussion 
141 
 
an increase level of the PIKFYVE enzymatic product phosphatidylinositol 3,5-bisphosphate 
(PI(3,5)P2) after phosphorylating this amino acid in vitro. Nevertheless, substitution of this serine 
residue in the PKB consensus motif to alanine has been shown to be associated with impaired 
epidermal growth factor receptor (EGFR) degradation (Er et al. 2013). Supported by other 
experiments in that study, the authors concluded a correlation between the EGFR breakdown 
and the PI(3,5)P2 level, thus indicating PIKFYVE and its phospho-site as a regulator in receptor 
trafficking (Er et al. 2013). The FSK/db-cAMP-dependent regulation of the S307 phospho-site 
identified in the present study might suggest the intracellular cAMP level as a regulator of 
PIKFYVE activation.  
In contrast to the upregulated phopsho-site found for PIKFYVE, FSK/db-cAMP treatment was 
also associated with a downregulation of phosphorylation events at certain amino acid residues 
(Figure 5.2, table 5.1, table 5.3). For example, such a downregulation was identified for the Ras-
related protein Rab-12 (Table 5.3). Rab-12 belongs to the family of Ras GTPases and has been 
demonstrated to mediate lysosome-dependent degradation of the transferrin receptor in 
mouse embryonic fibroblasts (MEF) cells (Matsui et al. 2011). Considering the potential role of 
the PIKFYVE phospho-site identified within the present study, the significant downregulation of 
Rab-12 might suggest a role of cAMP in receptor degradation. This hypothesis is further 
supported by the study of Salazar and González (2002) which demonstrated that PKA inhibition 
results in a diminished ligand-activated EGFR degradation independent from alterations in 
receptor-ligand internalization.  
Two phospho-sites of the CREB-regulated transcription coactivator 3 (CRTC3) have been 
identified as being highly downregulated after FSK/db-cAMP treatment (Table 5.3). CRTC3 
belongs to the transducers of regulated CREB (TORC) family which act as CREB1 coactivators 
(Iourgenko et al. 2003; Conkright et al. 2003). The regulation of TORC activity has been well 
studied for CRTC2. Here, the salt-inducible kinase 2 (SIK2) phosphorylates CRTC2, thus mediating 
its binding to 14-3-3 proteins and promotes its translocation from the nucleus to the cytoplasm 
(Screaton et al. 2004). Similarly, SIK1 has been demonstrated to be able to phosphorylate and 
deactivate all three members of the TORC family suggesting the SIKs as important modulator of 
these transcriptional coactivators (Katoh et al. 2006). In turn, phosphorylation of SIK by PKA is 
associated with a downregulation of their kinase activity which directly affects the TORC 
phospho-pattern and TORC-mediated gene expression (Screaton et al. 2004; Sonntag et al. 
2018). The two CRTC3 phospho-sites identified within the present study (S329 and S370) are 
known SIK targets (Clark et al. 2012). Together with S62 and S162, these phospho-sites are 
important for the regulation of CRTC3’s function as a transcriptional coactivator (Clark et al. 
2012). CRTC3 in vitro phosphorylation at S162, S329 and S370 with SIK1-3 was associated with 
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an increased binding to 14-3-3 (Clark et al. 2012). Therefore, the data presented here are in line 
with the current literature which suggests SIK inactivation upon PKA stimulation as being 
associated with a phosphorylation decrease of CRTC3 thus inducing the expression of its target 
genes (Sonntag et al. 2018). 
 
6.1.3. FSK/db-cAMP treatment alters the phosphorylation pattern of lysosomal and 
lysosome-associated proteins 
cAMP-dependent changes in the phosphorylation pattern of lysosomal and lysosome-associated 
proteins were investigated by enriching these organelles followed by their separation into a 
soluble and membrane fraction. The effect of changes in protein expression and degradation on 
the detection of regulated phospho-sites has been described in detail in the previous section. 
However, dealing with enriched organelles further complicates the interpretation of phospho-
data sets as lysosome-associated proteins might dissociate after stimulation, thus being 
identified with a downregulated phospho-site although the phosphorylation pattern might not 
necessarily change. Similarly, treatment induced membrane remodeling might also be 
associated with changes in the composition of posttranslationally modified proteins potentially 
being reflected in the data set as a regulated PTM-site. Therefore, investigating the non-
phospho-enriched lysosomal fractions plays an important role in order to distinguish between 
proteins with regulated phosphorylation sites and those with changed subcellular localization 
after cell stimulation. 
No significantly regulated phosphopeptides were identified in the soluble lysosomal fraction. 
Among the highly regulated phosphopeptides in this fraction, the two non-lysosomal proteins 
Golgin subfamily member 1 and PRRCA2 were found. In contrast, 238 proteins found in at least 
two out of three PKA and DMSO treated replicates featured “lysosome” as a gene ontology (GO) 
annotation in the non-phospho-enriched proteomic data set of the soluble lysosomal fraction. 
Therefore, the absence of phosphopeptides derived from lysosomal enzymes in the soluble 
fraction after phospho-enrichment might have been rather caused by the low stoichiometry of 
these phospho-sites present within these samples than by the loss of the lysosomal proteins 
during the organelle enrichment and fractionation. To my knowledge, nothing is known about 
kinases phosphorylating proteins inside the lumen of lysosomes. In contrast, the lysosomal 
tartrate-resistant acid phosphatase type 5 has been demonstrated to be involved in protein 
dephosphorylation (Ek-Rylander et al. 1994; Suter et al. 2001). Therefore, it seems to be unlikely 
that this PTM persists over a longer period once the phosphoprotein has reached this 
degradative organelle. Arylsulfatase B and β-glucuronidase are examples for two lysosomal 
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hydrolases detected as being phosphorylated directly at the amino acid residue in human lung 
tumors (Gasa and Makita 1983; Fujita et al. 1985). However, these phosphoproteins were 
identified in homogenates without any lysosomal enrichment, thus lacking the evidence that 
these phosphorylations occur in mature lysosomes (Gasa and Makita 1983; Fujita et al. 1985). 
Most lysosomal enzymes feature a phosphorylation at the mannose carbohydrate moiety. Here, 
the mannose-6-phosphoate group is posttranslationally attached to the hydrolases during 
transport through the Golgi apparatus and has an important role in delivering these enzymes to 
the endosomes (Tabas and Kornfeld 1980; Varki and Kornfeld 1980; Waheed et al. 1981; 
reviewed by Braulke and Bonifacino 2009). Similarly to the phosphopeptide enrichment, metal 
based affinity chromatography such as TiO2 or Fe3+-immobilized metal affinity chromatography 
(IMAC) can also be used for enriching M6P containing peptides (Kang et al. 2018; Čaval et al. 
2019). Compared to IMAC-based techniques, Čaval et al. (2019) demonstrated that the TiO2 
method used in this study to enrich for phosphopeptides only yielded low amounts M6P-
containing peptides during MS analysis using HCD for peptide fragmentation. Although it 
remains elusive how many M6P-containing peptides after TiO2 enrichment were not identified 
due to suboptimal peptide fragmentation in the study of Čaval et al. (2019), the results indicate 
that a competition among the phospho- and M6P-peptides was probably not the reason for the 
missing detection of phosphopeptides derived from lysosomal hydrolases in the soluble fraction. 
This finding further supports the hypothesis mentioned earlier, that lysosomal enzymes are not 
excessively phosphorylated directly at the protein moiety in mature lysosomes.  
FSK/db-cAMP treatment followed by preparation of the lysosomal membrane fraction and 
phosphopeptide enrichment was associated with the detection of upregulation of known PKA 
targeted phospho-sites of the CD44 antigen and the CAD protein (PhosphoSitePlus online 
repository; phosphosite.org, retrieved 09.05.2019) (Carrey et al. 1985; Tzircotis et al. 2006) 
(Table 5.5). The same CAD phospho-site identified here has also been found as being highly 
upregulated after FSK/db-cAMP treatment in the whole cell phospho-data set described in the 
previous section. This supports the reproducibility of the stimuli applied in the two independent 
experiments. Furthermore, the CD44 antigen as well as the CAD protein were not regulated in 
the non-phospho-enriched proteomic data set upon FSK/db-cAMP treatment, thus indicating a 
cAMP-mediated phosphorylation of the detected amino acid residues. Significantly or highly 
regulated phosphopeptides after FSK/db-cAMP treatment have been identified for the 
lysosomal proteins Mucolipin 1, RPTOR, mTOR, RUBCN as well as for the lysosome-associated 
protein SNAPIN. None of these phospho-sites have previously been listed as direct PKA targets 
in the PhosphoSitePlus online repository (retrieved 09.05.2019) (Figure 5.3, table 5.4, table 5.5, 
table 5.6).  
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Together with mLST8 (mammalian lethal with SEC13 protein 8) and the two inhibitory subunits 
PRAS40 (Proline-rich AKT1 substrate 1) and DEPTOR (DEP domain-containing mTOR-interacting 
protein), the serine/threonine kinase mTOR and its regulatory associated protein RPTOR are 
components of the mechanistic target of rapamycin complex 1 (mTORC1) (Kim et al. 2002; Kim 
et al. 2003; Sancak et al. 2007; Vander Haar et al. 2007; Peterson et al. 2009). The importance 
of mTORC1 signaling in different cellular processes has been reviewed in detail by Saxton and 
Sabatini (2017). Upon activation of the mTOR signaling pathway, RPTOR binds substrates to the 
mTORC1 complex, thus enabling their phosphorylation by the mTOR kinase (Nojima et al. 2003; 
Schalm et al. 2003). The highly upregulated RPTPOR phospho-site (S877) identified within the 
present study has recently been assigned as a TANK-binding kinase 1 target (Antonia et al. 2019). 
Here, RPTOR phosphorylation at S877 has been demonstrated to inhibit mTOR activity (Antonia 
et al. 2019). The S877 containing RPTOR phosphopeptide detected as being exclusively present 
in the lysosomal membrane fraction of the FSK/db-cAMP treated samples featured one tryptic 
missed cleavage site (MCS). In addition to this, the same phospho-site was identified in a peptide 
without MCS in the present data set. This peptide was found in all three replicates of the FSK/db-
cAMP stimulated samples and the DMSO controls without a treatment-induced regulation. 
Therefore, it is reasonable to assume that the upregulation identified for the RPTOR phospho-
site at S877 was rather caused by a slightly different tryptic cleavage efficiency of this peptide 
within the different sample groups than by cAMP-mediated regulation. However, the mTOR 
S2448 phospho-site was found to be upregulated after FSK/db-cAMP treatment in the lysosomal 
membrane fraction. A cAMP-dependent regulation of the mTOR protein level was not detected 
in the non-phospho-enriched proteomic data set, thus suggesting its presence in the lysosomal 
membrane fraction independent from the treatment. The mTOR S2448 phospho-site has been 
previously assigned as a PKB target whereas more recent studies indicate a p70S6 kinase (S6K) 
dependent phosphorylation at this position (Navé et al. 1999; Sekulić et al. 2000; Chiang and 
Abraham 2005; Holz and Blenis 2005). As the p70S6 kinase is located downstream of mTOR in 
the mTOR signaling pathway, its phosphorylation at S2448 was hypothesized as being part of 
feedback loop (Chiang and Abraham 2005; Holz and Blenis 2005). In 2010, Rosner et al. 
demonstrated a correlation between a diminished mTOR activity and a downregulation of mTOR 
phosphorylation at S2448. Here, mTOR activity was monitored indirectly by quantifying the two 
S6K target sites S235 and S236 of 40S ribosomal protein S6 (S6) upon inhibition of mTOR itself 
or phosphoinoside-3-kinase, an upstream kinase in the mTOR signaling pathway (Rosner et al. 
2010). Both S6 phospho-sites were also found in the present study as being upregulated in the 
lysosomal membrane fraction after FSK/db-cAMP treatment. Together with the phosphorylation 
of mTOR at S2448, these findings indicate the activation of S6K upon FSK/db-cAMP treatment, 
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thus potentially reflecting the stimulation of the mTOR signaling pathway under the conditions 
applied in this study. However, recent studies suggest a PKA dependent phosphorylation of the 
S6 phospho-sites S235 and S236 in medium-sized spiny neurons which is independent of the 
mTOR signaling pathway (Biever et al. 2015). Based on these findings, further experiments are 
required in order to elucidate whether the S6 phosphorylation found in the present study was 
caused by the activation of an mTORC1 dependent or independent pathway (or both). 
Nevertheless, the role of PKA in regulating mTORC1 activity is controversially discussed in 
literature. Whereas activation of PKA was shown to inhibit phosphorylation of S6K in different 
cell types; thus indicating a decrease in mTOR activity, the lab of Martinez and co-workers 
suggested a PKA dependent stimulation of mTOR in human adrenocortical cells (Joussineau et 
al. 2014; Jewell et al. 2019). Besides the potential involvement of PKA in mTOR activation, cAMP 
itself was hypothesized to regulate the mTORC1 pathway in a PKA independent manner by 
releasing the mTOR activator Rheb from a complex with the cAMP-specific 3’,5’-cyclic 
phosphodiesterase 4D (Kim et al. 2010). Taking together these findings, further experiments are 
necessary in order to evaluate the role of PKA in mTOR signaling.  
Mucolipin 1 is a lysosomal cation channel which is phosphorylated by PKA at S557 and S559, 
thus regulating the channel activity (Vergarajauregui et al. 2008). Within the present study, an 
additional phospho-site at the cytosolic S10 position of this transmembrane protein has been 
identified as being upregulated upon FSK/db-cAMP treatment. The Mucolipin 1 protein level in 
the lysosomal membrane fraction was not affected by the stimulation which indicates a cAMP 
dependent regulation of the S10 phospho-site. The function of which is unknown.  
 
6.1.4. Elevated intracellular cAMP level leads to a downregulation of SNAPIN S133 
phosphorylation in the lysosomal membrane fraction 
Originally identified in neurons as a protein involved in docking and release of synaptic vesicles 
via its interaction with SNAP-25, SNAPIN has been demonstrated to play important roles in 
retrograde vesicle transport, lysosome maturation and late endocytic vesicle trafficking (Ilardi 
et al. 1999; Lu et al. 2009; Cai et al. 2010; Ye and Cai 2014; Di Giovanni and Sheng 2015). 
Additionally, SNAPIN was identified as a subunit of the two complexes BLOC-1 and BORC 
(Starcevic and Dell'Angelica 2004; Pu et al. 2015). Similar to Mucolipin 1, SNAPIN has already 
been described as a PKA target (Chheda et al. 2001). Here, PKA-dependent phosphorylation of 
S50 has been demonstrated to enhance the binding of SNAPIN to SNAP-25 (Chheda et al. 2001; 
Song et al. 2011).  
Neither the phospho nor the non-phospho S50 containing peptides were found in the present 
phospho-data set of the lysosomal membrane fraction after FSK/db-cAMP treatment. This might 
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have been caused by the intrinsic properties of the tryptic peptide that contains this side which 
might have hampered its detection via mass spectrometry. The fact that the S50 phospho-site 
is not listed in the PhosphoSitePlus repository in data from large-scale high-throughput 
experiments further supports this hypothesis (according to phosphosite.org, retrieved 
08.11.2019). In contrast, other SNAPIN phosphopeptides were found in the lysosomal 
membrane fraction, thus indicating the association of this protein with the lysosomes. Among 
those, the phosphopeptide containing the S133 phospho-site was downregulated in the 
lysosomal membrane fraction after FSK/db-cAMP treatment (Figure 5.3, table 5.4). SNAPIN was 
not detected in the non-phospho enriched proteomic data set. This hampers conclusions about 
changes in its lysosome association upon elevated intracellular cAMP levels. The properties of 
SNAPIN described above as well as its presence in the two complexes BLOC-1 and BORC suggest 
an important role of this protein in proper lysosome function, which might also be linked with 
its phosphorylation pattern. Further biochemical assays were performed in order to validate the 
changes in SNAPIN phosphorylation detected by mass spectrometry in FSK/db-cAMP treated 
cells.  
 
6.1.5. Investigating the effect of elevated intracellular cAMP levels on SNAPIN’s 
protein level, lysosomal association as well as phosphorylation 
As described earlier, the downregulation observed for SNAPIN’s S133 phospho-site after FSK/db-
cAMP treatment could either be caused by stimulus-induced dephosphorylation, changes in 
protein expression and degradation, or dissociation from the lysosomes. SNAPIN was not 
identified in the non-phospho enriched proteomic data set, thus requiring additional methods 
in order to evaluate the influence of the FSK/db-cAMP treatment on SNAPIN itself and its 
phosphorylation status. The influence of elevated cAMP levels on whole cell SNAPIN level and 
its association to the lysosomes was investigated by Western Blot and immune detection.  
6.1.5.1. FSK/db-cAMP treatment does not affect SNAPIN’s protein level but might lead to 
its dissociation from lysosomes  
When analyzing whole cell lysates, no changes in the intracellular SNAPIN level were identified 
upon FSK/db-cAMP treatment, thus indicating that its balance of expression and degradation 
was not altered due to the stimulus (Figure 5.4). Compared to that, investigating the SNAPIN 
amount present in the enriched lysosomal fraction suggested a FSK/db-cAMP-dependent 
dissociation of SNAPIN from these organelles, although its relative intensity did not significantly 
change between the treated and non-treated samples (Figure 5.5). Here, the failure to reach 
significance was probably caused by one measurement outlier in the control group which lowers 
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the mean abundance and increases the standard deviation. Therefore, repetition of the 
experiment is required to increase the robustness of this assay. If the dissociation is verified, it 
would be one explanation for the downregulation of the S133 phospho-site observed in the 
phosphoproteomic data set of the lysosomal membrane fraction. However, protein 
translocation can be associated with changes in the PTM pattern of the membrane anchoring 
binding partner or of the transposed polypeptide itself (Zwang et al. 2009; Huang et al. 2015). 
Hence, changes of the phosphorylation status of SNAPIN S133 as well as at other PTM-sites could 
also be associated with its translocation.  
6.1.5.2. FSK/db-cAMP treatment alters the phosphorylation pattern of SNAPIN 
In order to investigate alterations in SNAPIN’s phosphorylation profile upon FSK/db-cAMP 
treatment, 2D-gelelectrophoresis was performed with whole cell lysate. As the isoelectric point 
(PI) is also influenced by other acidic protein modifications such as acetylation and glycosylation 
with sialic acid, a phosphatase treated sample was also analyzed by 2D-gelelectrophoresis in 
order to map different SNAPIN proteoforms to phosphorylated isoform (Gruener and Ismond 
1997; Barrabés et al. 2010). FSK/db-cAMP treatment was associated with an increase and 
decrease of the PI of SNAPIN, thus probably representing phosphorylation and 
dephosphorylation events (Figure 5.6). This was in line with the observations made in the 
phosphoproteomic data set of the lysosomal membrane fraction as well as with the PKA-
dependent phosphorylation of SNAPIN at S50 described in literature (Chheda et al. 2001). 
Considering the number of proteoforms found in the phosphatase treated sample as well as in 
the DMSO control of the first replicate, three different SNAPIN phosphorylation sites have been 
detected in this experiment. Although the tendency seemed to be similar, precise determination 
of the number of SNAPIN isoforms identified in the FSK/db-cAMP treated sample and non-
treated samples of the second replicate was difficult, as the relatively high background signal 
might have hindered the detection of faint proteoform pattern.  
The results obtained after 2D-gelelectrophoresis suggests SNAPIN as a highly phosphorylated 
protein. In addition to the PKA mediated S50 phosphorylation, the leucine-rich repeat kinase 2 
has been reported to phosphorylate SNAPIN at T117 (Chheda et al. 2001; Yun et al. 2013). The 
SNAPIN S133 phospho-site identified within the present study as being downregulated upon 
FSK-db-cAMP treatment in the lysosomal membrane fraction has been previously detected in a 
proteome wide screen for possible cyclin-dependent kinase (CDK) 2 substrates (Chi et al. 2008). 
In order to further elucidate potential kinases involved in the phosphorylation of SNAPIN at 
S133, the NetPhos 3.1 web tool was used (cbs.dtu.dk/services/NetPhos, 09.11.2019) (Blom et 
al. 1999; Blom et al. 2004). This algorithms makes predictions about possible targets for 17 
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different kinases based on phospho-sites assigned to these enzymes in literature (Blom et al. 
2004). Although a bioinformatic investigation using the NetPhos 3.1 web tool supports the 
phosphorylation potential of this phosphopeptide at this position, the algorithm was not able to 
predict a kinase involved in modifying the serine 133 with high confidence. Among the kinases 
above the 0.5 score-threshold (CDK5, Glycogen synthase kinase-3, MAPK p38), CDK5 was 
predicted with the highest probability as being responsible for SNAPIN phosphorylation at S133 
(score 0.593). Together with the identification of the S133 phospho-site in the large scale CDK2 
substrate screen, the results of the bioinformatics analysis indicate the involvement of cyclin 
dependent kinases in phosphorylating SNAPIN at this position. Comparison of the amino acid 
composition adjacent to serine 133 with the CDK consensus sequence (S/T-P-X-R/K) further 
supports this hypothesis (reviewed by Malumbres 2014). However, additional experiments are 
necessary in order to unravel the potential role of CDKs in SNAPIN phosphorylation.  
Within the present study, two to three SNAPIN proteoforms were identified after incubating the 
cell lysate with an alkaline phosphatase. This indicates the presence of at least one 
phosphorylation independent isoform with a different PI compared to the unmodified protein 
(Figure 5.6). It is reasonable to assume that this second isoform neither features highly complex 
PTMs such as branched glycans nor results of proteolytic cleavage of the original protein or 
consists of an alternative splicing variant as its molecular weight was similar to the unmodified 
SNAPIN proteofom. Besides phosphorylation, the only SNAPIN PTM validated in classical 
biochemical approaches is O-GlcNAcylation (Song et al. 2011). However, as this PTM is not 
known to change the PI of a protein, SNAPIN O-GlcNAcylation does probably not cause the 
occurrence of the additional proteoform in the 2D-gel (reviewed by Hart et al. 2011). Therefore, 
further studies are required in order to characterize the different non-phosphorylated SNAPIN 
isoforms.  
In summary, the results of the biochemical approaches described in this section strongly 
demonstrate alterations in SNAPIN’s phosphorylation pattern upon elevated intracellular cAMP 
levels. These changes might be caused by the activation of PKA but in order to further elucidate 
the role of this kinase on SNAPIN phosphorylation, additional experiments with PKA-specific 
inhibitors are required. In addition to its passive fate as being affected by intracellular cAMP 
levels, SNAPIN might also be involved in modulating the amounts of this second messenger 
inside the cell. This hypothesis is based on the interaction of SNAPIN with proteins involved in 
GPCR signaling such as the adenylyl cyclase type VI and the regulator of G protein signaling 7 
(Hunt et al. 2003; Chou et al. 2004).  
6 Discussion 
149 
 
6.1.6. SNAPIN KO is associated with a decrease in the MPR300 level 
After identification of SNAPIN as a lysosome-associated protein with regulated phosphorylation 
sites upon elevation of cAMP levels, the role of this protein in different cellular processes was 
investigated. For this purpose, the CRISPR-Cas9 method was used in order to generate a 
functional SNAPIN gene knock-out in HEK 293 and HeLa cells (Figure 5.7). Once generated, the 
proteomes of the HEK 293 SNAPIN KO and wt cells were compared by a mass spectrometry-
based approach (Figure 5.8, table 5.7). Although no significant changes in the protein levels were 
observed according to the standard thresholds, manual comparison of the abundance values of 
the single replicates indicated a SNAPIN KO-dependent decrease in the MPR300 abundance. In 
order to validate this finding, the MPR300 levels in HEK 293 and HeLa SNAPIN KO cells were 
investigated by Western Blot quantification and compared to those detected in the 
corresponding wt cells. Here, SNAPIN KO was associated with a decrease in the MPR300 level, 
thus supporting the findings of the MS-based proteome comparison (Figure 5.9). Furthermore, 
the cell type independent reduction of the MPR300 abundance after knocking out SNAPIN 
indicates that the observations originally made in the MS-based analysis of HEK 293 cells were 
not caused by secondary effects of the CRISPR-Cas9 method. For example, such an effect could 
have been caused by the insertion of the Cas9-plasmid DNA next to regulatory genomic regions 
under the selection pressure of the antibiotic.  
The transmembrane protein MPR300 plays an important role in binding newly synthesized 
lysosomal hydrolases at the Golgi apparatus and in delivering these enzymes to the endosomal 
compartment (reviewed by van Meel and Klumperman 2008). Once the cargo is delivered, the 
MPR300 is sorted back to the Golgi apparatus to start another round of this transport cycle 
(Duncan and Kornfeld 1988). In addition to that, the MPR300 has been described as being 
located at the plasma membrane (Kaplan et al. 1977). Here, the receptor is able to bind M6P 
containing enzymes and mediate their internalization and transport to endosomes (Kaplan et al. 
1977).  
The decreased MPR300 level detected in the SNAPIN KO cells could be explained by a 
dysregulation of its degradation. As the MPR300 continuously cycles between the TGN and the 
endosomal compartment, a precise sorting machinery is required in order to prevent the 
receptor from reaching the lysosomes which might induce its degradation. The role of the 
“Retromer” complex in retrograde protein transport from endosomes to the Golgi apparatus 
has been reviewed in detail within the past years (Lucas and Hierro 2017; Vagnozzi and Praticò 
2019). However, different studies indicate the involvement of additional proteins in MPR300 
recycling although the exact mechanism is still debated in literature. Whereas the Pfeffer group 
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suggested a combinatory contribution of Rab9 and Tip47 (Perilipin-3) in MPR retrieval to the 
TGN, more recent results from Bulankina et al. (2009) indicate that Tip47 is not involved in this 
process (Riederer et al. 1994; Dıáz and Pfeffer 1998; Carroll et al. 2001). However, Dıáz and 
Pfeffer (1998) demonstrated a decrease in the MPR300 level upon Tip47 knock down which is 
similar to the observations made within the present study in the SNAPIN KO cells. The authors 
assigned this phenomenon to a reduced MPR300 half-life, caused by a Tip47-dependent 
missorting of this receptor and its degradation in the lysosomal compartment (Dıáz and Pfeffer 
1998). Based on this, one could hypothesize a similar role of SNAPIN in MPR300 endosome/TGN 
sorting. Such an impact would explain the decreased MPR300 levels detected in the SNAPIN KO 
cells. However, this explanation would only be valid if the retrograde transport of late 
endosomes (LE), the LE-lysosome fusion and the lysosomal function is not affected by the 
SNAPIN KO itself. In 2010, Cai et al. identified SNAPIN as a regulator in late endosomal retrograde 
transport. Furthermore, characterization of SNAPIN KO neurons demonstrated an increased 
LAMP-1 level as well as a decrease in the abundance of mature Cathepsin D, a proteoform often 
used as an indicator for lysosome maturation as its precursor isoform is cleaved in the acidic 
environment of these organelles (Lu et al. 2009; Cai et al. 2010). The authors predicted SNAPIN 
as a protein involved in endosome-lysosome fusion and lysosome maturation (Lu et al. 2009; Cai 
et al. 2010). Based on these findings, it remains elusive whether the SNAPIN KO might lead to 
an increase in lysosome-based degradation of missorted MPR300 and further experiments are 
required in order to answer this question. 
A diminished biosynthesis rate might be another explanation for the decrease in the MPR300 
level detected in the SNAPIN KO cells. So far, little is known about the influence of SNAPIN on 
gene transcription and protein translation. In 2009, Ginter-Matuszewska et al. described the 
interaction of SNAPIN with Pumilio homolog 2 (Pumilio2) and Nanos homolog 1 (NANOS1). In 
Drosophila, Pumilio and NANOS have been demonstrated to form a complex which inhibits 
translation of mRNA by removing the poly-A-tail (Wreden et al. 1997). This suggests a similar 
function in humans. Although originally described as being predominantly expressed in human 
germ cells (plus Pumilio2 in embryonic stem cells), database analysis of Pumilio2 and NANOS1 
indicates a high protein expression in different tissues such as colon and kidney 
(proteinatlas.org, retrieved 12.11.2019) (Moore et al. 2003; Jaruzelska et al. 2003; Uhlén et al. 
2015). Based on the SNAPIN interaction, one could hypothesize a regulatory function of SNAPIN 
upon binding to these proteins. In this case, SNAPIN KO could be associated with the release 
Pumilo2 and NANOS1 from a regulatory complex thus promoting posttranscriptional inhibition 
of protein biosynthesis. This might then be associated with the reduced MPR300 level detected 
in the SNAPIN KO cells. Nevertheless, this function of SNAPIN is highly speculative as not only 
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the involvement of Pumilio2 and NANOS1 in regulation of mRNA translation needs to be further 
validated in humans. In fact, SNAPIN interaction would also need to inhibit Pumilio2 and 
NANOS1 function. Additionally, the impact of both proteins on MPR300 mRNA translation would 
need to be demonstrated.  
 
6.1.7. MPR-mediated endocytosis is decreased in SNAPIN KO cells 
The proteome comparison of SNAPIN KO cells revealed a decrease in the MPR300 compared to 
their wt counterparts. The reason for the downregulation in the SNAPIN KO cells remains 
elusive. As the MPR300 has important functions in the endocytosis of M6P containing acidic 
hydrolases, the internalization of ASA was investigated in HEK 293 wt and SNAPIN KO cells. Both 
cell types were also incubated with FSK/db-cAMP or DMSO in order to determine the influence 
of elevated intracellular cAMP levels on the internalization process. Such a cAMP-dependent 
effect would justify further investigations of the potential role of the altered SNAPIN 
phosphorylation pattern detected after FSK/db-cAMP treatment on MPR mediated endocytosis.  
In both cell types, FSK/db-cAMP treatment was not associated with alterations in ASA 
internalization (Figure 5.10). Analysis of the cell lysates by Western Blotting and pCREB immune 
detection suggested a successful activation of PKA upon elevated cAMP levels in the wt cells 
(data not shown). Together, these results indicate that the FSK/cb-cAMP dependent changes in 
the SNAPIN phosphorylation status have no effect on the endocytosis kinetics of ligand-MPR 
complex. Investigations of the pCREB level in SNAPIN KO cell lysates yielded inconclusive results 
regarding the PKA activation after FSK/db-cAMP treatment (data not shown). As a stimulus-
induced activation of PKA was demonstrated for the wt cells, further investigations are required 
in order to determine whether the SNAPIN KO influences parts of the intracellular cAMP 
signaling pathway.  
However, when comparing the two different genotypes, significant, treatment-independent 
differences in the MPR mediated internalization of ASA were observed (Figure 5.10). Here, 
SNAPIN KO cells showed a strong decrease in the endocytosis rate compared to their wt 
counterparts. The easiest explanation for this observation would be the downregulation of 
MPR300 identified in the SNAPIN KO cells in previous experiments. Nevertheless, this would 
require that the levels of this receptor at the plasma membrane are diminished upon 
SNAPIN KO. If the MPR300 levels displayed at the cell surface are not altered, the reduced ASA 
endocytosis rate observed after SNAPIN KO would rather be caused by a dysfunction of the 
internalization machinery after ligand binding than by the decreased amounts of surface 
exposed receptor itself. So far, little is known about a potential role of SNAPIN in modulating the 
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endocytosis kinetics after formation of ligand-receptor complex. In 2010, Cai et al. demonstrated 
an impaired degradation of EGFR in murine SNAPIN KO cells. As the EGF/EGFR internalization 
rate was not altered between the wt and SNAPIN KO cells, the authors concluded that at least 
part of this observation was caused by defects in cargo delivery to the lysosomes (Cai et al. 
2010). The EGFR can be internalized via adaptor protein 2 containing, clathrin-coated plasma 
membrane fissions (Beguinot et al. 1984; Hanover et al. 1984; Sorkin et al. 1996). Similarly, the 
cytosolic domain of the MPR300 contains the YXXφ (φ = bulky hydrophobic residue) motif 
enabling the binding to the clathrin adaptors AP1 and AP2 (Jadot et al. 1992; Doray et al. 2007). 
These similarities might indicate a common internalization mechanism of these receptors. 
However, an alternative, clathrin-independent route for EGFR endocytosis has been described, 
thus further complicating the comparison to the MPR300 based internalization process 
(Sigismund et al. 2005; Henriksen et al. 2013). Therefore, the findings of Cai et al. (2010) 
regarding the EGFR endocytosis rate in SNAPIN KO cells might only be transferable with certain 
limitations to the uptake of MPR300-ligand complexes as the exact mechanism involved in EGFR 
internalization was not investigated. Hence, independent experiments need to be performed in 
order to identify the potential role of SNAPIN in MPR300 endocytosis. Additionally, further 
studies investigating the influence of SNAPIN in MPR300 cell surface localization are required. 
 
6.1.8. SNAPIN KO is associated with a reduced size of LE/lysosomes 
SNAPIN KO has been demonstrated to alter late endosome trafficking in neurons due to 
alterations in dynein-driven transport (Cai et al. 2010). In 2015, Pu et al. reported a SNAPIN 
knock down mediated perinuclear clustering of LE/lysosomes in HeLa cells by influencing the 
kinesin mediated anterograde transport. In order to further investigate SNAPIN-dependent 
LE/lysosome positioning, HeLa wt and SNAPIN KO cells were stained with an anti-LAMP-2 
antibody and analyzed by confocal microscopy. Here, the influence of elevated intracellular 
cAMP levels in both genotypes were investigated by treating the cells with FSK/db-cAMP or 
DMSO (control).  
In HeLa wt cells, the LAMP-2 signal was distributed throughout the whole cell with slight 
accumulation at the perinuclear region (Figure 5.11). For this cell type, no difference in the signal 
pattern was observed for the treated and non-treated cells (Figure 5.11). The missing effect of 
elevated intracellular cAMP levels on LAMP-2 signal distribution indicate that the alterations of 
the SNAPIN phosphorylation status detected upon FSK/db-cAMP treatment in the previous 
experiments were not associated with changes of LE/lysosomes subcellular localization. 
Recently, Tapia et al. (2019) demonstrated a PKA-induced translocation of lysosomes to the 
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Golgi region, triggered by the activation of the KDEL-receptor (KDELR), a GPCR located at the 
Golgi apparatus and involved in the regulation of membrane trafficking at this organelle 
(Giannotta et al. 2012; Cancino et al. 2014). In order to demonstrate the impact of protein 
kinase A on this process, the authors activated the KDELR with an artificial ligand in the presence 
or absence of an cAMP analog and/or PKA inhibitors in HeLa cells in which the adenylyl cyclase 9, 
a protein involved in PKA activation at the Golgi apparatus, was knocked down (Cancino et al. 
2014; Tapia et al. 2019). However, these findings of Tapia et al. (2019) appear contradictory to 
the results obtained within the present study. The reasons for these different outcomes remain 
unclear. One possible explanation might be the activation of additional pathways due the 
simultaneous stimulation of the KDELR and cell treatment with cAMP analogs or PKA inhibitors 
which contributed to lysosome repositioning in the studies of Tapia et al. (2019).  
Compared to the wt cells, SNAPIN KO was associated with smaller LAMP-2 positive puncta and 
a more homogeneous LE/lysosome distribution throughout the whole cell (Figure 5.11). This 
observation was independent of the treatment, although the FSK/db-cAMP stimulated 
SNAPIN KO cells might have featured a slight shift of the LAMP-2 positive structures towards the 
perinuclear region compared to the DMSO treated control (Figure 5.11). In order to further 
investigate the potential changes in LE/lysosome positions after FSK/db-cAMP treatment of the 
SNAPIN KO cells, additional experiments with statistical analysis of treatment-dependent LAMP-
2 signal redistribution are needed. Such a LE/lysosome re-localization might require dynein-
driven retrograde transport mechanism of at least one of these organelles. So far, different 
effectors are known to mediate dynein-dependent movement of LE/lysosome from the cell 
periphery towards the perinuclear region (for review see Pu et al. 2016). In 2010, Cai et al. 
identified SNAPIN as an interaction partner of the dynein intermediate chain. Within the same 
study, overexpression of a SNAPIN version carrying the L99K substitution which abolishes the 
binding to dynein was demonstrated to strongly affect LE retrograde transport (Cai et al. 2010). 
A similar tendency was observed for SNAPIN KO in cortical neurons (Cai et al. 2010). At first sight, 
these findings might be in contradiction with the potential FSK/db-cAMP treatment dependent 
changes in the distribution of LE/lysosomes described within the present study for the 
SNAPIN KO cells. Nevertheless, the results published by Cai et al. (2010) indicate that the LE 
movement towards the perinuclear region was not totally abolished upon SNAPIN KO and 
overexpression of the L99K proteoform. This might suggest the presence of at least partial 
compensatory mechanisms mediating LE/lysosome movement within the cells if SNAPIN is 
absent.  
Recently, SNAPIN was identified as a subunit of BORC (Pu et al. 2015). BORC mediates the 
binding of ADP-ribosylation factor-like protein 8 to LE/lysosomes which facilitates the 
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recruitment of kinesin-1 to those organelles thus promoting their anterograde transport (Pu et 
al. 2015). Here, SNAPIN knock down (KD) was correlated with a perinuclear clustering of LAMP-
1 positive structures (lysosomes) (Pu et al. 2015). Such a juxtanuclear accumulation of 
LE/lysosomes was not observed in cells lacking SNAPIN within the present study. Similar to the 
LE/lysosome distribution in SNAPIN KO cells shown in Figure 5.11, Cai et al. (2010) detected 
LAMP-1 positive structures throughout the whole cytoplasm of MEF cells lacking SNAPIN. 
Compared to the wt cells, an increase in the colocalization of LAMP-1 and MPR300 was observed 
after SNAPIN KO (Cai et al. 2010). As the MPR300 is not located to mature lysosomes, the results 
indicate an accumulation of late endosomes/immature lysosomes in the SNAPIN KO cells 
(Sahagian and Neufeld 1983; Griffiths et al. 1988; Cai et al. 2010). This phenomenon might also 
be associated with impaired LE-lysosome fusion after SNAPIN KO. In 2009, Lu et al. identified 
SNAPIN as an interaction partner of Syntaxin-8, a late endosome SNARE component, potentially 
indicating its role in LE fusion events (Antonin et al. 2002). Therefore, impairments in the LE 
fusion machinery after SNAPIN KO might be another explanation for the reduced size of LAMP-
2 positive structures compared to the wt cells.  
Very recently, the regulatory function of the two BORC subunits Diaskedin and Myrlysin on 
LE/lysosomal size was published (Yordanov et al. 2019). The authors demonstrated an increased 
PI(3,5)P2 level (PIKFYVE activity) in Diaskedin KO cells which was associated with a reduced 
LE/lysosome size (Yordanov et al. 2019). As SNAPIN is also a BORC subunit, this finding might 
suggest a similar function of SNAPIN in LE/lysosome size regulation which would explain the 
LAMP-2 staining pattern observed after knocking down this protein within the present study. 
However, Yordanov et al. (2019) showed that the knock out of the BORC subunit 6 (Lyspersin) 
did not affect the size of LE/lysosomes. Therefore, the effect might have rather been caused by 
individual subunits than by the whole BORC, thus hampering conclusion about the role of 
SNAPIN in regulating LE/lysosome size via modulating the PI(3,5)P2 levels. 
 
6.1.9. The exocytosis of the lysosomal hydrolase β-hexosaminidase is upregulated in 
SNAPIN KO cells 
SNAPIN might play a key role in the secretion of synaptic vesicles (SV) by interacting with SNAP-
25 and potentially modulating the recruitment of synaptotagmin-1 to the SNARE complex (Ilardi 
et al. 1999; Tian et al. 2005). A similar SNAPIN function has been demonstrated in the secretion 
of insulin in pancreatic cells (Song et al. 2011; Somanath et al. 2016). Based on the involvement 
in these secretory events, the role of SNPAIN in lysosome exocytosis was investigated in HeLa 
wt and SNAPIN KO cells. In addition, the effect of cAMP on the exocytosis of lysosomes was 
analyzed by treating the cells with FSK/db-cAMP or DMSO (control).  
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Elevation of the intracellular cAMP and Ca2+ levels was not associated with an increase in the 
exocytosis of β-hexosaminidase (β-Hex) in HeLa wt cells (Figure 5.12A). This finding was 
surprising as both compounds have already been described in potentiating each other to 
promote exocytosis of lysosomes in rat fibroblasts (Rodríguez et al. 1999). However, the 
exocytosis behavior might differ among cell types which might explain the discrepancy between 
the lysosome secretion of HeLa wt cells and rat fibroblast. Nevertheless, the β-Hex exocytosis 
was increased in HeLa cells upon SNAPIN knock-out. Here, the exocytosis was triggered in the 
presence of Ca2+ and ionomycin in a cAMP independent manner, yielding a maximum β-Hex 
activity of approx. 110 µU/mg protein in the supernatant. In comparison to the wt samples, a 
1.2-2.3-fold higher total β-Hex activity was measured for the SNAPIN KO cells (Figure 5.12B). It 
is reasonable to assume that this difference contributed to the increased β-Hex activity detected 
in the supernatant of Ca2+ stimulated cells after SNAPIN knock-out. However, as for these 
samples a 3.4-4.9-fold increase in the β-Hex activity was observed, the different basal β-Hex 
levels do not fully explain the discrepancy between the exocytosis rates detected for the two 
cell types. Hence, these findings indicate an effect of SNAPIN on lysosome exocytosis.  
In non-professional secretory cells, the exocytosis of lysosomal hydrolases can be ascribed to 
different cellular processes. For example, these enzymes can enter the secretory pathway when 
missing the binding to MPR at the Golgi apparatus (reviewed by Braulke and Bonifacino 2009). 
Additionally, conventional lysosomes have been described to be able to fuse with the plasma 
membrane in a Ca2+-regulated way (Rodríguez et al. 1997). Here, the SNARE machinery involved 
in Ca2+-dependent secretion of conventional lysosomes comprises SNAP-23, Syntaxin-4 as well 
as synaptotagmin-7 and the lysosomal TI-VAMP/VAMP7 (Martinez et al. 2000; Rao et al. 2004). 
SNAPIN is a known regulator of SV and insulin secretion in neurons and pancreatic cells (Ilardi et 
al. 1999; Song et al. 2011; Somanath et al. 2016). In these processes, SNAPIN’s function is 
modulated by PKA-dependent phosphorylation at S50 (Chheda et al. 2001; Song et al. 2011). 
Based on its lysosome-association, one could hypothesize a similar function of SNAPIN in 
exocytosis of these organelles. In addition, SNAPIN has been demonstrated to interact with 
SNAP-23, a component of the SNARE complex involved in exocytosis of lysosomal enzymes, thus 
further suggesting its involvement in the secretion of conventional lysosomes (Buxton et al. 
2003; Rao et al. 2004). However, the results mentioned above clearly demonstrates that neither 
SNAPIN nor cAMP were directly involved in the secretion of β-Hex in HeLa cells. In contrast, the 
data might suggest an inhibitory effect of SNAPIN in lysosome exocytosis as the β-Hex release 
was significantly increased in SNAPIN KO compared to the wt cells.  
Considering the smaller size and higher number of LAMP-2 positive structures in the microscopic 
analysis of SNAPIN KO cells (Figure 5.11), the increase in β-Hex secretion might have also been 
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associated with changes in the subcellular localization of LE/lysosomes. In this case, SNAPIN 
itself would not act as a negative regulator of lysosome secretion but its knock out would cause 
a redistribution of LE/lysosomes which favors the fusion of these organelles with the plasma 
membrane.  
As mentioned earlier, lysosomal hydrolases might escape the endosomal transport route when 
missing the binding to MPR, thus entering the secretory pathway departing from the Golgi 
apparatus and being released into the extracellular space (reviewed by Braulke and Bonifacino 
2009). The MPRs are crucial for delivering lysosomal hydrolases to the endosomal system as 
cells lacking the MPR300 have been shown to feature an increased proportion of secreted 
lysosomal hydrolases, a process which can be reversed by (re-)introducing this receptor (Kyle et 
al. 1988). Based on the observed downregulation of the MPR300 in SNAPIN KO compared to wt 
cells (Figure 5.8 and figure 5.9), the diminished receptor level might have additionally 
contributed to the increased β-Hex release via the secretory pathway in this cell line. 
Nevertheless, the exocytosis of post-Golgi vesicles has been demonstrated to be Ca2+-
independent (Jaiswal et al. 2009). Therefore, this pathway would rather continuously contribute 
to an increased secretion of lysosomal hydrolases whereas it would not be affected by the Ca2+ 
stimulus. Hence, it is reasonable to assume that the increased extracellular β-Hex activity 
observed after Ca2+ stimulation of the SNAPIN KO cells has been mostly caused by the exocytosis 
of conventional lysosomes or another yet unknown mechanism.  
In addition to the possibilities described above, one has to mention that the increased β-Hex 
activity detected in supernatant of the HeLa SNAPIN KO cells could have also been caused by an 
increase in cellular apoptosis. A lactate dehydrogenase (LDH) assay, performed with the 
supernatants and the cell lysates, failed to deliver clear results (data not shown). Although the 
LDH activity values of the SNAPIN KO and wt supernatants were close to the blanks and no 
genotype specific differences were observed, only very weak activities were measured for 
random lysates samples of both cell types. In case of the cell lysates, a slightly higher LDH activity 
was determined compared to the supernatants but the values were still close to the blanks. 
Therefore, one cannot exclude that the low LDH activity measured in the supernatants was 
simply caused by the small proportion of active LDH in the cell lysates. Hence, further 
experiments are required in order to investigate potential differences in the apoptosis behavior 
of Hela wt and SNAPIN KO cells under the conditions used for examining lysosomal secretion. 
However, tests by Rodríguez et al. (1997) revealed only a minor amount of LDH release when 
treating rat fibroblasts with PBS containing 1 mM Ca2+ and 10 µM ionomycin for 10 min. 
Although this finding might not be easily transferable to the HeLa cells investigated within the 
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present study, it suggests that the treatment itself is not necessarily associated with a 
tremendous induction of apoptosis.  
 
6.1.10. BLOC1S6 potentially interacts with SNAPIN S133E but not with the S133A 
isoform 
SNAPIN was found to be phosphorylated at S133. In order to identify possible interaction 
partners of this SNAPIN isoform, pull-down assays with HEK 293 SNAPIN KO cells expressing the 
phosphomimetic S133E or the non-phosphorylatable S133A SNAPIN proteoform were 
performed. HEK 293 SNAPIN KO cells were used as a control.  
As expected, the different SNAPIN proteoforms were detected in the lysates of the stably 
transfected HEK cells used for the IP (Figure 5.13). In contrast, no SNAPIN signal was observed 
for the untransfected HEK 293 SNAPIN KO cells thus highlighting the functional gene knock out 
present within this cell line and its suitability as a control in the immunoprecipitation assay. After 
incubation with the Myc-Trap beads, SNAPIN was detected in the supernatant which indicates 
an incomplete pull-down (Figure 5.13). Additionally, a non-distinct signal pattern below the 
SNAPIN signal was observed when incubating the membrane containing the supernatant 
samples with the SNAPIN antibody. This pattern might be attributed to smaller SNAPIN 
polypeptides caused by minor amounts of plasmids with nonsense mutations. Nevertheless, the 
presence of these SNAPIN versions in the supernatant after the immunoprecipitation indicates 
that they have not bound to the Myc-Trap beads and therefore probably not interfered with the 
pull-down assay itself.  
In the MS data set of the eluted proteins from the Myc-Trap beads, SNAPIN was found in the 
untransfected SNAPIN KO cells (Figure 5.14). However, these identifications were solely based 
on feature mapping of precursor ions between different runs but without evidence on MS2 level. 
As SNAPIN was not detected in the IP input samples after Western Blot analysis of the 
untransfected SNAPIN KO cells, it is reasonable to assume that the detection of this protein in 
the control samples might have been caused by false feature alignment on MS1 level and can 
be disregarded. Similarly, the peptide comprising the S133E substitution was found by MS1 
feature mapping in the S133A samples and vice versa. Comparable to the detection of SNAPIN 
in the KO sample, this finding is probably also caused by false data alignments between the 
different raw files as the evidence for the identification on MS2 level is missing.  
In total, seven proteins were shared as potential interaction partners of the SNAPIN S133A and 
S133E proteoforms (Figure 5.15, table 5.9). Among those, BORCS7 and BORCS8 are known 
subunits of BORC whereas BLOC1S1 and BLOC1S2 can be associated with BORC and the BLOC-1 
complex (Starcevic and Dell'Angelica 2004; Pu et al. 2015). As SNAPIN has also been identified 
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as a subunit of these complexes, these data indicated a successful precipitation of known 
SNAPIN-associated proteins thus indicating the reliability of this immunoprecipitation assay as 
well as of the data analysis pipeline for identifying SNAPIN interaction partners (Starcevic and 
Dell'Angelica 2004; Pu et al. 2015). However, when comparing the normalized abundance ratios 
determined for these proteins in the S133A and S133E based pull down, a high variability 
between the single replicates was observed. This hinders conclusions about the proteoform-
based regulation of SNAPIN’s interaction with these proteins although BLOC1S1, BLOC1S2 and 
BORCS7 were found in all three replicates with MS2 based identifications (Table 5.9). A high ratio 
variability among independent replicates is a well-known issue in affinity purification assays. 
Another problem in MS-based pull-down approaches might be derived from false positive 
identifications like those obtained for the SNAPIN detection in the knock-out cells. Therefore, 
the MS data presented here can only be used as a starting point for the identification of S133A 
and S133A specific SNAPIN binding proteins but needs to be validated before deducing further 
working hypothesizes.  
Data analysis revealed a potential SNAPIN S133A isoform specific interaction with the E3 
ubiquitin-protein ligase NEDD4-like and Niban 2 (Figure 5.14, table 5.8). In case of the S133E-
proteoform, five proteins have been identified as isoform-specific potential binding partners 
(Figure 5.14, table 5.8). The BLOC1 subunit 6 was one of the proteins uniquely identified in this 
group. As mentioned earlier, other BLOC-1 subunits (BLOC1S1 and BLOC1S2) were also found to 
co-immunoprecipitate but binding of these proteins to SNAPIN might not have been favored by 
one of the proteoforms. This finding is interesting as it might suggest the selective interaction 
of SNAPIN S133E to a specific subunit of BLOC-1 without promoting the co-precipitation of other 
components of this complex. However, when interpreting these data, one has to keep in mind 
that BLOC1S1 and BLOC1S2 are also subunits of BORC (Pu et al. 2015). Therefore, it might be 
possible that SNAPIN’s interaction with the BORC is independent from the substitution whereas 
its binding to BLOC1S6 is enhanced by a negatively charged residue at position 133.  
BLOC-1 is a complex involved in the biogenesis of lysosome related organelles (Falcón-Pérez et 
al. 2002). Recently, a regulatory role of BLOC-1 in the formation of recycling endosome (RE) 
tubules in HeLa cells has been suggested (Delevoye et al. 2016). Here, the authors hypothesized 
that the recruitment of BLOC-1 to budding RE facilitates the binding of motor protein kinesin-
like protein KIF13A to these structures, thus linking RE to microtubules and promoting their 
elongation (Delevoye et al. 2016). Based on the identification of the S133E proteoform as a 
potential interaction partner of BLOC1S6, one could hypothesize a contribution of the S133 
phosphorylated SNAPIN isoform in this process.  
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6.2. Development of non-antibody-based methods for enhancing the 
identification of specific PTM  
 
A major challenge in bottom-up MS-based PTM analysis is the low abundance of 
posttranslationally modified peptides within a complex mixture. In order to solve this problem, 
PTM enrichment strategies are used. Within the present study, two novel methods aiming at 
enhancing the identification of different amino-acid specific modifications were developed and 
tested regarding their functionality.  
 
6.2.1. Serial digestion workflow  
Trypsin is a protease, that cleaves C-terminal of lysine and arginine residues (Olsen et al. 2004). 
This proteolytic enzyme has an impaired cleavage efficiency when lysine residues are modified 
by PTMs such as di- and trimethylation as well as acetylation (Peters et al. 2003; Smith et al. 
2003; reviewed by Burlingame et al. 2005). In the serial digestion workflow, proteins are first 
digested with trypsin (Figure 5.16, step 1). Afterwards, primary amines are modified with a 
biotin-derivative (NHS-biotin) and incubated with a second protease assumed to cleave N-
terminal of lysine residues regardless of their modification status (Figure 5.16, step 2.1 + step 
3.1). Therefore, the second proteolytic enzyme releases biotin-containing peptide fragments 
formerly located N-terminal of the modification site (Figure 5.16, peptide mixture after step 3.1). 
Efficient removal of biotinylated amino acid residues from PTM containing peptides is crucial, 
before incubating the double digested mixture with streptavidin-beads (Figure 5.16, step 4.1). 
Here, biotinylated peptides are depleted, thus leaving non-biotin containing, posttranslationally 
modified peptide species in the supernatant (Figure 5.16, peptide mixture after step 4.1).  
Based on the specificity of trypsin, the proteolytic cleavage with this enzyme in the beginning of 
the workflow might lead to peptides featuring both, an internal PTM-containing as well as a C-
terminal unmodified lysine residue (Figure 5.16, see succinylated peptide after step 1). In the 
course of the biotinylation procedure, this C-terminal lysine residue is biotinylated and needs to 
be separated from the PTM containing amino acid sequence in order to prevent the loss of this 
PTM site during streptavidin incubation (Figure 5.16, see succinylated peptide after step 2.1). 
Therefore, the efficiency of the workflow would be enhanced if the second protease would also 
cleave adjacent to biotinylated lysine residues in order to remove this C-terminal biotin-
containing amino acid (Figure 5.16, see succinylated peptide after step 3.1). For tryptic peptides 
featuring a C-terminal arginine, such a cleavage is not required as all biotinylated amino acid 
stretches are removed when the second enzyme cleaves adjacent to the PTM containing lysine 
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residue (Figure 5.16, see di-methylated peptide after step 3.1). Therefore, peptides containing 
a lysine PTM site would be present in the supernatant after streptavidin incubation even if the 
second enzyme does not cleave next to biotinylated lysine residues but here, the yield would be 
restricted to peptides featuring a C-terminal arginine residue after tryptic digestion.  
In this study, the proteases LysN and LysArginase were used for the second digestion. LysN 
cleaves N-terminal of lysine residues, whereas LysArginase is able to hydrolyze the peptide 
bonds N-terminal of arginine and lysine side chains (Nonaka et al. 1995; Tallant et al. 2006; 
Tallant et al. 2007; Huesgen et al. 2015). Both enzymes have already been described in cleaving 
adjacent to methylated lysine residues (Taouatas et al. 2010; Huesgen et al. 2015). Based on 
these properties, it was assumed that these proteases might have an expanded cleavage 
capability which enables them to cleave also next to biotinylated lysines. Therefore, both 
enzymes were tested regarding their ability to cleave adjacent to biotinylated lysine residues.  
6.2.1.1. LysN digestion of a synthetic peptide is incomplete irrespective of lysine 
biotinylation 
Incubation of the synthetic peptide with sulfo-NHS-biotin was associated with up to three 
biotinylation events (Figure 5.17B). As the peptide featured only two primary amines, 
biotinylation at three positions indicates an unspecific reaction of the NHS-biotin with another 
amino acid. The reactivity of NHS-esters towards non-amine groups have been known for 
decades (Miller et al. 1992). For example, Miller and colleagues demonstrated an O-biotinylation 
of serine’s hydroxyl group with different NHS-biotin derivatives under mild conditions 
influenced on the presence of a histidine residue in a close-by position (Miller and Kurosky 1993; 
Miller et al. 1997). Here, histidine was hypothesized to affect the nucleophilicity of serines’ 
hydroxyl group in presence of an additional amino acid located between these residues (Miller 
and Kurosky 1993). Both amino acids were also present within the sequence of the synthetic 
peptide used in this study, but probably their distance was too large for the histidine to influence 
the reactivity of the serine side chain. The unspecific biotinylation event cannot be mapped to a 
specific site based on the MS1 data. Nevertheless, its finding is of importance for the 
interpretation of MS2-based large scale studies in general. The primary amine reactive property 
of the NHS group is commonly used in different biochemical approaches such as in protein cross-
linking based interaction studies or in peptide labeling for MS-based quantifications (Ross et al. 
2004; Fasci et al. 2018). In these approaches, peptides with products of unknown side reactions 
will not be found during classical database searches thus lowering the identification. 
The detection of the peak corresponding to the C-terminal, biotinylated cleavage product after 
LysN digestion indicates the capability of this enzyme to hydrolyze the peptide bond adjacent to 
biotin-containing lysine residues. However, as this peak was also detected in the non-digested, 
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NHS-biotin treated sample in two similar, independent experiments (data not shown), the ability 
of LysN to cleave N-terminal of biotinylated lysines needs to be further investigated.  
The non-biotinylated peptides were not digested completely by LysN. Reliable conclusions about 
the cleavage efficiency are not possible based on the signal intensities of the different species, 
as the ionization behavior is an intrinsic property of each peptide and might be influenced by its 
amino acid composition and modification status. Nevertheless, the incomplete digestion 
indicated suboptimal cleavage conditions. Therefore, the next step aimed at optimizing LysN’s 
digestion behavior by varying the peptide to protease ratio as well as by adding different 
divalent cations to the digestion buffer.  
6.2.1.2. Adjustments of the peptide:LysN ratio influence the cleavage efficiency of LysN 
Different peptide:LysN mass ratios were tested regarding their influence on the relative cleavage 
efficiency of a synthetic precursor peptide. Here, a peptide:LysN mass ratio of 25:1 yielded the 
highest abundance ratio of cleaved versus non-cleaved peptides (Figure 5.18A). Compared to 
that, a tremendous reduction in the cleavage efficiency was observed when reducing the 
peptide:LysN ratio to 50:1 and 100:1, respectively. Similar investigations were performed by 
Taouatas et al. (2010). Here, the authors used BSA as a substrate for investigating LysN’s 
cleavage efficiency at eight different ratios ranging from 50:1 to 1000:1 (Taouatas et al. 2010). 
In that study, BSA cleavage was most efficient at ratios 50:1, 85:1 and 100:1. A BSA:LysN ratio of 
25:1 was not tested by the authors, thus hindering conclusion whether a further increase in the 
protease proportion would have led to an even higher efficiency.  
LysN is a metalloendopeptidase requiring divalent cations as co-factors (Nonaka et al. 1995). 
Therefore, the effect of different cations on LysN’s hydrolytic activity was investigated. Among 
the different conditions tested, the highest cleavage efficiency was observed for samples 
containing 0.1 mM MgCl2 or no additional cations in the digestion buffer (Figure 5.18B). 
However, as these samples also featured the biggest variance, reliable conclusions whether 
these conditions might be more beneficial than adding 1 mM MnCl2 or 1 mM MgCl2 to the 
digestion buffer cannot be drawn. Interestingly, the cleavage efficiency might have been 
reduced in presence of 0.1 mM ZnCl2 and even totally abolished at a 10-fold higher 
concentration of this salt. This is surprising as LysN was originally identified as a zinc-
metalloendopeptidase (Nonaka et al. 1995). In 1995, the same authors investigated the activity 
of the metal-deprived LysN apoenzyme upon (re-)addition of different divalent cations (Nonaka 
et al. 1995). Here, the presence of Zn(CH3COO)2 restores LysN’s activity whereas its catalytic 
function was even increased after adding MnCl2 to the digestion buffer (Nonaka et al. 1995). 
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Such a correlation was not observed within the present study. The reasons for these divergent 
observations remain elusive.  
Based on the findings described in this section, a protein:LysN ratio of 25:1 as well as a MgCl2 
concentration of 0.1 mM in the digestion buffer were used in further LysN digestion 
experiments.  
6.2.1.3. LysN and LysArginase digestion of NHS-biotin treated complex samples is 
associated with a low identification rate of biotinylated peptides 
In order to avoid a bias by one specific peptide sequence on the evaluation of the digestion 
efficiency, LysN’s and LysArginase’s cleavage capabilities at biotinylated BSA and proteins from 
HEK 293 cell lysates were investigated.  
By comparing the numbers of biotin-containing BSA peptides detected after proteolysis with 
these proteases, a strong reduction in the identification of biotinylated species was identified in 
the LysArginase treated sample (Figure 5.19B). One possible explanation for this observation 
might be a higher number of missed cleavages compared to the LysN digest. This could lead to 
peptide masses incompatible with the MS acquisition settings or to amino acid sequences with 
more MCS than those searched during database analysis. Such an increase in the proportion of 
MCS was observed for LysN but not for LysArginase (Figure 5.19E). Therefore, it is reasonable to 
assume that the reduced number of biotinylated peptides observed in the LysArginase digested 
samples was at least partially caused by other effects such as a charge state reduction of the 
biotin-containing peptides. Here, derivatization of the basic ε-amino group of lysine followed by 
LysArginase digestion might yield peptides containing only one primary amine at the N-
terminus. Although this peptide will be protonated in the acidic chromatography conditions, it 
might only be singly charged after electrospray ionization. Compared to that, LysN digestions 
might yield higher charge states as the phenomenon described above might be partially 
compensated by the increased peptide length and by the potential presence of internal arginine 
residues within the sequence. As singly charged precursor ions are not fragmented during 
proteomic MS data acquisition, reliable conclusions about a charge reduction in the biotinylated, 
LysArginase-derived peptides cannot be drawn. Therefore, additional experiments with 
fragmentation of singly charged precursor ions are required in order to investigate this 
hypothesis. Nevertheless, peptides comprising an N-terminal biotinylation were found after 
LysN digestion of biotinylated BSA, thus indicating the capability of this protease to cleave 
adjacent to this modification although the biotinylation-dependent increase in the proportion 
of MCS suggests a reduced cleavage efficiency (Figure 5.19D+E). Compared to that, approx. 95 % 
of the biotinylated peptides found after LysArginase digestion featured their modification at an 
internal lysine residue. The bias towards these peptides might also be explainable by the 
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hypothesized charge state reduction mentioned before. Here, peptides containing an internal 
biotinylated lysine feature two basic residues, one at the side chain of the N-terminal residue 
and the other at its α-amino group. Based on this, the precursor ion might be multiply charged 
after ESI, thus explaining its preferential detection compared to peptides featuring the 
modification at the N-terminus. 
Comparable to the observations made for BSA digestion, only slight biotinylation-dependent 
differences in proportion of MCS were detected for the LysArginase digested proteins from HEK 
293 lysate (Figure 5.20C). This finding indicates that the observations made for the digested BSA 
samples where not caused by a protein specific sequence effect but rather applies to a wide 
range of proteins, thus further supporting the hypothesis of a biotinylation-dependent charge 
state reduction of LysArginase derived peptides. In contrast, an increase in the number of missed 
cleavages as well as a reduced median protein sequence coverage was observed when 
comparing the biotinylated to non-biotinylated LysN digested samples (Figure 5.20C+D). This 
indicates a less efficient LysN cleavage adjacent to biotin-containing lysine residues similar to 
the observations made in the BSA biotinylation experiment (Figure 5.19E + Figure 5.20C). 
However, when comparing the BSA and the HEK protein samples digested with LysN, an increase 
in the mixture complexity was associated with a reduced proportion of identified, biotin-
containing peptides (Figure 5.19B + Figure 5.20A). Among those, approx. 80% featured their 
biotinylation site at an internal lysine thus indicating a stronger impairment of LysN’s cleavage 
adjacent to biotinylated residues in the complex peptide mixture compared to the BSA sample 
(Figure 5.19D + Figure 5.20B).  
In summary, LysN is able to cleave adjacent to biotinylated lysine residues but its cleavage is 
strongly impaired. Reliable conclusions about LysArginase’s cleavage ability at these modified 
residues cannot be drawn based on the potential charge state reduction of N-terminal 
biotinylated peptides. Nevertheless, both enzymes were used in the serial digestion workflow, 
as their primary task was to cleave N-terminal to PTM containing lysine residues. Any additional 
cleavage event adjacent to biotinylated lysines was assumed to increase the efficiency of the 
workflow. Lysine PTM containing peptides which featured a C-terminal arginine residue after 
tryptic digestion are assumed to be present in the supernatant after streptavidin incubation 
irrespective of LysN’s and LysArginase’s capability to cleave next to biotinylated lysine residues 
(see section 6.2.1 and Figure 5.16).  
6.2.1.4. Applying the complete serial digestion workflow does not lead to an enhanced 
identification of peptides containing methylated lysine residues 
As the serial digestion workflow was intended to enhance the identification of multiple different 
lysine modifications, the supernatant after streptavidin incubation was analyzed by a non-
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restrictive search algorithm in order to identify a range of unknown PTMs within the sample. 
Considering the biotinylated and non-biotinylated samples of the LysN and LysArginase groups 
at once, methylation was the most frequently reported lysine/arginine modification.  
In order to monitor the proportion of this PTM among the different samples taken at each step 
of the workflow, the corresponding raw data were analyzed by setting methylation at lysine and 
arginine as a dynamic modification in a classical database search (Table 5.11). The highest 
number of peptide identification was obtained after tryptic digestion of the protein mixture. 
Considering the sequential arrangement of the workflow, the next step comprised the 
biotinylation of the tryptic peptides. Here, an efficient removal of excess quenched NHS-biotin 
is crucial in order to prevent binding of free biotin to the streptavidin beads. Using the classical 
C18 reversed phase sample clean-up procedure after NHS-biotin treatment yielded a low 
binding efficiency of biotinylated peptides to the streptavidin beads (data not shown). This was 
probably caused by the inefficient removal of excess, free biotin during the C18 reversed phase 
sample clean-up. Size exclusion chromatography (SEC) also failed to deliver a good separation 
of peptides and compounds with a low molecular mass (data not shown). Among the different 
methods tested, SCX chromatography was identified as the most feasible sample clean-up 
procedure after NHS-based peptide biotinylation. However, SCX chromatography of the non-
biotinylated sample was associated with a tremendous reduction in the number of identified 
peptides. In case of the NHS-biotin treated samples, the loss after SCX chromatography was even 
higher. This indicates that the biotinylation of peptides’ α- and ε-amino groups influences the 
ability of the resulting secondary amine to get protonated in an acidic environment, thus altering 
the retention at the SCX stationary phase. In addition, the biotinylation independent 
identification loss observed after SCX chromatography-based sample clean-up demonstrates the 
limitation of this method in terms of the peptide recovery. Interestingly, the reduced number of 
peptide identifications after SCX chromatography was associated with an increased proportion 
of methylated peptides, indicating a weak increase in the number of identifications of this PTM 
by the chromatographic procedure. After SCX-chromatography of the non-biotinylated samples, 
an increased number of methylations were found at lysine and arginine residues. Compared to 
that, methylations were almost exclusively identified at arginine side chains among the 
biotinylated peptides after SCX chromatography-based sample clean-up. This suggests an 
interference of the NHS-biotin treatment and the detectability of lysine methylation. The 
usability of SCX chromatography for enhancing the identification of methylated peptides is 
already known. In 2012, the Acuto group performed a large scale analysis to identify arginine 
methylation sites by a cation exchange-based method (Uhlmann et al. 2012). Under acidic 
chromatography conditions, the authors aimed at separating modified from unmodified 
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peptides by using the higher positive charge state of arginine methylated peptides caused by 
the inefficiency of trypsin to cleave adjacent to this PTM containing residue (Uhlmann et al. 
2012). With this technique, they were able to detect 39 arginine methylation sites out of 4-6 mg 
starting material in four independent experiments (Uhlmann et al. 2012). Compared to that, 73-
101 methylarginine containing peptides were detected after SCX chromatography-based sample 
clean-up of the biotinylation and non-biotinylated mixtures within the present study by using 
only 1/80 of the amount of starting material. Here, the identification of peptide methylation was 
not restricted to the presence of a missed tryptic cleavage adjacent to the modified residue, as 
more than 60 % of all methylated peptides featured their modification at the C-terminus (Table 
5.12). Therefore, the SCX chromatography method applied in this study appears to be useful for 
enhancing the identification of methylated peptides irrespective of the presence of a missed 
cleavage site C-terminal of the PTM containing amino acid. Furthermore, the enhanced 
identification was not restricted to arginine methylations as also an increased number of 
methyllysines were detected in the non-biotinylated sample group after SCX chromatography-
based sample clean-up.  
The second digestion of the biotinylated and non-biotinylated peptides with LysN or LysArginase 
was associated with a reduction in peptide identifications compared to the singly digested 
samples (Table 5.11). This might have been caused by the protease-specific removal of C-
terminal basic amino acids thus potentially lowering the charge state of these peptides during 
ESI and influencing their detection during MS analysis compared to tryptic peptides. In addition 
to the reduced identification of total peptides after double digestion, a tremendous decline of 
detected peptide methylation was observed. One possible explanation for this observation 
might be the capability of trypsin to cleave C-terminal of monomethylated residues (Table 5.12). 
As the cleavage ability of LysN and LysArginase next to monomethylated residues has already 
been demonstrated, the second digestion step might remove the methylated amino acids 
located at the C-terminus of the peptide thus explaining the decline in the detection of peptide 
methylation in the double digested samples (Taouatas et al. 2010; Huesgen et al. 2015).  
Incubation of the biotinylated and non-biotinylated samples with streptavidin correlated with a 
reduced number of peptide identifications (Table 5.11). In case of the unbiotinylated sample, 
this might indicate an unspecific binding of non-biotin containing peptides to the streptavidin 
beads. Compared to the non-biotinylated samples, a tremendous reduction in the identification 
rate was observed when incubating the biotinylated peptides with streptavidin. This indicates a 
successful precipitation of biotinylated peptides by the streptavidin beads, although reliable 
conclusions about the completeness of the pull-down cannot be drawn based on these numbers. 
Additionally, this reduction indicates a successful biotinylation of the peptides by the NHS-ester 
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which was further verified by the detection of a high proportion of biotin-modified peptides in 
the complex samples (Figure 5.21). However, the reduced peptide complexity in the supernatant 
after depletion did not yield an enhanced identification of methylated peptides.  
In summary, the serial digestion workflow was not associated with an enhanced identification 
of lysine PTM containing peptides. However, the SCX chromatography conditions applied for 
sample clean-up yielded an increased number and proportion of detected lysine and arginine 
methylation (Table 5.11). Here, a reduction of the sample complexity is assumed to further 
improve the identification of these PTM-containing peptides. Therefore, peptide fractionation 
after or during SCX chromatography should be investigated as a strategy for improved 
methylation detection in proteomics.  
 
6.2.2. Nα-selective derivatization workflow  
As the application of the complete serial-digestion workflow was not associated with an 
increased identification of lysine modifications, a second method was tested. The Nα-selective 
derivatization workflow is based on the selective in vitro modification of peptides’ α-amino 
group, followed by NHS-based biotinylation of primary amines in the side chain of lysine and 
their subsequent pull-down by streptavidin beads. Here, an efficient selective derivatization of 
the α-amino group was assumed to be the bottleneck reaction during this workflow. 
Transamination, acetylation and reductive alkylation have already been described as Nα-
selective derivatization methods in different proteomic or peptide-based approaches 
(Sonomura et al. 2011; Mikami et al. 2012; Chen et al. 2017). Therefore, these techniques were 
selected and tested regarding their selectivity and efficiency under the experimental conditions 
used within the present study. In addition to the methods mentioned above, peptides were also 
propionylated by using propionic anhydride according to the procedure originally described for 
Nα-selective acetylation (Mikami et al. 2012). This method was used as in vitro acetylation by 
acetic acid anhydride might be indistinguishable from endogenous protein acetylation.  
6.2.2.1. Reductive alkylation is a highly selective and efficient method for derivatization of 
α-amino groups 
The different derivatization methods were tested regarding their reactivity by using a synthetic 
peptide containing an internal lysine residue as a reactant (Figure 5.23). The expected mass 
shifts were observed after applying the different methods to the peptide. In addition to that, 
the peptide transamination experiment yielded an additional mass shift of 74 m/z probably 
caused by an unspecific side reaction. This side reaction might reflect the high reactivity of the 
N-terminal carbonyl group generated by this derivatization method (Dixon and Fields 1972). 
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Based on this observation, in vitro transamination is not feasible for a derivatization of peptides 
in MS approaches as unknown side products impair peptide detection in large scale MS 
experiments. Therefore, this method was not further investigated within the present study. In 
contrast, peptide derivatization with the other methods was associated with the detection of 
one to two potential modification sites. After incubation with NHS-biotin, the doubly derivatized 
peptides were not found to be biotinylated, thus indicating the derivatization of both, the α- and 
the ε-amino group. In addition to that, NHS-biotin treatment of the derivatized samples yielded 
peptides featuring one derivatization and one biotinylation site. This suggest the presence of 
one primary amine group after applying the different derivatization methods and prior to the 
biotinylation process. However, mapping of the different modification sites to specific amino 
acids was not possible based on the MS1 data acquired with MALDI-TOF MS. Additionally, the 
findings obtained by analyzing the synthetic peptide might not be transferable to the plethora 
of peptides generated in a bottom-up MS experiment. Hence, the acetylation, propionylation 
and reductive alkylation method were applied to peptides of HEK proteins digested with trypsin. 
Selectivity, efficiency and reproducibility were investigated by LC-MS2 measurements.  
The percentage of MS2 spectra successfully matched to a peptide sequence (PSMs) were almost 
identical between the different derivatization techniques and the input (Table 5.13). This 
indicates that unexpected side reactions were not highly abundant after applying the 
derivatization technique to the HEK peptides.  
Compared to the non-derivatized input, a higher number of peptides were identified in the 
derivatized sample groups (Figure 5.24). This might be attributed to multiple reasons. For 
example, reductive alkylation, propionylation and acetylation might alter the chromatographic 
behavior of peptides during LC thus rectifying the elution pattern throughout the gradient 
leading to a less complex peptide mixture entering the spectrometer at a given time point. 
Especially the addition of the phenyl-group during reductive alkylation with benzaldehyde is 
expected to increase the hydrophobicity of the peptides which then leads to a delayed elution 
in reversed-phase chromatography. Another possibility might be the occurrence of varying 
numbers of modifications at one specific amino acid residue. Peptides found as being singly and 
doubly modified at the N-terminus will be listed twice in the output table. At least for reductive 
alkylation, such a double modification of the N-terminus has already been described (Chen et al. 
2017). A third reason for the increased number of identifications might be an incomplete 
derivatization of peptides. In this case, the peptide sequence will be identified as unmodified 
and modified during database analysis, thus yielding two entries in the output table.  
Among the three derivatization methods tested, reductive alkylation yielded the highest 
proportion of derivatized peptides (Figure 5.24). So far, little is known about the efficiency of 
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anhydride based Nα-selective derivatization of complex peptide mixtures. In the original paper 
in which the acidic anhydride-based derivatization method was described, the authors tested 
the efficiency on Cytochrome C derived peptides (Mikami et al. 2012). Although they reported 
an efficient modification of peptides, this observation might be difficult to extrapolate to more 
complex samples (Mikami et al. 2012). In peptides derived from one single, low molecular mass 
protein, only a limited number of different amino acids are present at the N-termini. Compared 
to that, proteolytic digestion of a complex sample yields a more representative peptide mixture 
thus allowing more reliable conclusions about the reactivity of a derivatization method. This 
might explain the difference in the acetylation efficiency detected by Mikami et al. (2012) and 
in the present study. Additionally, one has to keep in mind that a distinction between in vitro 
and endogenous acetylation sites is not possible when using acetic acid anhydride for the 
derivatization procedure. Therefore, endogenous acetylation sites might have increased the 
number of acetylated peptides detected in this experiment. However, their contribution to the 
total number of detected acetylated peptides is expected to be rather low as these endogenous 
modifications are usually only found in minor amounts without prior enrichment in shotgun 
proteomics. Nevertheless, in order to prevent this bias, the propionylated data set might yield 
more comprehensive results regarding the derivatization efficiency. Here, the proportion of 
derivatized peptides was lower compared to the acetylated sample group. This was probably 
not only caused by the endogenous acetylation sites raising the proportion of acetylated 
peptides but also by derivatization-based differences in behavior during LC and ESI. 
Sequence comparison of the derivatized peptides identified among the three technical 
replicates indicates a high reproducibility of each individual method (Figure 5.25). Importantly, 
the three derivatization techniques featured a high selectivity towards modification of the α-
amino group (Figure 5.26).  
Among the different methods tested, reductive alkylation was the only derivatization technique 
yielding a high reproducibility, efficiency and Nα-selectivity. Therefore, this method was used in 
order to investigate the derivatization-based workflow for enhancing PTM identification.  
6.2.2.2. Applying the complete Nα-selective derivatization workflow enhances the 
identification of arginine but not of lysine methylated peptides 
Similar to the procedure described for the serial digestion method, the MS data of the 
derivatized and streptavidin incubated samples were used for database analysis using an 
unrestricted PTM search in order to get an overview about the different potential modifications 
present after applying the complete workflow. Among the different modifications reported by 
the algorithm in the NHS-biotin treated samples, 1.3-1.5 % of the peptides featured a 
methylation site either at lysine or arginine residues (Table 5.14). In case of these samples, 
6 Discussion 
169 
 
methylation was almost exclusively detected at arginine side chains. Compared to that, 
methyllysine containing peptides were more abundant than methylation at arginine residues in 
the non-biotinylated samples. For monitoring the proportion of these PTMs at the different 
steps of the workflow, each sample taken during the validation study of the method was 
analyzed in a classical database search by setting lysine and arginine methylations as dynamic 
modifications.  
Starting with the highest number of identifications directly after tryptic digestion of proteins 
from HEK 293 cell lysate, each additional step in the workflow was associated with a decline in 
the number of peptide detections (Figure 5.28, table 5.15). Interestingly, this reduction was not 
uniform throughout the different peptide species. Compared to the non-biotinylated sample 
(without SCX chromatography-based sample clean-up), the peptide mixture modified with NHS-
biotin and desalted via SCX chromatography featured a tremendous loss of lysine containing 
species (Figure 5.28). As the number of arginine containing peptides was nearly identical 
between these samples, this finding indicates alterations in the retention of biotinylated 
peptides during SCX chromatography. Direct comparison of the number of peptide 
identifications after SCX chromatography of biotinylated and non-biotinylated samples further 
supports this biotinylation effect (Table 5.15). As already discussed in sections of the serial 
digestion workflow, this phenomenon might be ascribed to the influence of the biotinylation on 
the ability of the amine group to get protonated under the acidic conditions used in this study.  
Similar to the observations made in the serial digestion workflow, SCX chromatography was 
associated with an increased detection of methylated peptides (Table 5.15). Whereas the NHS-
biotin treated samples featured only an increase in methylarginine containing peptides, a higher 
number of methylated peptides was identified at lysine and arginine residues in case of the non-
biotinylated samples. Incubation with streptavidin was not associated with huge changes in the 
proportions of peptide methylations identified for the single sample groups. The missing 
improvement of methyllysine identification in the NHS-biotin treated, streptavidin incubated 
samples was surprising as peptides featuring this PTM were found in the non-biotinylated 
samples, thus indicating their potential detectability. It is reasonable to assume that the missing 
identification of these peptides was probably not caused by the introduction of missed cleavage 
sites next to methylated lysine residues. Such an MCS would have resulted in the formation of 
peptides with an internal methylated and a C-terminal, unmodified lysine residue. Although this 
peptide would have been biotinylated by the NHS-biotin treatment, it should have been 
detectable in the non-streptavidin incubated sample group but here, methyllysine containing 
peptides were only found in minor proportions. Therefore, this observation might rather 
indicate a side reaction occurring at monomethylated lysine residues after incubation with NHS-
6 Discussion 
170 
 
biotin. If the NHS-ester were able to react with the secondary amine present at the 
monomethylated lysine residue, such a peptide would not have been identified during database 
analysis as this mass shift was not set as a variable modification. Besides that, biotinylation at 
monomethylated lysine residues would also lead to a depletion of these peptides during 
streptavidin incubation. This would dramatically affect the usability of the present workflow for 
enhancing the identification of this PTM. A preliminary database analysis of the biotinylated and 
non-biotinylated samples after SCX chromatography with a mass shift of 240 m/z (biotinylation 
+ methylation) set as a variable modification at lysine residues was associated with the 
identification of up to 105 high confident peptide groups featuring this modification (data not 
shown). Here, the modification was predominantly found in biotinylated samples suggesting 
that at least some of these peptides are true identifications. However, as this modification is not 
commonly searched in MS data analyses, further verification of the identifications is required in 
order to validate the reactivity of the NHS-ester with monomethylated lysine side chains.  
Applying the complete derivatization workflow to a peptide mixture was associated with an 
increase in the detection of methylarginines which were identified with a high reproducibility 
among the different replicates (Figure 5.30). An improvement in the identification of arginine 
modifications was expected as the sample complexity was reduced by the biotinylation and 
depletion of unmodified lysine containing peptides. However, a similar effect was achieved by 
SCX chromatography of the biotinylated and non-biotinylated sample which also resulted in an 
increased identification of monomethylated peptides. This demonstrates the applicability of the 
SCX chromatography-based sample clean up procedure for enhancing the identification of these 
peptides. Possible steps for further improving the SCX chromatography-associated increase in 
the number of identifications of methylated peptide have already been described in section 
6.2.1.4. In addition to that, utilization of SCX columns with a higher capacity might further 
enhance the identification rate as additional peptides were detected when applying a second 
round of sample clean-up with the flow through of the first chromatographic step (data not 
shown). 
The methylated peptides found in the different steps during the workflow (applied to a complex 
peptide mixture) were compared in order to investigate their redundancy. This comparison 
revealed only a partial overlap among the methylated peptides found at the different steps of 
the workflow (Figure 5.29). In case of methylarginines, it might therefore be beneficial to 
investigate the biotinylated samples before and after streptavidin incubation to get the most 
comprehensive methylation data set. Due to the potential interference of the NHS-biotin 
treatment with monomethylated lysine residues, the highest yield of unique identifications of 
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methyllysine containing peptides might be achieved by SCX-chromatography without 
biotinylation.  
 
6.2.3. SCX chromatography increases the identification of unique methylated 
peptides in a large-scale analysis 
The utilization of SCX chromatography for enhancing the identification of methylated peptides 
has been described in the previous sections dealing with the serial digestion and the 
derivatization-based workflows. However, the starting material desalted by the SCX 
chromatography-based method differed between these two techniques, as the derivatization 
workflow comprised an Nα-selective reductive alkylation of the peptides prior to the NHS-
treatment. Therefore, SCX chromatography of these samples was assumed to yield different 
peptide populations as the physicochemical properties might be altered depending on the 
derivatization/biotinylation/modification status. Therefore, methylated peptide species 
identified in the single samples were compared regarding their redundancy (Figure 5.31). For 
lysine methylations, the highest number of modified peptides is obtainable by analyzing non-
biotinylated samples with and without reductive alkylation of the α-amino group. Here, many of 
the identified methylated peptides were non-redundant between the workflows even after 
stringent filtering of peptides that only occurred in single replicates. In case of methylarginine, 
all samples featured a unique set of modified peptides. Taken together, this would justify the 
utilization of all four strategies to obtain the most comprehensive result. Additionally, one has 
to consider the unique methylarginine containing peptides identified after applying the 
complete Nα-derivatization workflow, thus adding an additional layer of analysis for the 
achievement of detailed methylation data sets.  
Among the samples featuring an increased identification of methyllysines, 109-212 peptides 
with lysine monomethylation sites were identified within the present study by using only 50 µg 
of derivatized or non-derivatized peptides as starting material. In 2013, Cao et al. detected 323 
monomethylated sites (at lysine) in an antibody-based large scale approach. However, the 
authors used 20 mg protein as starting material and did an SCX chromatography-based 
fractionation of the peptide samples after the enrichment (Cao et al. 2013). In a similar 
approach, Guo et al. (2014) identified 234 monomethylated peptides (at lysine) by 
immunoaffinity purification (10 mg protein starting material). Compared to these studies, the 
afore-mentioned number of methylated peptides detected in the study presented here without 
method optimization and with the low amount of starting material is remarkable. Fine tuning of 
the single steps is assumed to improve the identification even further.  
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In samples with an increased methylarginine detection, 73-118 peptides have been identified to 
contain a methylated arginine residue. These numbers are comparable to those obtained by 
Uhlmann et al. (2012) in a large-scale arginine methylation analysis performed on T-cells. Here, 
the authors identified 39, 66 and 215 arginine methylation sites by SCX-, IEF- and HILIC-based 
enrichment/fractionation methods, respectively. In an antibody based approach, Guo et al. 
(2014) identified 2053 monomethylarginine containing peptides. However, the authors used 
10 mg of proteins as a starting material which is 200 times more than the amount of derivatized 
or non-derivatized peptides used in this study. Considering the potential increase in detection 
of methylarginine containing peptides after method improvement, the procedures presented 
here might be a valuable alternative for large-scale methylation studies with limited amount of 
starting material.  
 
6.2.4. A potential workflow for comprehensive analysis of protein lysine and arginine 
methylation  
Considering all aspects mentioned in the previous sections, a potential workflow for the 
comprehensive analysis of protein methylation would start with trypsin digestion of the protein 
mixture (Figure 6.1). A subfraction of this tryptic digest is directly used for SCX chromatography 
followed by LC-MS2 analysis. The remaining peptide mixture is split into two groups. Here, one 
group is treated with NHS-biotin prior to SCX-based sample clean-up and MS analysis. Compared 
to that, the second group of the tryptic peptides is derivatized at their α-amino groups by 
reductive alkylation. Afterwards, these peptides are split again into two parts, one of which is 
biotinylated and the other one remaining unbiotinylated. After SCX chromatography of both of 
these parts, the non-biotinylated peptides and a small fraction of the NHS-biotinylated sample 
are analyzed by LC-MS2. Additionally, the remaining biotinylated peptides are incubated with 
streptavidin before they are also used for MS-based analysis of peptide methylation. After the 
database search, the methylation sites identified by the different samples can be integrated and 
are assumed to yield a comprehensive overview of the occurrence of this PTM at lysine and 
arginine side chains within different proteins. Besides its standalone application, this workflow 
could also be used in combination with enrichment strategies for other PTMs thus potentially 
contributing to the identification of PTM-crosstalk. 
6 Discussion 
173 
 
 
Figure 6.1:  Overview of a workflow suggested for the comprehensive analysis of protein methylation sites.   
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7. Appendix 
 
7.1 Phosphoproteomic data 
 
7.1.1. Phosphoproteomic analysis of samples from whole cell lysate after Torin1 
treatment 
 
Figure 7.1:  Phosphopeptide enrichment from whole cell lysate digest (Torin1 vs. DMSO).  
TiO2-based phosphopeptide enrichment was performed with peptides derived from tryptic digestion of whole cell 
lysate. Phosphopeptides were fractionated via SCX chromatography prior to LC-MS2 measurement. The experiment 
was performed in three biological replicates. Raw data were analyzed using the MaxQuant software. Statistical 
analysis (Torin1 vs DMSO) was either performed on phosphopeptides found in at least two out of three replicates 
(left, adjusted p-value threshold 0.05) or on the complete peptide data set (right, adjusted p-value threshold 0.15) by 
using the limma package implemented in an R-script.  
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7.1.2. Phosphoproteomic analysis of samples from whole cell lysate after FSK/db-
cAMP treatment by using the complete peptide data set 
 
Figure 7.2:  Phosphopeptide enrichment from whole cell lysate digest (FSK/db-cAMP vs. DMSO, complete data set).  
TiO2-based phosphopeptide enrichment was performed with peptides derived from tryptic digestion of whole cell 
lysate. Phosphopeptides were fractionated via SCX chromatography prior to LC-MS2 measurements. The experiment 
was performed in three biological replicates. Raw data were analyzed using the MaxQuant software. Statistical 
analysis (FSK/db-cAMP vs DMSO) was performed on the complete peptide data set (adjusted p-value threshold 0.15) 
by using the limma package implemented in an R-script. 
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7.1.3. Phosphoproteomic analysis of samples from the lysosomal soluble fraction 
after Torin1 treatment 
 
Figure 7.3:  Phosphopeptide enrichment from lysosomal soluble fraction (Torin1 vs. DMSO).  
Lysosomes from isotopically labeled cells were enriched and subsequently separated into a water soluble and 
membrane fraction. After tryptic digestion, phosphopeptide enrichment was performed by TiO2. The experiment was 
performed in three biological replicates. Phosphopeptides derived from the soluble fractions were analyzed with an 
LTO Orbitrap Velos mass spectrometer. Raw data were searched against a human reference database by using the 
Mascot search engine. Statistical analysis (Torin1 vs DMSO) was either performed on phosphopeptides found in at 
least two out of three replicates (left, adjusted p-value threshold 0.05) or on the complete peptide data set (right, 
adjusted p-value threshold 0.15) by using the limma package implemented in an R-script.  
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7.1.4. Phosphoproteomic analysis of samples from the lysosomal soluble fraction 
after FSK/db-cAMP treatment 
 
Figure 7.4:  Phosphopeptide enrichment from lysosomal soluble fraction (FSK/db-cAMP vs. DMSO).  
Lysosomes from isotopically labeled cells were enriched and subsequently separated into a water soluble and 
membrane fraction. After tryptic digestion, phosphopeptide enrichment was performed by TiO2. The experiment was 
performed in three biological replicates. Phosphopeptides derived from the soluble fractions were analyzed with an 
LTO Orbitrap Velos mass spectrometer. Raw data were searched against a human reference database by using the 
Mascot search engine. Statistical analysis (FSK/db-cAMP vs DMSO) was either performed on phosphopeptides found 
in at least two out of three replicates (left, adjusted p-value threshold 0.05) or on the complete peptide data set 
(right, adjusted p-value threshold 0.15) by using the limma package implemented in an R-script. 
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7.1.5. Phosphoproteomic analysis of samples from the lysosomal membrane fraction 
after Torin1 treatment 
 
Figure 7.5:  Phosphopeptide enrichment from lysosomal membrane fraction (Torin1 vs. DMSO). 
Lysosomes from isotopically labeled cells were enriched and subsequently separated into a water soluble and 
membrane fraction. After tryptic digestion, phosphopeptide enrichment was performed by TiO2. The experiment was 
performed in three biological replicates. Phosphopeptides derived from the membrane fractions were analyzed with 
an Orbitrap Fusion Lumos mass spectrometer. Raw data were searched against a human reference database by using 
the Mascot search engine. Statistical analysis (Torin1 vs DMSO) was either performed on phosphopeptides found in 
at least two out of three replicates (left, adjusted p-value threshold 0.05) or on the complete peptide data set (right, 
adjusted p-value threshold 0.15) by using the limma package implemented in an R-script. 
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7.1.6. Phosphoproteomic analysis of samples from the lysosomal membrane fraction 
after FSK/db-cAMP treatment by using the complete peptide data set 
 
Figure 7.6:  Phosphopeptide enrichment from lysosomal membrane (FSK/db-cAMP vs. DMSO, complete data set).  
Lysosomes from isotopically labeled cells were enriched and subsequently separated into a water soluble and 
membrane fraction. After tryptic digestion, phosphopeptide enrichment was performed by TiO2. The experiment was 
performed in three biological replicates. Phosphopeptides derived from the membrane fractions were analyzed with 
an Orbitrap Fusion Lumos mass spectrometer. Raw data were searched against a human reference database by using 
the Mascot search engine. Statistical analysis (FSK/db-cAMP vs DMSO) was performed on the complete peptide data 
set (adjusted p-value threshold 0.15) by using the limma package implemented in an R-script. 
 
 
 
 
 
 
 
 
 
 
7 Appendix 
180 
 
7.2 2D-gel electrophoresis of FSK/db-cAMP and DMSO treated sample 
 
Figure 7.7:  Immune detection of SNAPIN after 2D-gelelectrophoresis and Western Blot in FSK/db-cAMP and DMSO 
treated samples.  
The SNAPIN signals depicted here are derived from the same analysis as the one shown in section 5.1.3.3 (first 
replicate, FSK/db-cAMP and DMSO samples). The only difference between figure 7.7 and figure 5.6A is that the signals 
of both samples shown in figure 7.7 were detected with the same exposure time (Exposure time FSK/db-cAMP sample 
and DMSO control: 3 min).  
 
7.3 SNAPIN KO via CRISPR-Cas9 
 
7.3.1. Alignment of the sequencing reads to the reference sequence for HEK 293 
SNAPIN KO clone A7 
 
Figure 7.8:  Detailed analysis of HEK 293 SNAPIN KO clone A7. 
KO cells were generated with the CRISPR-Cas9 method. Monoclonal cell populations were prepared, and the KO was 
validated by NGS. Sequencing data were analyzed with the “outknocker” web-tool (Schmid-Burgk et al. 2014). Here, 
the alignment of the sequencing reads to the reference sequence is shown for HEK 293 SNAPIN KO clone A7. 
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7.3.2. Alignment of the sequencing reads to the reference sequence for HeLa SNAPIN 
KO clon A12 
 
Figure 7.9:  Detailed analysis of HeLa SNAPIN KO clone A12.  
KO cells were generated with the CRISPR-Cas9 method. Monoclonal cell populations were prepared, and the KO was 
validated by NGS. Sequencing data were analyzed with the “outknocker” web-tool (Schmid-Burgk et al. 2014). Here, 
the alignment of the sequencing reads to the reference sequence is shown for HeLa SNAPIN KO clone A12. 
 
7.4 PCA plot proteome comparison 
 
Figure 7.10:  PCA plot of proteome comparison samples.  
The colors represent the different treatments and genotypes investigated in the present study. Isotopically labeled 
whole cell protein samples were digested and analyzed by LC-MS2. Data processing was performed with PD. 
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7.5 pCMV6_SNAPIN vector map 
 
Figure 7.11:  Vector map of the pCMV6_SNAPIN plasmid obtained from Origene (Rockville, USA).  
Image source: https://www.origene.com/drawmapbysku?SKU=RC202602 
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